Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,glutamate receptor activity (GO:0008066),-0.816729123957956,-2.3547365733327204,0.0,0.0,0.0,14/19,12.16%,GRM5;GRM1;GRIA4;GRM8;GRIA1;GRIK1;GRIA2;GRID2;GRIK2;GRM3;GRIK5;GRID1;GRIK3;GRIN2D
prerank,ligand-gated channel activity (GO:0022834),-0.7144630025964332,-2.315767938336519,0.0,0.0,0.0,16/29,12.16%,GRIN2A;GRIA4;GRIN2B;GRIA1;GRIK1;GRIA2;GRIN3A;GRID2;GRIK2;GRIN1;GABRB1;GRIK5;GRIA3;GRID1;GRIK3;GRIN2D
prerank,ligand-gated ion channel activity (GO:0015276),-0.7144554119886674,-2.2986727558683935,0.0,0.0,0.0,16/30,12.16%,GRIN2A;GRIA4;GRIN2B;GRIA1;GRIK1;GRIA2;GRIN3A;GRID2;GRIK2;GRIN1;GABRB1;GRIK5;GRIA3;GRID1;GRIK3;GRIN2D
prerank,transmitter-gated ion channel activity (GO:0022824),-0.676275650033732,-2.174703307011525,0.0,0.0013717568296630536,0.004,16/29,13.79%,GABRB3;GRIA4;GRIK1;GRIA2;GLRA3;GRID2;GRIK2;GABRA2;GABRB1;GRIK5;GABRA3;GABRG3;GRID1;GRIK3;GRIN2D;GABRA4
prerank,sodium channel activity (GO:0005272),-0.6156048471112141,-2.1089304224102596,0.0,0.004389621854921771,0.019,17/37,21.22%,HCN1;GRIK1;SCN2A;GRIK2;SCN1B;GRIK5;SCN9A;CACNA1G;HCN2;GRIK3;PKD2;PKD2L1;SCN8A;CACNA1I;KCNK1;SCN4B;SCN1A
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.6710525260483419,-2.0620721647680305,0.0,0.005304126408030474,0.028,3/21,1.76%,GRM5;GRM1;GRIA1
prerank,voltage-gated cation channel activity (GO:0022843),-0.4806848247567284,-2.0440579068920415,0.0,0.005487027318652214,0.034,35/97,17.77%,KCNMA1;KCND2;CACNA2D3;CACNB2;GRIN2A;HCN1;CACNA1E;GRIN2B;KCNH7;KCNC2;CACNA1C;KCNB2;OPRM1;GRIN3A;CACNB4;KCNH1;KCNC1;GRIN1;CACNG4;KCNC3;CACNA2D2;KCNQ2;HCN2;KCNH8;PKD2;GRIN2D;NCS1;HVCN1;CACNA2D1;CACNG3;CACNG2;CACNB1;KCNG2;CACNA1I;KCNK1
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.7137231755375457,-1.985824891372353,0.0,0.010151000539506596,0.07,13/17,12.16%,GRIN2A;GRIA4;GRIN2B;GRIA1;GRIK1;GRIA2;GRIN3A;GRIK2;GRIN1;GRIK5;GRIA3;GRIK3;GRIN2D
prerank,sialyltransferase activity (GO:0008373),-0.6778920036410098,-1.9509484691527743,0.0,0.014754006790153732,0.112,13/20,13.93%,ST3GAL6;ST6GALNAC3;ST8SIA6;ST3GAL5;ST3GAL2;ST6GALNAC5;ST6GALNAC4;ST8SIA1;ST8SIA5;ST6GAL2;ST8SIA3;ST6GAL1;ST6GALNAC6
prerank,ligand-gated cation channel activity (GO:0099094),-0.4731021279261893,-1.9457518521729704,0.0,0.014376011574868803,0.12,21/75,13.82%,GRIN2A;GRIA4;GRIN2B;GRIA1;GRIK1;GRIA2;GRIN3A;GRIK2;KCNJ2;GRIN1;TRPM4;KCNK6;KCNJ3;GRIK5;GRIA3;TRPM2;KCNJ9;MCOLN1;GRIK3;GRIN2D;KCNN2
prerank,lipase activity (GO:0016298),0.7158665047616345,1.9439086046763097,0.0,0.01745824871942533,0.014,5/43,1.78%,DDHD1;CEL;LIPA;LIPG;MGLL
prerank,transforming growth factor beta receptor binding (GO:0005160),-0.673000056629423,-1.9311805119114702,0.0,0.01616178955675743,0.144,8/18,12.28%,SMAD3;TGFBR2;TGFBR1;ENG;SMAD7;TGFB2;FERMT2;SMAD2
prerank,voltage-gated potassium channel activity (GO:0005249),-0.48055697798050506,-1.901841688808034,0.0,0.020576352444945805,0.184,18/80,11.96%,KCNMA1;KCND2;HCN1;KCNH7;KCNC2;KCNB2;KCNH1;KCNK2;KCNC1;KCNJ2;KCNK6;KCNJ3;KCNC3;KCNJ9;KCNQ2;HCN2;KCNH8;PKD2
prerank,chemoattractant activity (GO:0042056),0.7498581606348199,1.8968521155896128,0.0,0.02570242172582063,0.043,4/26,3.00%,GPNMB;LGALS3;VEGFA;HGF
prerank,ion channel activity (GO:0005216),-0.4683640623873418,-1.893088788079209,0.0,0.0210195354206831,0.202,28/80,12.16%,TRPM3;GRIN2A;GRIA4;GRIN2B;GRIA1;GRIK1;GRIA2;TRPC1;GRIN3A;GRID2;UNC80;GRIK2;TMEM63B;GRIN1;TRPM4;GABRB1;GRIK5;GRIA3;NALCN;TRPM2;GRID1;MCOLN1;LRRC8A;TMEM120A;TMC4;GRIK3;PKD2;GRIN2D
prerank,monocarboxylic acid binding (GO:0033293),0.7983310773903716,1.866952756450517,0.0,0.03329999292779277,0.086,5/18,6.24%,PSAP;PYGL;RXRA;RARA;NR1H4
prerank,cholesterol binding (GO:0015485),0.6743752764941846,1.8566753263728881,0.0,0.03127936228897039,0.106,12/47,8.31%,OSBPL8;SOAT1;ABCA1;GRAMD1B;NPC1;ABCG1;OSBPL1A;VDAC2;NR1H3;STARD5;SCARB2;GRAMD1C
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.8000011721739629,1.842035120064978,0.0,0.02667232443245537,0.133,10/16,13.40%,ATP6V0D2;ATP6V1A;ATP6V1C1;TCIRG1;ATP6V0D1;ATP6V1B2;ATP6V0A1;ATP6V0E1;ATP6V0C;ATP6V0B
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.8000011721739629,1.842035120064978,0.0,0.02667232443245537,0.133,10/16,13.40%,ATP6V0D2;ATP6V1A;ATP6V1C1;TCIRG1;ATP6V0D1;ATP6V1B2;ATP6V0A1;ATP6V0E1;ATP6V0C;ATP6V0B
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.7523075158932855,1.8395203889896425,0.0,0.02410901013634927,0.139,11/22,13.40%,ATP6V0D2;ATP6V1A;ATP6V1E1;ATP6V1C1;TCIRG1;ATP6V0D1;ATP6V1B2;ATP6V0A1;ATP6V0E1;ATP6V0C;ATP6V0B
prerank,voltage-gated sodium channel activity (GO:0005248),-0.5976447950209176,-1.8187635034432919,0.0,0.04663973220854382,0.419,13/22,25.52%,HCN1;SCN2A;SCN1B;SCN9A;CACNA1G;HCN2;PKD2;SCN8A;CACNA1I;SCN4B;SCN1A;HCN3;SCN2B
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.6173413014133453,-1.8018902059472481,0.0034602076124567475,0.05238282080206647,0.482,10/19,13.79%,GRIK1;GRID2;GRIK2;GABRA2;GRIK5;GABRA3;GABRG3;GRID1;GRIK3;GABRA4
prerank,sterol transfer activity (GO:0120015),0.7764104421767168,1.7887194209649855,0.0014388489208633094,0.05734549752977904,0.331,6/17,8.31%,ABCA1;GRAMD1B;ABCG1;PLTP;STARD5;GRAMD1C
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.8131196888126832,1.7796228527015312,0.0,0.05970289994173848,0.376,3/14,5.06%,DHRS3;AKR1A1;RDH12
prerank,cholesterol transfer activity (GO:0120020),0.782572748149915,1.7751717392054034,0.0014749262536873156,0.058679113751401814,0.405,6/16,8.31%,ABCA1;GRAMD1B;ABCG1;PLTP;STARD5;GRAMD1C
prerank,GTPase inhibitor activity (GO:0005095),0.8058071376054112,1.7549672372929463,0.001447178002894356,0.07776856247744011,0.522,4/13,2.00%,IQGAP2;IQGAP1;IPO5;GPS1
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.6485611777635424,-1.7518335507065976,0.003246753246753247,0.07378437912022918,0.639,6/16,4.36%,PTPRD;PTPRM;PTPRT;PTPRG;PTPRO;PTPRN2
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.6485611777635424,-1.7518335507065976,0.003246753246753247,0.07378437912022918,0.639,6/16,4.36%,PTPRD;PTPRM;PTPRT;PTPRG;PTPRO;PTPRN2
prerank,triglyceride lipase activity (GO:0004806),0.741422033830641,1.7448589849404765,0.0027739251040221915,0.0817951282595298,0.57,2/20,1.07%,CEL;LIPG
prerank,water transmembrane transporter activity (GO:0005372),0.8005660778672178,1.7403329554166032,0.007692307692307693,0.08162104315833894,0.597,1/11,1.90%,AQP1
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.5365272909346306,-1.7391020518373854,0.004608294930875576,0.07846449065672667,0.674,10/28,13.79%,GRIK1;GRID2;GRIK2;GABRA2;GRIK5;GABRA3;GABRG3;GRID1;GRIK3;GABRA4
prerank,serine-type endopeptidase activity (GO:0004252),0.5893022636687641,1.7130366343717611,0.0,0.11673471861996701,0.751,15/80,9.79%,F7;CD5L;PCSK4;KLK3;TMPRSS4;HGF;F11;RHBDF2;HTRA2;F10;PROC;CTSH;HP;HPR;PLAU
prerank,amino acid transmembrane transporter activity (GO:0015171),0.6324414662811039,1.6953970578351387,0.0,0.13720890289859466,0.832,11/47,7.56%,SLC7A2;SLC6A6;SLC36A2;SLC36A4;SLC43A2;SLC38A6;SLC1A5;SLC7A4;SLC7A7;SLC38A1;SLC38A7
prerank,cation transmembrane transporter activity (GO:0008324),0.6240634052760363,1.693521638230824,0.002325581395348837,0.13245233837480677,0.838,12/48,8.78%,SLC7A2;SLC6A6;ATP1B4;SLC36A2;SLC36A4;SLC38A6;SLC1A5;SLC8B1;SLC38A1;MFSD12;SLC38A7;MMGT1
prerank,sterol binding (GO:0032934),0.5986603470018783,1.6875834264101182,0.0022988505747126436,0.1346453169210581,0.859,12/56,8.31%,OSBPL8;SOAT1;ABCA1;GRAMD1B;NPC1;ABCG1;OSBPL1A;VDAC2;NR1H3;STARD5;SCARB2;GRAMD1C
prerank,phospholipase inhibitor activity (GO:0004859),0.800087983850918,1.6715117782549869,0.006349206349206349,0.15954899524141483,0.917,4/10,5.73%,ANXA4;ANXA1;ANXA5;ANXA2
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.6589230403027783,1.669015033898423,0.0025412960609911056,0.15533757559418504,0.919,9/32,7.56%,SLC6A6;SLC36A2;SLC36A4;SLC43A2;SLC38A6;SLC1A5;SLC38A1;MFSD12;SLC38A7
prerank,ligand-gated calcium channel activity (GO:0099604),-0.5589415735544296,-1.6501684650767772,0.025,0.16022119770464466,0.906,9/19,12.16%,GRIN2A;RYR3;GRIN2B;RYR2;GRIN1;TRPM4;TRPM2;MCOLN1;GRIN2D
prerank,ferrous iron binding (GO:0008198),0.6787162209869763,1.645746611641986,0.012096774193548387,0.1994604916194344,0.964,10/21,17.14%,CDO1;FTL;ACP5;HEPH;TET2;EGLN3;FTO;FECH;ALKBH1;FTH1
prerank,serine-type peptidase activity (GO:0008236),0.5527573927553342,1.6420946541975068,0.002171552660152009,0.1989686123896411,0.97,16/96,9.79%,F7;CD5L;PCSK4;TPP1;KLK3;TMPRSS4;HGF;F11;RHBDF2;HTRA2;F10;PROC;CTSH;HP;HPR;PLAU
prerank,ligand-gated anion channel activity (GO:0099095),-0.5803360203027818,-1.6402070914329732,0.02572347266881029,0.1626903599980382,0.919,8/17,8.97%,GABRB3;GLRB;GLRA3;GABRA2;GABRB1;GABRA3;GLRA1;GABRG3
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.7392551652194838,1.6327117822080142,0.011560693641618497,0.21271729815966472,0.981,4/13,3.73%,ERN1;VEGFA;ITGA5;PDGFA
prerank,transmembrane receptor protein kinase activity (GO:0019199),-0.4220018546389441,-1.630397983576249,0.009009009009009009,0.16701466009916646,0.937,15/60,9.03%,ERBB4;EPHA5;ACVR1;CSF1R;NTRK3;EPHA6;TGFBR2;RYK;EPHA3;FGFR2;NTRK2;FLT3;EGFR;IGF1R;EPHA7
prerank,voltage-gated calcium channel activity (GO:0005245),-0.45571880130310743,-1.628127531819979,0.014150943396226415,0.16256565483170515,0.942,16/37,17.02%,CACNA2D3;CACNB2;CACNA1E;CACNA1C;OPRM1;CACNB4;CACNG4;CACNA2D2;CACNA1G;PKD2;NCS1;CACNA2D1;CACNG3;CACNG2;CACNB1;CACNA1I
prerank,inward rectifier potassium channel activity (GO:0005242),-0.5239011067772027,-1.6265893262024225,0.011811023622047244,0.15769239380996147,0.945,16/24,37.94%,KCNJ2;KCNK6;KCNJ3;KCNJ9;KCNN2;KCNK1;ABCC9;KCNJ6;KCNJ13;ABCC8;KCNJ12;KCNJ16;KCNJ10;KCNN1;KCNN3;KCNJ15
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.5789705886052099,1.6179739460597082,0.00563063063063063,0.24032502283092988,0.989,20/55,19.77%,SLC7A2;SLC6A6;SLC36A2;SLC36A4;SLC38A6;SLC7A4;SLC16A1;SLC38A1;SLC38A7;SLC25A32;SLC23A2;SLC23A1;SLC38A9;SLC7A1;SLC36A1;SLC16A9;ABCC1;SLC19A1;SLC19A2;SLC7A8
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.6679300031252708,1.609796337329746,0.019801980198019802,0.25205346588670324,0.992,7/18,14.07%,TRIM29;ANXA1;BAIAP2;ANXA2;PDLIM5;RAB10;PPP1CA
prerank,alkali metal ion binding (GO:0031420),-0.6122436118933121,-1.6075508330391557,0.016891891891891893,0.1739387660012752,0.965,3/13,4.55%,CAPN3;ATP1A2;IMPA1
prerank,mannose binding (GO:0005537),0.7572268895617998,1.6046667360207294,0.011510791366906475,0.2572569939077986,0.992,2/12,4.37%,CLEC4D;CLN5
prerank,ephrin receptor activity (GO:0005003),-0.5596999060085769,-1.6041319810469563,0.02456140350877193,0.16414653263260354,0.968,5/17,9.57%,EPHA5;EPHA6;EPHA3;EPHA7;EFNB3
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.5596999060085769,-1.6041319810469563,0.02456140350877193,0.16414653263260354,0.968,5/17,9.57%,EPHA5;EPHA6;EPHA3;EPHA7;EFNB3
prerank,calcium channel activity (GO:0005262),-0.3937385922339139,-1.6002108960129797,0.0,0.16282245510015386,0.972,33/84,17.02%,SLC24A3;CACNA2D3;CACNB2;CACNA1E;SLC24A2;ORAI1;TRPC1;CACNA1C;OPRM1;CACNB4;RYR2;GRIN1;TRPM4;CACNG4;CACNA2D2;TRPC7;TRPM2;TRPC4;MCOLN1;SLC24A4;CUL5;PKD2;NCS1;PKD1;PKD2L1;CACNA2D1;CACNG3;PKD2L2;ORAI2;ANXA9;CACNG2;CACNB1;CACNA1I
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.6680900191047596,-1.5886478302068698,0.02824858757062147,0.17096009402829257,0.979,3/10,3.20%,CACNB2;CACNA1C;CACNB4
prerank,phosphatase inhibitor activity (GO:0019212),0.6718570170875523,1.586356885576476,0.017264276228419653,0.30160243781314916,0.998,7/20,11.50%,LGALS3;MGAT5;ENSA;PPP1R9B;STYXL1;BOD1;STYX
prerank,semaphorin receptor activity (GO:0017154),0.746730771598008,1.5829069614255262,0.0273972602739726,0.299628091705199,1.0,4/11,5.48%,PLXNA1;PLXNC1;PLXND1;NRP2
prerank,N-acyltransferase activity (GO:0016410),0.5910233696287763,1.5683261768828525,0.021383647798742137,0.33454715502422594,1.0,17/32,20.96%,BAAT;TGM2;NAT8;SAT1;CERS6;GLYAT;PLAAT1;NAT10;SIRT1;PLAAT3;SIRT7;NAA10;NAT14;TLCD3B;NMT2;CERS1;NAA80
prerank,alanine transmembrane transporter activity (GO:0022858),0.7416001387399329,1.5681097975648137,0.03225806451612903,0.32398094893692186,1.0,4/12,7.56%,SLC6A6;SLC36A2;SLC36A4;SLC38A7
prerank,carboxylic ester hydrolase activity (GO:0052689),0.5279647128570748,1.5580730676524157,0.008639308855291577,0.34315157760737125,1.0,19/85,14.95%,CEL;LIPA;PLA2G7;LIPG;MGLL;PLA2G2D;PNPLA7;AOAH;PON3;PGAP1;ABHD4;PLAAT1;PAFAH1B2;PLA2G4F;ESD;PLAAT3;TARS2;GDE1;PRDX6
prerank,low-density lipoprotein particle binding (GO:0030169),0.687725706629835,1.5573076787580935,0.025899280575539568,0.33461643378898553,1.0,5/16,5.50%,CD36;STAB2;SORL1;PLTP;THBS1
prerank,actin monomer binding (GO:0003785),0.6408617966000567,1.5571148206848366,0.021828103683492497,0.3246143121268148,1.0,5/22,4.43%,MTSS1;LIMA1;MRTFA;ABL2;MYL2
prerank,histone acetyltransferase binding (GO:0035035),0.6403733494715015,1.5499339770732528,0.021592442645074223,0.3359684193800522,1.0,5/21,5.08%,EPAS1;FOXP3;KANSL1;CITED2;TAF7
prerank,chemorepellent activity (GO:0045499),-0.4966053658072198,-1.548509331591739,0.043824701195219126,0.21785390533435034,0.994,8/25,12.08%,NRG3;SEMA5A;SEMA4G;SEMA3E;SEMA3A;EPHA7;DPP4;SEMA6A
prerank,alpha-actinin binding (GO:0051393),0.6293000835492569,1.546089514079807,0.03723404255319149,0.3389239428684516,1.0,5/24,6.79%,PPARG;PALLD;RARA;DAG1;PDLIM5
prerank,heme binding (GO:0020037),0.5345890122374879,1.5397514471569798,0.008968609865470852,0.3499131850479106,1.0,19/65,19.33%,FLVCR1;PGRMC1;BACH1;CYBB;PTGES2;HMOX1;CAT;FLVCR2;CYB5A;CYCS;HEBP1;HMOX2;CYB5R4;CYP46A1;HCCS;COX15;RSAD1;CYP27A1;PXDNL
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.7319736582158315,1.536460988890401,0.04146730462519936,0.350431236255502,1.0,5/10,16.90%,CYBB;CYBA;NCF2;NCF4;NCF1
prerank,sulfotransferase activity (GO:0008146),-0.4595401378692412,-1.535804005032358,0.03,0.2288456193699217,0.995,15/33,22.95%,UST;TPST1;CHST11;GAL3ST1;CHST1;CHST7;CHST2;GAL3ST4;CHST9;CHST8;TPST2;SULT1A1;HS3ST3A1;CHST12;SULT4A1
prerank,calcium-release channel activity (GO:0015278),0.6612473830678439,1.5349480572058687,0.03347280334728033,0.3454164314952967,1.0,4/17,3.45%,MCOLN3;TPCN2;MCOLN2;RASA3
prerank,potassium channel activity (GO:0005267),-0.3730406817790668,-1.5346816748844556,0.0,0.22362291336726473,0.995,21/89,13.96%,KCNMA1;KCND2;HCN1;GRIK1;KCNH7;KCNC2;KCNB2;KCNH1;GRIK2;KCNK2;KCNC1;KCNK6;GRIK5;KCNC3;KCNQ2;HCN2;KCNH8;GRIK3;PKD2;KCNN2;PKD2L1
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.7052394023106663,1.527218513335559,0.033381712626995644,0.3609824731561878,1.0,4/13,7.56%,SLC7A2;SLC7A4;SLC7A7;SLC38A7
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.5984136793920738,1.526766953154556,0.017811704834605598,0.3528953694140249,1.0,12/29,18.36%,HPSE;GALC;GLA;IDUA;ABHD10;HEXD;MOGS;CTBS;GUSB;NEU1;ACER2;GANC
prerank,acetylcholine receptor activity (GO:0015464),-0.5012588411218506,-1.5163571474793578,0.03305785123966942,0.24417271568002352,0.998,12/22,47.90%,CHRM3;CHRM2;ANXA9;CHRNA7;CHRFAM7A;CHRNB2;CHRNA5;HRH3;CHRNA3;CHRNB4;CHRM1;CHRNB3
prerank,protein phosphatase inhibitor activity (GO:0004864),0.6125949913061443,1.5123491198410954,0.030612244897959183,0.3907253053678053,1.0,6/26,9.40%,LGALS3;MGAT5;ENSA;PPP1R9B;STYXL1;BOD1
prerank,MAP kinase kinase kinase activity (GO:0004709),0.7151493477395559,1.5070484259225128,0.04962406015037594,0.39950529047920735,1.0,2/11,1.50%,MAP3K20;MAP3K1
prerank,cyclic nucleotide binding (GO:0030551),-0.49907301826053735,-1.4968325387249213,0.04797047970479705,0.2659046693329885,0.999,8/21,14.94%,HCN1;KCNH1;RAPGEF4;PDE11A;PDE4B;PDE4A;PDE5A;RAPGEF2
prerank,transferrin receptor binding (GO:1990459),-0.6171550173711584,-1.4967721451879752,0.055865921787709494,0.2581484970269436,0.999,4/10,18.24%,SNX2;RGMA;HFE;CHUK
prerank,aminopeptidase activity (GO:0004177),0.5853153396360562,1.491987128711792,0.03470437017994859,0.44273749265717255,1.0,10/26,19.74%,ANPEP;NPEPPS;MMP14;CTSH;LTA4H;METAP1D;LNPEP;BLMH;RNPEPL1;LAP3
prerank,neuropeptide receptor activity (GO:0008188),-0.44623892331402104,-1.4888375871327963,0.048034934497816595,0.2627502224588889,0.999,16/29,38.83%,SORCS3;OPRM1;SORCS1;HCRTR2;GPR37;TACR3;SORCS2;GALR1;NPY1R;NPSR1;SSTR2;NMUR2;NPY2R;KISS1R;NTSR1;GAL
prerank,ADP binding (GO:0043531),0.5987066855449398,1.4864756519840083,0.0398936170212766,0.45332801390569816,1.0,9/25,12.31%,ERN1;ABCG1;PRKAG2;ABCD1;MYO9B;LONP1;ATP5F1A;ATP5F1D;MYH9
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.5110114082421858,1.4775670333694224,0.013201320132013201,0.47659696409431196,1.0,14/75,8.61%,CBR3;SORD;DHRS3;PGD;PHGDH;AKR1A1;UGDH;HADHA;IMPDH2;RDH12;ABCC4;KCNAB2;SDR42E1;GRHPR
prerank,manganese ion binding (GO:0030145),0.5250026269220185,1.4715496907599732,0.04009433962264151,0.4891542650461209,1.0,14/48,13.07%,GALNT3;ARG1;GYG1;MGAT5;ABL2;FAM20C;B4GALT7;PIM1;ARG2;ADPRM;HMGCL;TDP2;WRN;DYRK2
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.5317989156219076,1.467922412034702,0.02403846153846154,0.4919936903611965,1.0,17/49,16.13%,OPTN;MINDY1;IKBKE;TNIP1;ZRANB3;BABAM2;PRPF8;RAD23A;TAB2;ZFAND6;EPS15;TNFAIP3;ZFAND2B;SQSTM1;UBQLN2;BRCC3;RNF169
prerank,growth factor receptor binding (GO:0070851),0.4914599804017669,1.4643254874323886,0.009698275862068966,0.49481547020612365,1.0,10/95,4.64%,CD300LF;SDCBP;GRB2;ERN1;VEGFA;PIBF1;IL6;ITGA5;PDGFA;ATXN2
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.5507518075329557,1.4630321345607897,0.041212121212121214,0.48925529657806205,1.0,7/34,6.80%,IQGAP2;IQGAP1;GAB2;KIF16B;ARAP2;ARHGAP9;ARAP1
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.6018086083858387,-1.4595287908806234,0.06515580736543909,0.3027010070789805,1.0,4/10,18.54%,SLCO2B1;SLCO1B1;SLCO5A1;SLCO4A1
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.6355104680683796,1.4546064569860002,0.05401459854014599,0.5125638895572778,1.0,1/16,0.17%,CDO1
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.548536835545722,1.4491983034042695,0.043586550435865505,0.5241548207195466,1.0,11/35,13.54%,SYK;FRK;TEC;ABL2;MELK;DYRK1A;PKDCC;PTK2B;FES;BTK;FGR
prerank,metalloaminopeptidase activity (GO:0070006),0.6350635716263205,1.4482546425071716,0.06926406926406926,0.5174716205398293,1.0,4/16,10.37%,ANPEP;NPEPPS;MMP14;LTA4H
prerank,vinculin binding (GO:0017166),0.695203652682915,1.4470896084336842,0.05701078582434515,0.5121645850285259,1.0,6/11,15.78%,SORBS3;ACTN1;DAG1;TLN1;CTNNA1;UTRN
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.5732984707110953,-1.4442610124522222,0.08035714285714286,0.3215694604801476,1.0,6/12,10.19%,ACVR1;BMPR1A;TGFBR2;TGFBR1;ENG;LTBP1
prerank,galactosyltransferase activity (GO:0008378),0.6880280314952192,1.4430043834732547,0.06431852986217458,0.5178548451386773,1.0,6/11,14.18%,B4GALT5;B4GALT7;B4GALT6;A4GALT;B4GALT3;B4GALT2
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.6359414148736452,1.4423898390477718,0.07163742690058479,0.5103125129797454,1.0,8/14,23.17%,CYBB;CYBA;NCF2;CYB5R4;NCF4;NCF1;MICAL1;AIFM1
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.5919590516631681,1.4420057363140724,0.07869742198100407,0.5025330441994583,1.0,8/22,16.13%,OPTN;IKBKE;ZRANB3;PRPF8;TAB2;TNFAIP3;SQSTM1;RNF169
prerank,outward rectifier potassium channel activity (GO:0015271),-0.5727310576845255,-1.43046207039079,0.0838150289017341,0.3386073437431432,1.0,3/11,11.96%,KCND2;KCNK2;PKD2
prerank,neuropeptide hormone activity (GO:0005184),-0.46469266510000135,-1.4276844052626938,0.07327586206896551,0.3349056366492239,1.0,17/22,49.38%,PPY;ADCYAP1;AGRP;CCK;PNOC;GRP;NPFF;NPY;CRH;GAL;NMB;VIP;SPX;CORT;NPPA;GHRH;CALCB
prerank,potassium ion antiporter activity (GO:0022821),-0.5107248415165451,-1.424374817432453,0.0625,0.3324315501005444,1.0,3/15,2.00%,SLC24A3;SLC9A9;SLC24A2
prerank,lipoprotein particle binding (GO:0071813),0.6044172300795767,1.4230843977286853,0.06509695290858726,0.5667176154249169,1.0,5/20,5.50%,CD36;STAB2;SORL1;PLTP;THBS1
prerank,phosphatidylinositol binding (GO:0035091),0.4760016875011454,1.4191130198212927,0.03205128205128205,0.5728551670450032,1.0,35/91,20.37%,MTM1;SNX8;MREG;SNX10;SNX27;DENND1A;MYO1E;EEA1;SNX9;ESYT1;SNX5;SNX24;APPL2;AIDA;PLEKHF2;SESTD1;DENND1B;PICALM;SNX16;PITPNA;FES;BCAS3;APPL1;PITPNC1;RNF34;WDFY3;SNX17;ESYT2;RUBCN;NCF1;PITPNM1;FCHO2;PIGU;GAP43;FRMPD2
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.5595866507774359,-1.415250970441587,0.0935672514619883,0.3417748869847323,1.0,9/11,29.79%,DCPS;NUDT3;NUDT5;NUDT4;NUDT16L1;NUDT16;NUDT1;NUDT11;DCP2
prerank,endopeptidase activity (GO:0004175),0.4540633972126735,1.4151920349814515,0.0,0.5779784008520094,1.0,87/257,25.42%,F7;MMP12;CTSB;CD5L;ADAM33;ADAMTS8;CTSL;PCSK4;TPP1;KLK3;TMPRSS4;MMP27;ADAM9;HGF;NLN;F11;RHBDF2;MMP14;HTRA2;F10;PITRM1;PROC;USP42;CTSS;CTSZ;CTSH;USP12;HP;HPR;BACE1;PLAU;ADAM17;USP40;USP26;USP48;CTSW;RHBDD1;OMA1;ATG4B;USP16;CAPN7;ADAM19;USP36;CASP6;USP8;PMPCB;PARL;ADAMTSL4;ACE;PSMB10;MASP1;SENP1;CASP2;CASP3;PSMA3;APEH;USP30;PSMA2;TYSND1;DDI2;AFG3L2;ADAMTS10;PSMA6;LGMN;ADAMTS2;ADAM10;MMP19;USP9X;USP2;PSMB3;FURIN;MALT1;PSEN2;PCSK7;SPRTN;MMP11;KLK1;USP47;CASP8;MMP28;ADAMTSL3;USP46;ZMPSTE24;CTSK;CTSO;RCE1;CELA1
prerank,MAP kinase kinase activity (GO:0004708),0.6256160227171416,1.41231118499991,0.07725947521865889,0.5799031843940189,1.0,4/15,9.07%,SBK2;MAPKAPK3;MAP2K5;MAP2K4
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.6590145835977459,1.410454266589353,0.10644677661169415,0.5779811879287525,1.0,2/11,6.13%,ARG1;ARG2
prerank,histone methyltransferase binding (GO:1990226),0.6623089037176326,1.4067901959270626,0.09253731343283582,0.583118227264303,1.0,5/11,11.61%,CTNNB1;LCOR;LCORL;CBX1;CBX3
prerank,protease binding (GO:0002020),0.4673742946321028,1.4049521739909474,0.021299254526091587,0.5798923134232774,1.0,31/99,19.16%,CCBE1;PSAP;VWF;TIMP1;FLOT1;CD28;PTEN;COL1A1;ANXA2;UBC;NLRC4;BFAR;TIMP2;LCOR;RAD23A;ITGB1;GSK3B;LONP2;ITGA3;COL3A1;TNFAIP3;PRKN;DERL2;SERPINC1;TWNK;NFRKB;ADAMTSL4;AMFR;CRADD;SRI;TYSND1
prerank,GABA receptor activity (GO:0016917),-0.45606831297370376,-1.4016840169429063,0.07777777777777778,0.3594525467747548,1.0,7/21,13.79%,GABRB3;GABRA2;GABRB1;GABBR1;GABRA3;GABRG3;GABRA4
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.5125106778560368,1.392516763046729,0.053613053613053616,0.621646053828638,1.0,14/53,17.31%,SLC7A2;SLC36A2;SLC36A4;SLC43A2;SLC38A6;SLC1A5;SLC7A7;SLC38A1;SLC38A7;SLC7A11;SLC38A9;SLC25A15;SLC7A1;SLC36A1
prerank,glutathione transferase activity (GO:0004364),0.5651061045425255,1.3912696139018124,0.09959072305593451,0.617115751826145,1.0,7/23,22.51%,MGST2;GSTM1;HPGDS;MGST1;GSTA4;GSTO1;GSTM5
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.5456843938867799,1.3867169502606087,0.08072916666666667,0.6263184032044093,1.0,5/28,4.59%,SBK2;SGK1;RPS6KA2;MAPKAPK3;MAP2K5
prerank,solute:anion antiporter activity (GO:0140323),0.6353094016296225,1.386143859079029,0.11208151382823872,0.6190183592662906,1.0,3/14,11.91%,SLC26A11;SLC26A1;SLC7A11
prerank,retinoid binding (GO:0005501),0.5749151928098714,1.385043496632985,0.08904109589041095,0.6146722212898167,1.0,3/22,4.64%,RBP1;RXRA;RARA
prerank,retinoic acid binding (GO:0001972),0.6296976610483229,1.3819698515717411,0.1238390092879257,0.6185126613310131,1.0,2/12,4.64%,RXRA;RARA
prerank,phosphatidylcholine transporter activity (GO:0008525),0.603929867480968,1.3789883141245871,0.09861111111111111,0.6214265037335543,1.0,7/17,13.51%,ABCA1;ABCG1;PLTP;ABCA3;PITPNA;PITPNC1;ATP8B1
prerank,signal sequence binding (GO:0005048),0.507613194235503,1.3778068513300172,0.08354114713216958,0.6175231975613875,1.0,11/35,13.59%,IPO5;KPNA4;TIMM22;KPNA2;BRAP;BABAM2;TOMM20;CAT;KDELR2;TNPO1;AP2B1
prerank,3'-5' DNA helicase activity (GO:0043138),-0.4879805041877593,-1.3759783296042567,0.10752688172043011,0.4035389579652503,1.0,5/16,17.61%,NAV2;FBH1;HELQ;MCM6;RECQL
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.5729123077901939,1.3750030156782382,0.09633649932157395,0.602575307589115,1.0,3/22,3.05%,HTR2B;HRH1;HTR6
prerank,serotonin receptor activity (GO:0099589),0.5729123077901939,1.3750030156782382,0.09633649932157395,0.602575307589115,1.0,3/22,3.05%,HTR2B;HRH1;HTR6
prerank,G protein-coupled amine receptor activity (GO:0008227),0.5729123077901939,1.3750030156782382,0.09633649932157395,0.602575307589115,1.0,3/22,3.05%,HTR2B;HRH1;HTR6
prerank,calcium ion transmembrane transporter activity (GO:0015085),-0.3656354848170853,-1.3749303959078136,0.03816793893129771,0.39663725203875533,1.0,20/55,15.91%,SLC24A3;CACNB2;SLC24A2;ORAI1;ITPR2;TRPC1;RYR2;ATP2C1;GRIN1;ATP2B3;TRPM2;SLC24A4;CUL5;PKD2;ATP2B2;ATP2B4;PKD1;PKD2L1;PKD2L2;ANXA9
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.5920256437871414,1.3739306410490706,0.10987482614742698,0.5983906496136363,1.0,3/18,5.70%,PIK3R5;WDR91;SOCS6
prerank,flavin adenine dinucleotide binding (GO:0050660),0.4862757860952891,1.3736128067015598,0.07710280373831775,0.5916406510471919,1.0,22/53,20.81%,XDH;POR;CYB5R3;NQO2;AIFM2;ACADL;ACADVL;CYBB;PRODH;GSR;QSOX1;SDHA;MICAL2;KDM1B;GCDH;CRY1;MTRR;CYB5R2;CYB5R1;MICAL1;ETFA;FOXRED2
prerank,wide pore channel activity (GO:0022829),-0.4376894198403889,-1.3734445278806688,0.06060606060606061,0.39033493005487707,1.0,12/23,47.40%,GJB1;GJB6;PANX1;GJD3;GJC1;PANX2;GJB2;GJD2;PRF1;GJA5;GJA4;PANX3
prerank,Toll-like receptor binding (GO:0035325),0.6396650399431659,1.3706662693856682,0.11738484398216939,0.595915880083016,1.0,4/11,16.60%,CD36;UNC93B1;MYD88;TLR1
prerank,cGMP binding (GO:0030553),-0.551815077738023,-1.3704327096583133,0.11572700296735905,0.38774197830458457,1.0,4/11,24.46%,PDE11A;PDE5A;RAPGEF2;PDE2A
prerank,chloride channel activity (GO:0005254),-0.34491488955655986,-1.3700323258442675,0.022556390977443608,0.3800525262370302,1.0,17/59,14.95%,GABRB3;ANO4;GLRB;ANO3;GLRA3;GABRA2;GABRB1;TTYH1;GABRA3;CLCC1;GLRA1;GABRG3;CLCN3;CLCN6;GABRA4;CLCN2;SLC1A4
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.5182995345730679,-1.3690601244575973,0.11411411411411411,0.374055224835287,1.0,7/13,13.79%,GLRB;GLRA3;GABRA2;GABRA3;GLRA1;GABRG3;GABRA4
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.5498227040842081,1.3686845725739787,0.0821566110397946,0.595898146045147,1.0,6/27,11.30%,SLC26A11;SLC26A1;SLC5A5;GET3;SLC39A14;XPR1
prerank,exoribonuclease activity (GO:0004532),0.636083495742995,1.3679837068054135,0.1141552511415525,0.5906956176407272,1.0,8/12,20.78%,EXOSC3;EXOSC9;CNOT7;EXOSC8;CNOT6;EXOSC10;EXOSC1;EXOSC7
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.4587922257884904,1.3676199157621982,0.04472843450479233,0.5845935098622761,1.0,26/100,16.11%,OSBPL8;IQGAP2;IQGAP1;GAB2;SNX27;DENND1A;CERT1;LANCL2;KIF16B;ARAP2;ARHGAP9;TECPR1;SNX24;ARAP1;SESTD1;DENND1B;ZFYVE19;BTK;RNF34;NCF4;CLVS2;SH3PXD2B;GOLPH3;GOLPH3L;MAPKAP1;RUBCN
prerank,sulfate transmembrane transporter activity (GO:0015116),0.6232239821247015,1.365893447431147,0.1174785100286533,0.583105507228806,1.0,2/14,5.34%,SLC26A11;SLC26A1
prerank,thyroid hormone receptor binding (GO:0046966),0.5418862577737312,1.3625749169766421,0.08496732026143791,0.5880484188003965,1.0,11/28,18.57%,TRIP12;MED12;NCOR1;GTF2B;TAF7;JMJD1C;NCOA3;MED16;GAS2L1;THRAP3;NCOA6
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.6254935603452346,1.3599364187212704,0.12112259970457903,0.5906707483405571,1.0,1/13,0.34%,GDF15
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.5258794102341813,-1.3593142784626997,0.14792899408284024,0.38534608997848985,1.0,6/12,13.79%,GABRB3;GABRA2;GABRB1;GABRA3;GABRG3;GABRA4
prerank,calcium-activated potassium channel activity (GO:0015269),-0.5476743456154667,-1.3577769073677741,0.12112676056338029,0.3807996959144637,1.0,11/11,45.28%,KCNMA1;KCNN2;PKD2L1;KCNMB4;KCNU1;KCNN1;KCNMB2;KCNN3;KCNMB3;KCNMB1;KCNN4
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.6253090035715232,1.3555474556159526,0.1161764705882353,0.600346404257347,1.0,2/12,3.02%,VEGFA;ITGA5
prerank,GABA-A receptor activity (GO:0004890),-0.46730542933762015,-1.3517920084531603,0.12811387900355872,0.3850817289984315,1.0,6/18,13.79%,GABRB3;GABRA2;GABRB1;GABRA3;GABRG3;GABRA4
prerank,actinin binding (GO:0042805),0.5629882597169331,1.3510525328716467,0.125,0.6094106542080355,1.0,4/21,6.79%,PPARG;RARA;DAG1;PDLIM5
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.4009807712344846,-1.3506230560156056,0.06598984771573604,0.37966008254828204,1.0,6/32,10.85%,KCNC2;KCNB2;KCNH1;KCNC1;KCNC3;KCNQ2
prerank,phospholipase binding (GO:0043274),0.6213343624761998,1.349422428496448,0.1432791728212703,0.608037712099358,1.0,6/13,13.77%,SYK;PDPK1;BLNK;BTK;DGKQ;PRKN
prerank,hexose transmembrane transporter activity (GO:0015149),-0.5250374573622784,-1.3476224540048862,0.13068181818181818,0.37777665444833824,1.0,5/12,16.78%,SLC2A3;MFSD4A;SLC2A5;SLC2A8;SLC2A6
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.47093134387739427,-1.346035661629217,0.0979020979020979,0.3736665604002158,1.0,7/18,10.19%,ACVR1;BMPR1A;TGFBR2;ACVR2B;TGFBR1;ENG;LTBP1
prerank,gap junction channel activity (GO:0005243),-0.43250718132157473,-1.3382600398902114,0.0851063829787234,0.37968233762411996,1.0,11/22,47.40%,GJB1;GJB6;PANX1;GJD3;GJC1;PANX2;GJB2;GJD2;GJA5;GJA4;PANX3
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.6142618139613713,1.3338018007534005,0.16047548291233285,0.6612368092174591,1.0,7/12,15.70%,GAB2;TRAT1;STAP1;BLNK;SH2B2;SHC1;FRS2
prerank,semaphorin receptor binding (GO:0030215),-0.4422726474735487,-1.332893939074454,0.128,0.38142678475088104,1.0,7/23,12.08%,RIT2;SEMA5A;SEMA4G;SEMA3E;SH3BP1;SEMA3A;SEMA6A
prerank,aspartic-type peptidase activity (GO:0070001),0.6463271638930768,1.3317990799430819,0.16941529235382308,0.661841540054996,1.0,2/10,9.40%,CTSD;BACE1
prerank,BMP receptor binding (GO:0070700),0.6254937692130775,1.3315115454039799,0.1566265060240964,0.6555440134684217,1.0,1/12,0.34%,GDF15
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.6375596658789398,1.3259965641917502,0.1480916030534351,0.6700502013195172,1.0,3/11,12.25%,SASH1;PPEF2;STK38
prerank,SUMO transferase activity (GO:0019789),0.5834814766089544,1.3254634862072234,0.14814814814814814,0.6647497617339705,1.0,7/16,23.72%,NSMCE2;PIAS4;TOPORS;PIAS2;PIAS1;RANBP2;EGR2
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.5547527226067375,-1.3237545195577631,0.1534526854219949,0.3914849596402601,1.0,6/10,23.50%,NAALAD2;DPP10;DPP6;DPP4;FAP;DPP8
prerank,5'-3' RNA polymerase activity (GO:0034062),0.5165046525976412,1.3230000291438857,0.12836970474967907,0.6671331880921794,1.0,8/27,14.17%,POLR2A;POLR2L;TENT2;POLR1A;POLR2G;POLR2I;POLRMT;POLR1D
prerank,small GTPase binding (GO:0031267),0.42506908992718634,1.3203400614837308,0.03578732106339468,0.6703609065954702,1.0,47/169,18.94%,IQGAP2;IQGAP1;MYO5A;DMXL2;ABCA1;OPTN;FGD6;RIC1;RANGRF;MYO9B;RAF1;SORL1;GCC1;SIKE1;SPHK2;TRIOBP;RAB3GAP2;KIF3A;MICALL1;AKAP13;HPS6;PICALM;RIN3;PAK2;ARHGEF2;STRN3;LZTR1;TRIP11;AP1G1;FGD5;OCRL;WHAMM;PARD6A;FGD3;RABGEF1;EXOC4;GOLGA4;MAPKAP1;RABGAP1;RANBP1;RAB29;GGA2;ERC1;RANBP9;MYCBP2;TNFAIP1;ANKRD27
prerank,Tat protein binding (GO:0030957),0.6349948517298899,1.3195234267475275,0.17450682852807284,0.6659581423104086,1.0,4/10,19.43%,MDFIC;CTDP1;SMARCB1;DNAJA1
prerank,MAP-kinase scaffold activity (GO:0005078),0.6175208954394216,1.3193598224988055,0.15981012658227847,0.6593584325753173,1.0,4/11,12.53%,IQGAP1;SH3RF1;AKAP13;SPAG9
prerank,sulfuric ester hydrolase activity (GO:0008484),0.6010156186348995,1.3183524437916534,0.16090225563909774,0.6564709898590929,1.0,6/12,12.80%,GALNS;GNS;ARSA;SULF2;SULF1;SGSH
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.5970856815446517,1.3161360345030477,0.1575037147102526,0.6583214621283303,1.0,3/14,4.72%,MTM1;MTMR3;PTEN
prerank,metallopeptidase activity (GO:0008237),0.4401698385214533,1.3140956867645261,0.06792058516196448,0.6586939247656719,1.0,30/113,21.47%,ANPEP;MMP12;ADAM33;ADAMTS8;MMP27;ADAM9;NLN;MMP14;ADAM8;PITRM1;PRPF8;COPS5;ADAM18;ADAM17;PSMD14;METAP1D;OMA1;ADAM19;BRCC3;LNPEP;PMPCB;ADAMTSL4;ACE;EIF3H;LAP3;AFG3L2;ADAMTS10;ADAMTS2;ADAM10;MMP19
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.4803931166523916,1.314060116566133,0.11961722488038277,0.6520715278503727,1.0,22/44,26.65%,SMYD3;CXXC1;SMYD5;EED;NSD3;DOT1L;N6AMT1;SETD7;KMT2E;KMT5B;SUV39H2;SMYD2;KMT2A;PRDM16;ASH1L;EHMT2;SETD3;SETD5;MEN1;KMT2D;SETD1B;KMT2C
prerank,glucose transmembrane transporter activity (GO:0005355),-0.46091365365185233,-1.313474708221882,0.13486842105263158,0.40401549770751977,1.0,5/17,16.78%,SLC2A3;MFSD4A;SLC2A5;SLC2A8;SLC2A6
prerank,CoA hydrolase activity (GO:0016289),0.5645546750196385,1.3128866231191523,0.14978601997146934,0.6496976554867622,1.0,9/16,23.92%,BAAT;ABCD1;ACOT9;ACAA2;NUDT7;ACOT2;ACOT6;ACOT13;ACOT8
prerank,metalloexopeptidase activity (GO:0008235),0.4687497545696111,1.3120477705348155,0.1073512252042007,0.6462946685660594,1.0,16/51,22.56%,ANPEP;CPQ;NPEPPS;CPXM1;MMP14;VASH2;LTA4H;METAP1D;CPM;LNPEP;ACE;RNPEPL1;LAP3;AGBL3;PEPD;XPNPEP3
prerank,platelet-derived growth factor binding (GO:0048407),0.6169292269595501,1.3119522573362457,0.16796267496111975,0.6402798313353597,1.0,4/11,13.02%,PDGFA;COL1A1;COL4A1;COL3A1
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.6371534749883192,1.3106302206736669,0.13858267716535433,0.6385573172681311,1.0,3/10,5.83%,DSE;RENBP;GALE
prerank,organic anion transmembrane transporter activity (GO:0008514),0.43354279118466793,1.3100423951017814,0.04880581516095535,0.6345141172929003,1.0,35/134,19.89%,CD36;SLC7A2;SLC6A6;SLC35D3;SLC36A2;SLC36A4;SLC38A6;SLC1A5;SLC25A1;SLC16A1;SLC26A1;SLC38A1;MFSD12;ABCC4;SLC38A7;SLC27A1;SLC35B3;SLC25A32;SLC35D1;SLC6A8;SLC23A2;SLC23A1;SLC38A9;SLC52A1;SLC25A42;SLC17A9;SLC25A15;SLC7A1;SLCO3A1;SLC36A1;ABCC1;SLC19A1;SLC19A2;SLC7A8;SLC25A17
prerank,E-box binding (GO:0070888),0.5048250404786092,1.3066352661911937,0.12546125461254612,0.6402943281675134,1.0,4/34,7.99%,PPARG;MITF;BHLHE40;SNAI2
prerank,protein phosphorylated amino acid binding (GO:0045309),0.47559668054842336,1.3061098013294856,0.1423444976076555,0.636062195011063,1.0,11/42,14.61%,SYK;GRB2;NCK2;FBXW7;ABL2;SH3BP2;STAP1;VAV1;PFN1;FGR;SHC1
prerank,retinoid X receptor binding (GO:0046965),0.6225900660253857,1.3060894625176207,0.15514592933947774,0.6301165084188813,1.0,1/11,0.13%,PPARG
prerank,phospholipase A2 activity (GO:0004623),0.5263157198484065,1.3050888730725934,0.14809960681520315,0.627780857508432,1.0,6/26,14.95%,PLA2G7;PLA2G2D;PLAAT1;PLA2G4F;PLAAT3;PRDX6
prerank,nuclear receptor binding (GO:0016922),0.4273975126176724,1.3034695901185838,0.07263157894736842,0.6278144297724209,1.0,34/111,17.42%,TRIP12;CTNNB1;KDM4C;RXRA;MED12;NCOR1;GTF2B;TAF7;STAT5B;NR1H4;DDX5;DCAF13;KDM3A;JMJD1C;LCOR;FOXP1;NCOA3;STRN;NCOA1;ESR1;MED16;SIRT1;PRPF6;BCAS3;PRKCB;GAS2L1;BUD31;DCAF1;LATS1;ASXL1;PPARGC1B;THRAP3;CRY1;ZBTB7A
prerank,transition metal ion binding (GO:0046914),0.40548360794072064,1.3001428532413775,0.00501002004008016,0.6338981552105715,1.0,112/397,21.26%,ANPEP;PPARG;MMP12;CBLB;ADAM33;SORD;GALNT3;LITAF;FTL;TIMP1;ARG1;AOC3;ZNF3;GYG1;NPEPPS;KDM4C;SLC11A2;DCT;RNF26;MGAT5;MSRB1;ABL2;EEA1;RXRA;FAM20C;P2RX4;ENPP1;B4GALT7;GTF2B;PIM1;ZMYND8;NQO2;ADAM8;PITRM1;SIRT6;ARG2;TET3;KDM3A;POLR2L;PIAS4;TES;TIMP2;RBAK;CALB1;PTGR2;CHD3;MEFV;HEPH;TET2;DOHH;ARIH2;LTA4H;ZFPL1;KDM2A;ADPRM;ARHGEF2;MT3;TAB2;EPRS1;HMGCL;TDP2;LACTB2;WRN;UBA5;DYRK2;KDM1B;ATAD3A;USP16;PRKN;SUV39H2;ZKSCAN5;KDM7A;PRDM2;MNAT1;TNKS;ATP7A;LNPEP;ALKBH8;SCD;RNF7;PTPN1;MYT1;MELTF;SIRT3;PGGT1B;ACE;CA2;BAZ1B;RABIF;TK1;FTH1;BIRC2;MYCBP2;PAM;ENPP5;GCH1;ALAD;KMT2A;SAP30L;PHF2;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E;JMJD6;SEC24C;SEC24B;RPS27
prerank,GDP binding (GO:0019003),0.45700656069879153,1.2998831868872274,0.09111361079865017,0.6291494339019571,1.0,20/63,16.96%,RASEF;RAP2A;RAB8B;RAB7A;RAB21;NRAS;RAB31;RAB28;ARL8B;RAB12;RAP2B;RAB10;RAB18;RAB11B;RIT1;ARL3;RRAS;RAB2A;RAB29;RAB22A
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),-0.3374598709879613,-1.2941120724839579,0.08181818181818182,0.43388436021084814,1.0,13/60,9.03%,ERBB4;EPHA5;CSF1R;NTRK3;EPHA6;RYK;EPHA3;FGFR2;NTRK2;FLT3;EGFR;IGF1R;EPHA7
prerank,phosphatidate phosphatase activity (GO:0008195),0.5955344501153655,1.2938250249670085,0.15844544095665172,0.6448629698409954,1.0,3/13,8.20%,PLPP3;LPIN3;PLPP5
prerank,filamin binding (GO:0031005),0.6136233489319942,1.2935330576558133,0.1811263318112633,0.6401531060701188,1.0,2/11,1.74%,FBLIM1;MICALL2
prerank,phospholipase C activity (GO:0004629),-0.41550315395850557,-1.2933880216644527,0.12931034482758622,0.4281893218565566,1.0,5/25,4.92%,PLCL1;CCR5;PLCB1;CHRM3;PLCH1
prerank,phospholipase activity (GO:0004620),0.4504486060760665,1.293095279675903,0.11538461538461539,0.6360587617271457,1.0,15/67,14.95%,DDHD1;LIPG;MGLL;PLD3;PLA2G2D;PNPLA7;ABHD4;PLAAT1;PLCB4;PLA2G4F;PLBD2;PLAAT3;GPLD1;GDE1;PRDX6
prerank,GTPase binding (GO:0051020),0.4138321192606741,1.2907415564311766,0.03763987792472025,0.6387830273407278,1.0,53/194,18.94%,IQGAP2;IQGAP1;MYO5A;DMXL2;ABCA1;OPTN;FGD6;RIC1;LCP1;RANGRF;MYO9B;RAF1;SORL1;GCC1;SIKE1;SPHK2;TRIOBP;RAB3GAP2;AMBRA1;KIF3A;MICALL1;AKAP13;HPS6;PICALM;LAMTOR1;RIN3;PAK2;ARHGEF2;STRN3;LZTR1;TRIP11;EPRS1;AP1G1;FGD5;OCRL;WHAMM;PARD6A;FGD3;RABGEF1;EXOC4;GOLGA4;MAPKAP1;BNIP3;RABGAP1;RANBP1;AIMP1;RAB29;GGA2;ERC1;RANBP9;MYCBP2;TNFAIP1;ANKRD27
prerank,zinc ion binding (GO:0008270),0.4059540398624308,1.2893349237825356,0.01606425702811245,0.6380863397901267,1.0,85/293,21.26%,ANPEP;PPARG;MMP12;CBLB;ADAM33;SORD;LITAF;TIMP1;ZNF3;NPEPPS;KDM4C;RNF26;MSRB1;EEA1;RXRA;P2RX4;ENPP1;GTF2B;ZMYND8;NQO2;ADAM8;PITRM1;SIRT6;TET3;POLR2L;PIAS4;TES;TIMP2;RBAK;CALB1;PTGR2;CHD3;MEFV;TET2;ARIH2;LTA4H;ZFPL1;KDM2A;ARHGEF2;MT3;TAB2;EPRS1;LACTB2;UBA5;KDM1B;ATAD3A;USP16;PRKN;SUV39H2;ZKSCAN5;KDM7A;PRDM2;MNAT1;TNKS;LNPEP;ALKBH8;PTPN1;MYT1;SIRT3;PGGT1B;ACE;CA2;BAZ1B;RABIF;TK1;BIRC2;MYCBP2;PAM;ENPP5;GCH1;ALAD;KMT2A;SAP30L;PHF2;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E;SEC24C;SEC24B;RPS27
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.4455640977039938,1.2888363784252015,0.1013215859030837,0.6343247313693501,1.0,16/74,9.20%,HK3;PAPSS2;FCSK;FAM20C;SHPK;DGKZ;NMRK1;COASY;DGKA;SPHK2;PIK3CA;PIK3C2G;IPPK;TKFC;PAPSS1;GALK2
prerank,neurexin family protein binding (GO:0042043),0.6250040711593275,1.2887998547957094,0.16716417910447762,0.6290192092028845,1.0,2/10,2.33%,CEL;SYTL3
prerank,clathrin adaptor activity (GO:0035615),0.5548279280517331,1.2868140850260361,0.18142857142857144,0.6304778568848964,1.0,11/15,26.75%,AP1G2;AP1G1;AP2B1;STON1;AP1M1;LDLRAP1;STON2;HIP1;AP2S1;AP2A2;AP2A1
prerank,amino acid:sodium symporter activity (GO:0005283),-0.5274395702878057,-1.2830832907473573,0.17981072555205047,0.44099508413810407,1.0,5/11,10.09%,SLC1A3;SLC6A15;SLC1A2;SLC6A1;SLC1A1
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.4418969264395388,1.2805284285451164,0.11836283185840708,0.6467539460242012,1.0,14/69,12.97%,SOAT1;BAAT;ZDHHC14;ZDHHC16;GTF2B;CERS6;CREBBP;GLYAT;ZDHHC12;ZDHHC18;PLAAT1;PLAAT3;LPCAT3;NAA10
prerank,hyaluronic acid binding (GO:0005540),0.613266066856189,1.2804988159178696,0.20317460317460317,0.6414694026005516,1.0,2/10,3.07%,CD44;STAB2
prerank,leucine zipper domain binding (GO:0043522),0.6131739113837992,1.2799458285410017,0.18529862174578868,0.6381398708917219,1.0,5/10,20.75%,MRTFA;ATF4;DDIT3;ERC1;PAWR
prerank,protein heterodimerization activity (GO:0046982),0.4093009057447146,1.2788823836682384,0.051829268292682924,0.6363197757298741,1.0,37/178,14.94%,EPAS1;SDCBP;AOC3;SLC51A;ADRA1A;ABCG1;IRAK2;ATF3;TFAP2B;EXT1;PDGFA;MICU2;MICU1;RALGAPA2;TAF7;GADD45A;HEXA;IRAK3;BHLHE40;CYBB;ATF4;CYBA;PAFAH1B2;VAPA;SMC1A;DDIT3;ITGB1;TPM4;PSMF1;ITGA3;UBA3;TENM1;ADCY8;GTF2A1;BAX;MCL1;SMC3
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.4658468147257919,-1.2782516574642493,0.15894039735099338,0.4439182101670888,1.0,6/15,6.17%,HS6ST3;NDST3;HS3ST4;HS6ST2;HS3ST5;HS3ST3B1
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.41495838292434495,1.2781371543051743,0.05834186284544524,0.6340403815640618,1.0,28/173,11.07%,PPARG;TFEC;IRX3;TRPS1;ZNF3;MITF;CEBPB;ZEB2;FOXP3;ATF3;FOXO3;ZNF692;JUN;MZF1;BACH1;NR3C1;BHLHE40;TGIF1;ZBTB20;ZNF177;ETV6;SNAI2;ZNF148;FOXP1;DACH1;FOXK1;NFATC3;PPARD
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.5196336074537015,-1.276754632422572,0.19345238095238096,0.4396066934629394,1.0,4/11,9.66%,RYR3;RYR2;TRPM2;MCOLN1
prerank,5'-nucleotidase activity (GO:0008253),0.5857559316223231,1.2767434659242236,0.19796215429403202,0.6336593392733356,1.0,4/13,12.90%,NT5C2;NT5E;NT5DC1;NT5C3B
prerank,UDP-galactosyltransferase activity (GO:0035250),0.6163842105476568,1.275293241566724,0.18153364632237873,0.6336568362986088,1.0,3/10,5.71%,B4GALT5;B4GALT7;B4GALT6
prerank,iron ion binding (GO:0005506),0.4611469553893065,1.2746563161828155,0.13427561837455831,0.6305907121231584,1.0,16/48,17.14%,CDO1;FTL;KDM3A;ACP5;HEPH;TET2;EGLN3;DOHH;FTO;KDM7A;FECH;ALKBH8;SCD;MELTF;ALKBH1;FTH1
prerank,channel activity (GO:0015267),0.4719801749188605,1.2733845497931382,0.1552346570397112,0.6297265155982742,1.0,5/41,14.53%,AQP1;MPV17;TMEM266;TRPV2;BAX
prerank,glycine binding (GO:0016594),-0.5102297768548013,-1.2714253692054902,0.18397626112759644,0.44314604382264944,1.0,6/11,8.50%,GRIN2B;GLRB;GRIN3A;GLRA3;GRIN1;GLRA1
prerank,GTPase regulator activity (GO:0030695),0.4069726981341929,1.2701053558337583,0.05572441742654509,0.6355514806171007,1.0,41/212,11.48%,ARHGAP24;IQGAP2;HTR2B;ARHGAP10;IQGAP1;ABR;ARHGAP19;ARHGAP15;VAV3;IPO5;GPS1;TBC1D22A;TBC1D25;GNAQ;TBC1D1;SOS1;TBC1D2;ARHGAP9;JUN;TBC1D12;ARHGAP31;MYO9B;RALGAPA2;ASAP1;ADAP1;TBC1D10A;RASA4;RAB3GAP2;FLCN;ARAP1;TBC1D2B;STXBP5;SIRPA;DLC1;ARHGAP18;EIF5;ARHGAP17;TBC1D22B;SEC23B;TBC1D15;ELMOD3
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.4763018309268784,1.2664882715946435,0.15920398009950248,0.6425718210839649,1.0,10/34,15.44%,SMYD3;NSD3;DOT1L;ETFBKMT;N6AMT1;CAMKMT;SETD7;KMT2E;KMT5B;SMYD2
prerank,metalloendopeptidase activity (GO:0004222),0.4403539559422821,1.264043136753044,0.13815789473684212,0.6457686828674614,1.0,8/76,5.87%,MMP12;ADAM33;ADAMTS8;MMP27;ADAM9;NLN;MMP14;PITRM1
prerank,metal ion transmembrane transporter activity (GO:0046873),0.5076526469897538,1.2615607586296451,0.17183462532299743,0.6492128910990372,1.0,9/27,13.74%,AQP1;SLC11A2;ATP2B1;TMEM165;SLC12A3;MMGT1;MAGT1;SLC23A1;SLC11A1
prerank,NF-kappaB binding (GO:0051059),0.5125920220835459,1.2584855944456796,0.1865771812080537,0.6547284134651152,1.0,10/24,25.72%,ANXA4;FOXP3;GSK3B;RELA;PSMA6;FAF1;BCL10;SETD6;HDAC1;COMMD7
prerank,lysine-acetylated histone binding (GO:0070577),0.5242324912828538,1.2571146821309156,0.1914008321775312,0.6491978624140534,1.0,12/20,28.03%,ZMYND8;BRD2;BRD7;BRD3;PHIP;MLLT3;ATAD2B;KMT2A;TAF1;CARM1;BAZ2A;SMARCA4
prerank,acetylation-dependent protein binding (GO:0140033),0.5242324912828538,1.2571146821309156,0.1914008321775312,0.6491978624140534,1.0,12/20,28.03%,ZMYND8;BRD2;BRD7;BRD3;PHIP;MLLT3;ATAD2B;KMT2A;TAF1;CARM1;BAZ2A;SMARCA4
prerank,peptidase inhibitor activity (GO:0030414),0.4838931887282359,1.2559292423406656,0.16938519447929737,0.6480386973218787,1.0,7/33,14.43%,TIMP1;ITIH2;RENBP;TIMP2;ITIH3;PSMF1;SLPI
prerank,cytokine receptor binding (GO:0005126),0.42404526040590373,1.2554122154407212,0.13516483516483516,0.6450280897373952,1.0,6/83,2.99%,CD300LF;SDCBP;SYK;VEGFA;PIBF1;IL6
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.518188931899899,1.255105011817881,0.18417639429312582,0.641424270266575,1.0,4/24,6.84%,OSBPL8;CERT1;LANCL2;SESTD1
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.5647381513631611,1.2503457421947768,0.20114942528735633,0.6531732466746349,1.0,2/15,5.70%,PIK3R5;SOCS6
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),-0.2924061560581595,-1.2493132294735487,0.06756756756756757,0.48061294363099255,1.0,34/91,18.43%,FRMPD4;TWF2;KRIT1;PLEKHA5;PLCB1;MYO1B;SNAP91;ADAP2;MAPT;STXBP6;KCNH1;PARD3;KCNJ2;SYT7;SYTL2;MARK1;WIPI1;GSDME;WDR45B;AMER1;SNX21;ACTN2;CGAS;SNX20;SNX18;HIP1R;PLA2G4E;CLVS1;RPH3A;ANXA9;OSBPL2;GSN;TTPAL;SLC9A1
prerank,cation channel activity (GO:0005261),-0.29161888235131606,-1.246807842025122,0.043478260869565216,0.47846878218647304,1.0,27/94,16.00%,SLC24A3;TRPM3;CACNB2;HCN1;CACNA1E;SLC24A2;ORAI1;TRPC1;UNC80;TMEM63B;RYR2;GRIN1;TRPM4;NALCN;TRPM2;MCOLN1;SLC24A4;CUL5;PKD2;HVCN1;PKD1;PKD2L1;TRPM6;PKD2L2;KCNK9;ANXA9;CALHM2
prerank,glycerophospholipid flippase activity (GO:0140333),-0.5034148955773551,-1.2464941012731336,0.2046783625730994,0.4719826245202454,1.0,4/11,11.84%,ATP8A2;ATP8A1;ABCB4;ATP10B
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.5934964844622644,1.2443644245649963,0.2078907435508346,0.6681931876981971,1.0,2/11,5.06%,AKR1A1;RDH12
prerank,anion:anion antiporter activity (GO:0015301),0.5458615209878793,1.2420547206937085,0.22733612273361228,0.671262735385428,1.0,2/17,5.34%,SLC26A11;SLC26A1
prerank,phosphotyrosine residue binding (GO:0001784),0.4632279706263442,1.2406047866298606,0.19070904645476772,0.6712277029320426,1.0,10/37,14.61%,SYK;GRB2;NCK2;ABL2;SH3BP2;STAP1;VAV1;PFN1;FGR;SHC1
prerank,double-stranded RNA binding (GO:0003725),0.4272802880561536,1.2396074569546636,0.1762749445676275,0.6698066128410508,1.0,17/70,15.96%,RFTN1;TLR8;TFRC;VIM;MBNL1;ACTN1;AGO2;HNRNPU;MSN;EIF4A1;AGO3;DROSHA;DUS2;SIDT2;MRPL44;ADARB1;HSPD1
prerank,GTPase activator activity (GO:0005096),0.3917341098233128,1.2387950785856174,0.05015045135406219,0.6678424476139142,1.0,89/313,17.88%,ARHGAP24;IQGAP2;HTR2B;ARHGAP10;IQGAP1;DENND4C;ABR;ARHGAP19;DENND2D;ARHGAP15;FGD6;VAV3;CYTH1;FNIP1;TBC1D22A;RIC1;TBC1D25;DENND1A;GNAQ;SERGEF;TBC1D1;SOS1;TBC1D2;RANGRF;ARHGAP9;RGL1;JUN;TBC1D12;RGL2;ARHGAP31;MYO9B;RALGAPA2;DOCK5;ASAP1;ADAP1;TBC1D10A;RASA4;RAB3GAP2;FLCN;DOCK10;ARAP1;DNMBP;TBC1D2B;STXBP5;AKAP13;DENND1B;VAV1;DLC1;ARHGAP18;LAMTOR1;ARHGAP17;RCBTB2;RIN3;TBC1D22B;SEC23B;DENND2A;ARHGEF2;TBC1D15;ELMOD3;DOCK2;DOCK1;FGD5;RAPGEF1;ARFGEF2;RASGEF1A;LAMTOR3;NPRL3;RAP1GAP2;OCRL;RGS11;RASGEF1B;FGD3;NUCB1;RABGEF1;ARRB1;TBC1D9;RABGAP1;NRP1;RANBP1;CCDC88C;GAPVD1;ARHGAP25;NPRL2;RABIF;RIC8B;SH3BP5;ARHGEF10;ITSN1;EIF2B2
prerank,amino acid binding (GO:0016597),-0.3678228453555234,-1.2369309600329839,0.14150943396226415,0.48448837392134747,1.0,15/31,27.14%,GRIN2B;GLRB;GRIN3A;GLRA3;AARS1;GRIN1;GLRA1;AGXT;GRM7;SHMT1;GLRA2;NOS1;AARS2;DDAH1;CAD
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.3921071721239767,1.2356179162392487,0.0717896865520728,0.673476191919498,1.0,80/232,24.74%,CBLB;NSMCE2;RNF149;TRIP12;ZNRF1;WWP1;RNF26;RNF19A;RNF130;TRIM17;BRAP;TRIM25;UHRF2;ZNRF3;CUL3;RNF10;RNF135;RNF128;NHLRC1;BFAR;PIAS4;SH3RF1;XIAP;NEDD4L;WWP2;RNF115;MEFV;TOPORS;HUWE1;TRIM7;ARIH2;RLIM;RNFT2;BIRC3;NHLRC3;STUB1;TRIM41;RNF34;FBXO6;PRKN;HECTD1;NEURL1B;TRAF3IP2;VPS11;CBL;RNF7;TMEM129;UBE2O;KCMF1;TRIM14;MYLIP;BIRC2;AMFR;MYCBP2;NFX1;RNF43;CBLL1;PIAS2;PELI2;DTX1;RNF19B;MKRN1;NEURL4;PIAS1;DTX2;NEURL2;UBR3;RNF125;IRF2BP1;SIAH2;RNF138;UBE2D3;ARIH1;EGR2;TRAF6;RNF150;RNF2;RNF180;RNF145;PRPF19
prerank,exopeptidase activity (GO:0008238),0.44363865308942857,1.2346901366526164,0.1739644970414201,0.6720623078876711,1.0,17/50,22.56%,ANPEP;NPEPPS;CTSA;CNDP2;CTSZ;CTSH;LTA4H;METAP1D;CPM;LNPEP;BLMH;ACE;PRCP;LAP3;DPEP2;DPP3;XPNPEP3
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.5617572730748902,1.2331529673176131,0.22087745839636913,0.6723551571130281,1.0,1/14,0.69%,AK8
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.5628211568580924,1.2331253006868168,0.23376623376623376,0.6678406943051824,1.0,2/14,1.89%,MINDY1;MINDY4
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.576050497266274,1.231382261032908,0.23529411764705882,0.668767576414653,1.0,4/12,14.03%,TENT4B;TENT5A;TENT2;TENT5D
prerank,DNA polymerase binding (GO:0070182),0.5263461081931403,1.224154891181532,0.24645892351274787,0.6878693202564627,1.0,7/18,17.36%,ACD;LONP1;POLG2;RTEL1;NAT10;CDK2AP1;CDT1
prerank,proton transmembrane transporter activity (GO:0015078),0.45130557289285256,1.2238895825954623,0.19390243902439025,0.6842016993503673,1.0,11/39,17.12%,SLC11A2;UQCRFS1;ATP6V1B2;COX6A1;CYB5A;COX8A;MFSD3;NNT;ATP6V1F;COX15;CLCN4
prerank,RNA methyltransferase activity (GO:0008173),0.516011175713729,1.2209117734922967,0.2390998593530239,0.6892090094166071,1.0,11/19,26.88%,TRMT12;LCMT2;TRDMT1;MEPCE;MRM2;FBL;TRMT13;METTL8;TGS1;FTSJ1;METTL4
prerank,phosphatidic acid binding (GO:0070300),0.5145016640502138,1.2208334062061472,0.2038404726735598,0.6848916915390346,1.0,10/19,24.71%,GRAMD1B;PLTP;SESTD1;MICALL1;PITPNC1;MAPKAP1;PITPNM1;GSDMD;PLEKHN1;ATP13A2
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.4060238419562224,-1.219048188084227,0.20149253731343283,0.5128541533833604,1.0,8/21,14.03%,PDE3B;PDE8B;PDE11A;PDE4B;PDE1C;PDE4A;PDE5A;PDE1A
prerank,ubiquitin protein ligase activity (GO:0061630),0.38653268595778684,1.2189190060777015,0.08823529411764706,0.6866720985972663,1.0,78/228,24.74%,CBLB;RNF149;TRIP12;ZNRF1;WWP1;RNF26;RNF19A;RNF130;TRIM17;BRAP;TRIM25;UHRF2;ZNRF3;CUL3;RNF10;UBE2K;RNF135;RNF128;NHLRC1;BFAR;SH3RF1;XIAP;NEDD4L;WWP2;RNF115;MEFV;TOPORS;HUWE1;TRIM7;ARIH2;RLIM;RNFT2;BIRC3;NHLRC3;STUB1;TRIM41;RNF34;FBXO6;PRKN;HECTD1;NEURL1B;TRAF3IP2;VPS11;CBL;RNF7;TMEM129;UBE2O;KCMF1;TRIM14;MYLIP;BIRC2;AMFR;MYCBP2;NFX1;RNF43;CBLL1;PELI2;DTX1;RNF19B;MKRN1;NEURL4;DTX2;NEURL2;UBR3;RNF125;IRF2BP1;UBE4A;SIAH2;RNF138;UBE2D3;ARIH1;UBE4B;TRAF6;RNF150;RNF2;RNF180;RNF145;PRPF19
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.5380118027417542,1.214980995158039,0.242467718794835,0.6955462020475811,1.0,3/16,4.72%,MTM1;MTMR3;PTEN
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.4987350171322104,-1.2110589987868916,0.25227963525835867,0.523164539002123,1.0,6/11,20.69%,ITPR2;TRPC1;TRPC7;TRPC4;RPH3A;CYTH2
prerank,store-operated calcium channel activity (GO:0015279),-0.4928264712189856,-1.2085027754304627,0.24166666666666667,0.5211903131970498,1.0,7/10,26.39%,ORAI1;TRPC1;TRPC7;TRPC4;ORAI2;ORAI3;TRPC5
prerank,palmitoyltransferase activity (GO:0016409),0.48264802343158975,1.2084273954276266,0.2222222222222222,0.7124342113625275,1.0,8/28,17.17%,ZDHHC14;ZDHHC19;ZDHHC16;ZDHHC12;ZDHHC18;ZDHHC24;ZDHHC17;ZDHHC4
prerank,acyl-CoA hydrolase activity (GO:0047617),0.5206413941916807,1.2083591414501014,0.22802197802197802,0.7080973664188286,1.0,9/17,23.92%,BAAT;ABCD1;PPT1;ACOT9;ACAA2;ACOT2;ACOT6;ACOT13;ACOT8
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.5448589860059964,1.208254460384043,0.26165413533834586,0.7038713674257482,1.0,10/13,32.71%,TRMT1L;TRMT10C;TARBP1;TRMT10A;FTSJ1;THUMPD3;METTL1;TRMT1;WDR4;TRMT5
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),-0.4841503985939363,-1.207509389320818,0.21764705882352942,0.5162683037149661,1.0,7/11,51.60%,CHRNA7;CHRNB2;CHRNA5;CHRNA3;CHRNA9;CHRNB4;CHRNA4
prerank,thioesterase binding (GO:0031996),0.5736532998538798,1.2060816550182456,0.24464831804281345,0.7067275874015471,1.0,5/11,16.29%,TRAF1;TRAF3;TRAF5;TRAF2;HAUS7
prerank,FMN binding (GO:0010181),0.5613164714897768,1.2056285005852445,0.26858877086494687,0.703923664386976,1.0,3/11,17.75%,POR;DUS2;MTRR
prerank,chloride channel regulator activity (GO:0017081),0.5392033465461827,1.203945186225783,0.2647058823529412,0.7050586488042918,1.0,3/14,5.64%,SGK1;STX8;VTI1B
prerank,cAMP binding (GO:0030552),-0.4789523091635165,-1.2028267313127945,0.22826086956521738,0.5198394648739549,1.0,5/11,14.94%,HCN1;RAPGEF4;PDE4B;PDE4A;RAPGEF2
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.5655374692868734,1.202681367119545,0.2589703588143526,0.7048843223473151,1.0,6/11,23.12%,SAMD8;SGMS2;PTDSS1;SGMS1;DPAGT1;AASDHPPT
prerank,transcription cis-regulatory region binding (GO:0000976),0.37880376702174534,1.2020429665952639,0.055,0.702652601580657,1.0,69/406,14.76%,EPAS1;PPARG;MMP12;TFEB;TRPS1;NFE2L2;ZNF3;CEBPB;TIPARP;GRHL1;ATF3;VEZF1;ARID4A;NR1H3;E2F3;FOXO3;TFAP2B;RUNX3;RXRA;JUN;NCOR1;RARA;MZF1;E2F1;LONP1;TAF7;AGO2;RNF10;NR3C1;NR1H4;ATF4;ZBTB20;BRCA1;ZNF177;ETV6;RREB1;SOX9;SNAI2;RBAK;RB1;GABPB1;GABPB2;FOXP1;IRF2;CHD3;BRD7;ARID5B;TBL1XR1;DACH1;NR5A1;DDIT3;XRCC5;PAX8;PSPC1;FOXK1;SALL2;CUX1;SP3;RORA;POLRMT;RFX5;RELA;BBX;SOX2;SUV39H2;ATF1;PRDM2;ZNF513;PER3
prerank,nuclear import signal receptor activity (GO:0061608),0.520080428796424,1.2010006344954423,0.2511144130757801,0.7018822918191049,1.0,5/15,16.83%,IPO5;KPNA4;KPNA2;TNPO1;KPNA3
prerank,I-SMAD binding (GO:0070411),-0.4477868945278278,-1.200093234092281,0.21451104100946372,0.518182996130664,1.0,6/13,12.28%,SMAD3;SMURF1;TGFBR1;SMAD1;SMAD7;SMAD2
prerank,calcium-dependent phospholipid binding (GO:0005544),0.4299282553339397,1.1993565278200282,0.2240566037735849,0.7030138691651519,1.0,8/49,10.01%,ANXA4;CPNE2;ANXA1;ESYT1;ANXA5;ANXA2;PLA2G4F;SYT17
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.5704994117356242,1.1992305438789188,0.27419354838709675,0.6991587747263194,1.0,1/10,0.51%,APOBEC1
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.5069043434597037,-1.199111799216727,0.2359882005899705,0.5134101721516504,1.0,8/10,49.34%,SLC6A1;SLC10A1;SLC10A6;SLC6A11;SLC10A3;SLC6A12;SLC6A13;SLC10A2
prerank,actin binding (GO:0003779),0.38506391484520025,1.1991089002012485,0.14168377823408623,0.6953501272084367,1.0,34/170,14.11%,IQGAP2;MTSS1;CXCR4;LIMA1;MRTFA;SYNPO2L;GAS2L3;SPEF1;LCP1;MSRB1;ABL2;MYO9B;MYL2;DAG1;PARVB;MYO19;PDLIM5;HNRNPU;VASH2;MEFV;CAPZB;MYO1F;ITGB1;COTL1;RUSC1;PFN1;MICAL2;MYH9;MACF1;SYNPO;CAP1;PHACTR4;PRKN;ADCY8
prerank,nucleotidase activity (GO:0008252),0.5302957044271938,1.1978526904148332,0.2841068917018284,0.695025310213689,1.0,5/15,17.17%,NT5C2;NT5E;NT5DC1;NT5C3B;BPNT2
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.38458012772693617,1.1930197200763115,0.1431472081218274,0.7066029879353918,1.0,31/181,13.41%,PPARG;MDFIC;ANXA4;NFE2L2;CTNNB1;FOXP3;ID2;RXRA;JUN;NCOR1;TCERG1;NR1H4;CREBBP;BHLHE40;ATF4;PIAS4;RB1;WWP2;NCOA3;HIPK2;NCOA1;GSK3B;SIRT1;RERE;PPARD;BCAS3;TBX6;HCLS1;RELA;BUD31;CTDP1
prerank,carbohydrate:cation symporter activity (GO:0005402),0.5712364793273299,1.1927835148241264,0.2735562310030395,0.7031679841716469,1.0,3/11,12.80%,SLC17A5;SLC23A2;SLC23A1
prerank,ribonuclease activity (GO:0004540),0.4210801459693971,1.18964022011361,0.23623853211009174,0.7093583130824542,1.0,18/56,16.82%,ERN1;RNASE3;AGO2;RNASEL;EXOSC3;EXOSC9;NOB1;CNOT7;AGO3;SND1;EXOSC8;LACTB2;N4BP1;RNASEH2A;RNASEH1;CNOT6;EXOSC10;EXOSC1
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.42942327099912264,1.1877153766837611,0.23157894736842105,0.7115058785285484,1.0,14/48,14.19%,ATP1B4;CALHM5;AQP1;CALHM6;RHD;TMEM165;GRIN3B;ATP6V1B2;MMGT1;TRPV2;PIEZO1;PIEZO2;TRPM7;SLC12A7
prerank,copper ion binding (GO:0005507),0.44093967753918983,1.184490267429523,0.22982885085574573,0.7178238653865266,1.0,10/42,18.26%,AOC3;DCT;P2RX4;HEPH;SNCG;MT3;ATP7A;SUMF1;RNF7;PAM
prerank,neuropeptide receptor binding (GO:0071855),-0.43903409869503596,-1.1838080644952054,0.2507462686567164,0.5395047413336913,1.0,7/14,38.83%,PPY;NMU;AGRP;SHANK1;NPY;APLN;GAL
prerank,cysteine-type peptidase activity (GO:0008234),0.4096525830295756,1.1828743409259093,0.22519509476031216,0.7186642673721821,1.0,32/73,25.18%,CTSB;TINAGL1;CTSL;CAPN2;USP42;CTSS;CTSZ;CTSH;USP12;USP40;USP26;USP48;CTSW;ATG4B;USP21;USP16;USP36;CASP6;USP8;BLMH;CASP2;CASP3;USP30;LGMN;USP9X;USP2;MALT1;USP47;CASP8;USP46;CTSK;CTSO
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.4566250374414271,1.1826171481967533,0.2568922305764411,0.7153980067523902,1.0,9/30,19.32%,SLC11A2;TMEM165;SLC39A14;SLC11A1;SLC39A12;ATP7A;SLC39A3;SLC39A11;SLC30A1
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.4799501182475969,-1.181148194143231,0.27450980392156865,0.5382987579882964,1.0,4/10,14.24%,PML;ANKRD13B;IDE;ANKRD13A
prerank,ATP binding (GO:0005524),0.3730529478138649,1.1799412171964159,0.12261306532663317,0.7198673311654853,1.0,63/266,18.33%,ABCA1;MAP3K20;TLK1;ERN1;ERCC6;ABCG1;PDK4;PRKAG2;MTHFS;LANCL2;PYGL;ABCD1;RUNX3;SIK3;P2RX4;DAPK1;SRPK2;ENPP1;MYO9B;LONP1;PIM1;SIK1;OLA1;STK3;IRAK3;HSPA1B;HNRNPU;P2RX3;NLRC4;TOP1;ABCA2;MAP4K3;ACVRL1;RTEL1;VPS4A;MYO1F;ATP5F1A;ATP5F1D;PI4K2A;ACVR1B;SARS2;STK38;MYH9;BTK;MTHFD1L;SYN1;DYRK2;HSPA1A;UHMK1;MTREX;LATS1;ATP7A;EIF4A3;HSPA13;PMVK;CARS2;HSPA4;PFKP;RRM1;SRPK1;EIF2B2;HSPA4L;STK4
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.3792556123093374,1.1775576164303987,0.14532520325203252,0.7236631461770128,1.0,29/188,10.33%,PPARG;TFEB;NFE2L2;CEBPB;GRHL1;ATF3;ARID4A;NR1H3;FOXO3;RXRA;JUN;NCOR1;MZF1;TAF7;RNF10;ATF4;ZBTB20;BRCA1;GABPB1;GABPB2;CHD3;BRD7;ARID5B;TBL1XR1;DDIT3;XRCC5;PAX8;PSPC1;FOXK1
prerank,nuclear localization sequence binding (GO:0008139),0.49802694594880953,1.1754342172072045,0.27521613832853026,0.726287257303852,1.0,4/18,4.70%,IPO5;KPNA4;KPNA2;BRAP
prerank,cell-cell adhesion mediator activity (GO:0098632),0.42753510520589005,1.1750102048435866,0.2545235223160434,0.7236563969817227,1.0,9/42,10.48%,TRIM29;PALLD;ANXA1;BAIAP2;ANXA2;PDLIM5;SIRPA;DSCAM;RAB10
prerank,ATP hydrolysis activity (GO:0140603),0.4340018787188755,1.1748596292030078,0.24179829890643986,0.7201012843929819,1.0,16/41,23.64%,KIF20B;MYO1E;ATP2B1;ABCD1;MYO19;HSPA1B;ABCA3;CHD3;HSPA1A;ABCG4;VWA8;TOR1A;CLPX;RUVBL2;VCP;ABCD2
prerank,receptor antagonist activity (GO:0048019),-0.4055973657626832,-1.173454749247553,0.21631205673758866,0.5476897422063933,1.0,8/17,43.51%,CCL5;DKK2;ESR2;DKK3;FST;IGSF1;WFIKKN1;AGTR2
prerank,voltage-gated anion channel activity (GO:0008308),0.5288284524738184,1.1729121356963943,0.27472527472527475,0.7221356718765259,1.0,6/15,17.12%,ANO6;VDAC2;VDAC1;GPR89A;GPR89B;CLCN4
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.5267224735094902,1.1718320468733439,0.27844311377245506,0.7212807404483756,1.0,3/13,15.60%,DCT;IDI1;EHHADH
prerank,1-phosphatidylinositol binding (GO:0005545),0.52391856841712,1.1713002996813662,0.2762039660056657,0.7189590332681292,1.0,6/15,13.35%,SNX10;EEA1;SNX9;SESTD1;PICALM;WDFY3
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.3791409273232918,1.1683293271077655,0.19076923076923077,0.7244855217674092,1.0,48/147,19.00%,DENND4C;ABR;DENND2D;FGD6;VAV3;CYTH1;FNIP1;RIC1;DENND1A;SERGEF;SOS1;RANGRF;RGL1;RGL2;DOCK5;RAB3GAP2;DOCK10;DNMBP;AKAP13;DENND1B;VAV1;LAMTOR1;RCBTB2;RIN3;DENND2A;ARHGEF2;DOCK2;DOCK1;FGD5;RAPGEF1;ARFGEF2;RASGEF1A;LAMTOR3;RASGEF1B;FGD3;NUCB1;RABGEF1;CCDC88C;GAPVD1;RABIF;RIC8B;SH3BP5;ARHGEF10;ITSN1;EIF2B2;MYCBP2;ANKRD27;ARFGEF1
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.4859644341492587,-1.1682351353215985,0.2857142857142857,0.5521894251740359,1.0,8/10,32.40%,IGSF11;SHISA6;SHISA7;SHANK2;NSF;GNAS;SHANK1;SHANK3
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.4561284693431167,1.1681301176949188,0.27099236641221375,0.7211753744865511,1.0,7/27,14.17%,POLR2A;POLR2L;POLR1A;POLR2G;POLR2I;POLRMT;POLR1D
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.4745978063424551,1.1674485435507207,0.26842105263157895,0.7195629539763144,1.0,7/24,17.17%,ZDHHC14;ZDHHC19;ZDHHC12;ZDHHC18;ZDHHC24;ZDHHC17;ZDHHC4
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),-0.4296470049025072,-1.1670637776478,0.25696594427244585,0.5478933953357202,1.0,2/15,1.65%,CX3CR1;CCR5
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.44971663097447917,1.1640199296496747,0.2648171500630517,0.7265979195978032,1.0,13/32,20.15%,KDM4C;TMLHE;TET3;HSPBAP1;TET2;EGLN3;FTO;KDM2A;KDM7A;ALKBH1;RIOX2;ALKBH5;JMJD4
prerank,solute:proton symporter activity (GO:0015295),0.5215178777641521,1.1628635360413517,0.31631205673758866,0.7260681288576689,1.0,4/16,11.27%,SLC36A2;SLC11A2;SLC17A5;MFSD3
prerank,gamma-tubulin binding (GO:0043015),-0.38459924912129934,-1.1615225106558704,0.26953125,0.5537291198534189,1.0,8/21,20.26%,TUBGCP5;PAK1;MARK4;RAB11FIP5;RACGAP1;GIT1;BRSK1;TUBGCP6
prerank,frizzled binding (GO:0005109),0.4367142457077324,1.1583328782532465,0.2822477650063857,0.7364966520944805,1.0,7/34,19.10%,SDCBP;ZNRF3;DVL1;FZD7;LRP6;CCDC88C;RNF43
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.4390560624524386,1.1582033054076522,0.24433249370277077,0.7329334088343575,1.0,13/35,22.16%,MMP12;GTF2B;AGO2;NR3C1;TAF1B;FOXP1;RELA;POU2F1;GTF2A1;SMARCB1;RRN3;TAF1;RUVBL2
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",-0.2934813546401948,-1.1581262672907928,0.15053763440860216,0.5547919938895793,1.0,27/72,18.43%,FRMPD4;TWF2;KRIT1;PLCB1;MYO1B;SNAP91;ADAP2;STXBP6;PARD3;KCNJ2;SYT7;SYTL2;MARK1;GSDME;AMER1;SNX21;ACTN2;CGAS;SNX20;SNX18;HIP1R;PLA2G4E;RPH3A;ANXA9;OSBPL2;GSN;SLC9A1
prerank,PDZ domain binding (GO:0030165),-0.2899541840939831,-1.157472127181048,0.19491525423728814,0.5494034847516999,1.0,16/61,12.24%,CADM1;NLGN1;F11R;GRIA1;DOCK4;FZD3;CIT;GRID2;ACOX1;CXXC4;ATP2B3;ADRB1;CLCN3;SNTG2;ATP2B2;ATP2B4
prerank,protein kinase activator activity (GO:0030295),0.40496565540476864,1.1546579619741306,0.2758229284903519,0.7403318407253852,1.0,13/60,13.11%,IQGAP1;GPRC5D;ERCC6;PRKAG2;CDKN1A;ABI1;STK3;INCENP;PAK2;DBF4;MT3;AFAP1L2;GAS6
prerank,phosphatidylinositol kinase activity (GO:0052742),0.5047756006179484,1.1531298964117618,0.2919605077574048,0.7411935547806985,1.0,4/15,11.78%,PIKFYVE;PIK3CA;PIK3C2G;PI4K2A
prerank,retinoic acid receptor binding (GO:0042974),0.497914968054656,1.1510016498063769,0.28969359331476324,0.7439355822952344,1.0,1/17,0.13%,PPARG
prerank,mannosyltransferase activity (GO:0000030),-0.3837175882221344,-1.1507589814015458,0.22821576763485477,0.5574689112243062,1.0,10/21,23.78%,TMTC2;DPY19L1;PIGZ;DPY19L4;DPY19L3;DPM1;TMTC1;POMT1;POMT2;ALG8
prerank,peptidoglycan binding (GO:0042834),-0.4770447627638019,-1.1502715482735086,0.29916897506925205,0.551891663036297,1.0,6/10,34.41%,NLRP3;RNASE7;TLR2;NOD1;PGLYRP1;JCHAIN
prerank,protein homodimerization activity (GO:0042803),0.36002642329354856,1.1496533602113486,0.068,0.7442621287699747,1.0,110/589,14.91%,PSAP;GDF15;IDH1;XDH;APOE;PHETA2;SLC51A;LILRB1;CPQ;ERN1;ATG7;VEGFA;MGLL;GYG1;TXN;ABCB7;CEBPB;ABCG1;GRHL1;KIF20B;TBC1D22A;FOXP3;TPI1;GSTM1;IRAK2;ATF3;TFRC;KYNU;TPD52;TMEM266;GLA;EEA1;ABCD1;TFAP2B;EXT1;PDGFA;PGRMC1;SNX9;SLC8B1;RIPK1;ENPP1;MYO9B;SH3GLB1;APPL2;MZF1;PEX11A;PON3;ACTN1;MVD;GADD45A;NQO2;GALE;PEX7;IRAK3;BHLHE40;SCARB2;HMOX1;RABEP1;NLRC4;CAT;RBPMS;SMIM1;PDCD6IP;GRHPR;HPGDS;PAFAH1B2;TYROBP;LHPP;PAPSS1;S100A16;TERF1;TPR;IL6R;DDIT3;DNTTIP1;MTCL1;TMEM192;POU3F3;RBPMS2;TPM4;PSMF1;CCDC66;HM13;DROSHA;STUB1;BST2;ALDH3A2;EPRS1;S100A1;DCLRE1B;SARS1;APPL1;MYH9;S100A6;WRN;MTHFD1L;UBA5;RELA;SSBP1;TARS2;INPP5F;SLC11A1;TENM1;ADCY8;GDNF;FECH;BAX;LRP6;MCL1;SNF8
prerank,LRR domain binding (GO:0030275),0.5157186340039758,1.1478101920227324,0.3072378138847858,0.7462501417826525,1.0,4/14,9.57%,MRTFA;LRRFIP2;ATF4;DDIT3
prerank,GDP-dissociation inhibitor activity (GO:0005092),-0.4384658620211509,-1.1454986811476895,0.2777777777777778,0.5560783174237819,1.0,5/13,13.03%,ARHGDIA;ITGB1BP1;GDI2;GPSM2;GDI1
prerank,WW domain binding (GO:0050699),0.449454868490613,1.142730170026027,0.3031446540880503,0.7583743871077548,1.0,6/26,14.26%,LITAF;KIF20B;PRRG4;TCEAL6;WBP11;DAZAP2
prerank,deoxyribonuclease activity (GO:0004536),0.5052177045178481,1.1398247142249818,0.3153961136023916,0.7636004421469736,1.0,4/14,11.12%,ZRANB3;DFFB;DNASE1L1;MBD4
prerank,magnesium ion binding (GO:0000287),0.3736129427437633,1.1395122511047275,0.25833333333333336,0.7605514229214289,1.0,22/135,13.07%,IDH1;MAP3K20;CERK;ERN1;RAP2A;ABL2;SIK3;SRPK2;SIK1;STK3;IRAK3;NLRC4;ENDOV;HPGDS;PGM1;PI4K2A;HMGCL;STK38;PGP;TDP2;WRN;DYRK2
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.4833394420854922,1.1392145397828004,0.32729805013927576,0.7577389388076503,1.0,6/18,18.01%,TNFAIP8;XIAP;BIRC3;MT3;GAS6;BIRC2
prerank,fatty acid synthase activity (GO:0004312),-0.47300290725544025,-1.137653485604062,0.315028901734104,0.5672198723336845,1.0,5/10,15.79%,ELOVL7;ELOVL4;ELOVL6;OXSM;MCAT
prerank,ATPase regulator activity (GO:0060590),0.42798611349483734,1.1366162586206663,0.29534313725490197,0.7615880755579797,1.0,7/38,12.08%,FNIP2;FNIP1;DNAJB6;MYBPC3;SIL1;BAG4;PFN1
prerank,protein phosphatase regulator activity (GO:0019888),0.4092346885108416,1.135387592297415,0.29723502304147464,0.7618003818991907,1.0,17/53,22.53%,LGALS3;MGAT5;PPP4R1;ENSA;PPP4R2;PPP1R9B;STYXL1;BOD1;PPP2R2A;PHACTR4;PPP2R2B;PPP2R5C;CABIN1;CALM2;PPP2R1A;PPP6R1;PPP1R15B
prerank,endoribonuclease activity (GO:0004521),0.4367113183712288,1.134276358904199,0.3007518796992481,0.761446005507274,1.0,8/32,12.49%,ERN1;AGO2;RNASEL;ENDOV;NOB1;AGO3;SND1;LACTB2
prerank,ubiquitin-protein transferase activity (GO:0004842),0.35485350052487974,1.1332900104772352,0.1706827309236948,0.76060538494064,1.0,119/346,24.76%,CBLB;RNF149;TRIP12;ZNRF1;WWP1;RNF26;BIRC6;UBE2Q2;RNF19A;RNF130;TRIM17;BRAP;TRIM25;UHRF2;ZNRF3;TSPAN17;UBE2L3;CUL3;RNF10;UBE2K;FBXL3;RNF135;RNF128;CNOT4;NHLRC1;BRCA1;BFAR;SH3RF1;XIAP;NEDD4L;KLHL20;WWP2;RNF115;FBXO11;RNF146;MEFV;TOPORS;HUWE1;TRIM7;RSPRY1;ARIH2;RLIM;RNFT2;FBXO9;BIRC3;MIB2;NHLRC3;ASB4;STUB1;TRAF1;TRIM41;CUL4A;RNF34;FBXO6;CHFR;FBXW2;TRAF3;TNFAIP3;PRKN;RNF123;HECTD1;NEURL1B;TRAF3IP2;VPS11;CUL1;TRAF5;CBL;TRAF2;CDC34;RNF7;TMEM129;UBE2M;UBE2O;KCMF1;TRIM14;MYLIP;BIRC2;AMFR;MYCBP2;TNFAIP1;NFX1;RNF43;UBE2S;CBLL1;FBXO7;PELI2;UBE2R2;DTX1;RNF19B;CUL4B;MKRN1;NEURL4;DTX2;TAF1;UBE2H;NEURL2;UBR3;KCTD10;RNF141;RNF125;MALT1;IRF2BP1;RNF168;SIAH2;OBI1;RNF138;UBE2D3;ARIH1;MIB1;TRAF6;FBXO4;RNF150;UBE2J2;RNF2;RNF180;RNF145;TTC3;PRPF19;UBE2E1
prerank,ubiquitin protein ligase binding (GO:0031625),0.3577825734447472,1.1311884927407556,0.20282542885973764,0.7633325415049229,1.0,83/254,23.76%,CXCR4;GGN;POLR2A;TPI1;IKBKE;FBXW7;CDKN1A;PSMD1;TANK;WASHC1;SNX9;JUN;RIPK1;TNFRSF1B;UBE2L3;CUL3;NPLOC4;UBE2K;TRIOBP;APC;SUMO2;HSPA1B;DET1;AMBRA1;RPS27A;UBC;MFHAS1;BRCA1;RPL23;PIAS4;RB1;XRCC5;FAF2;GSK3B;FOXO1;BAG4;ASB4;HM13;STUB1;TRAF1;FZD5;ACVR1B;CUL4A;RNF34;RELA;TRAF3;ATP6V0C;PRKN;HSPA1A;SQSTM1;CUL1;PRDX6;ARRB1;TRAF5;RTN4;HSPD1;TRAF2;LTBR;TNFRSF14;PSMA3;CCT2;BAG1;ATXN3;FBXO7;WFS1;DNAJA1;ACTG1;DTX1;SPOP;CUL4B;JKAMP;USP2;HSPBP1;VCP;FAF1;MFN2;SLF1;HSPA9;ARIH1;BCL10;EGR2;ISG15;PA2G4
prerank,purinergic nucleotide receptor activity (GO:0001614),0.5027490806839202,1.1305336626084639,0.34203296703296704,0.7613831335583365,1.0,5/15,7.23%,P2RY14;P2RX4;GPR171;PTAFR;P2RX3
prerank,androgen receptor binding (GO:0050681),0.45280834877120535,1.129551685791526,0.3129973474801061,0.7606592085682624,1.0,6/25,11.72%,KDM4C;DDX5;KDM3A;FOXP1;PRPF6;PRKCB
prerank,lipid phosphatase activity (GO:0042577),0.5139182009611919,1.128568931668447,0.3242467718794835,0.7600176442252092,1.0,2/14,7.14%,PLPP3;PLPP6
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.4598675230341191,1.1264000582003983,0.31911966987620355,0.7629854436990074,1.0,10/25,17.90%,TIPARP;PARP4;PARP2;SIRT6;PARP3;ZC3HAV1;SIRT1;TNKS;SIRT3;TNKS2
prerank,histone methyltransferase activity (GO:0042054),0.4289360276680156,1.123349674830775,0.3105196451204056,0.7686758729707234,1.0,9/32,15.44%,SMYD3;EED;NSD3;DOT1L;N6AMT1;SETD7;KMT2E;KMT5B;SMYD2
prerank,FAD binding (GO:0071949),0.4559520695946064,1.122331480269368,0.33636363636363636,0.7681490216062941,1.0,11/24,19.69%,CYB5R3;NQO2;PRODH;QSOX1;MICAL2;KDM1B;CRY1;MTRR;CYB5R2;CYB5R1;MICAL1
prerank,calcium activated cation channel activity (GO:0005227),-0.39280089739386015,-1.1219373995173394,0.30357142857142855,0.5948311728917999,1.0,5/17,13.96%,KCNMA1;TMEM63B;TRPM4;KCNN2;PKD2L1
prerank,receptor ligand activity (GO:0048018),0.3517466375714139,1.1209746320670417,0.24397590361445784,0.7686109463334935,1.0,12/245,5.10%,GPNMB;LGALS3;GDF15;TIMP1;VEGFA;IL36G;IL6;HGF;PDGFA;SEMA4B;OSGIN1;IGF1
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.39656714238847707,1.1185179059925596,0.3072562358276644,0.7725803678304303,1.0,17/60,19.82%,MTMR3;PPM1H;PPEF1;PTEN;PPEF2;PDP1;RPAP2;PPP3CA;PPP3R1;ILKAP;CTDP1;PPP6C;PPP1CA;SSU72;CTDSPL2;PPP2CA;CDC14B
prerank,cadherin binding (GO:0045296),0.35088899950453684,1.1174210417588932,0.21105527638190955,0.7722758801323779,1.0,76/315,16.81%,IQGAP1;TRIM29;IDH1;LIMA1;MRTFB;PRDX1;ANXA1;CTNNB1;AHNAK;PLIN3;BAIAP2;CD46;TBC1D2;NIBAN2;FASN;CLINT1;P2RX4;SNX9;CEMIP2;SNX5;DDX6;SH3GLB1;ABI1;TRIM25;ASAP1;ANXA2;CAPG;TBC1D10A;OLA1;STK24;APC;STX5;PDLIM5;TLN1;MICALL1;TES;ZC3HAV1;VAPA;ARHGAP18;PICALM;CAPZB;BMPR2;SERBP1;EIF5;ITGB1;RAB10;PKN2;PAK2;OLFM4;SND1;PFN1;STK38;MYH9;MACF1;RAB11B;EPS15;RPS26;HSPA1A;PPP1CA;RPL15;PRDX6;RTN4;CBL;CLIC1;PCBP1;CTNNA1;ESYT2;USP8;PUF60;RANBP1;MB21D2;GAPVD1;PTPN1;CHMP5;LRRC59;CAPZA1
prerank,G protein-coupled photoreceptor activity (GO:0008020),-0.43218594784638786,-1.1172991575957378,0.3054662379421222,0.5985052112810334,1.0,8/12,47.38%,ELOVL4;GPR88;RRH;GPR52;OPN1MW3;OPN1MW;OPN5;OPN4
prerank,mRNA 3'-UTR binding (GO:0003730),0.38233241110220584,1.1172424169105615,0.2973856209150327,0.7691191857598475,1.0,15/79,12.03%,RBMS1;CPEB4;CPSF1;UTP23;CELF1;IGF2BP3;DDX5;HNRNPU;ZFP36L2;LARP4B;HNRNPA0;EXOSC9;SERBP1;PUM2;EXOSC8
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.4945019125925627,1.117147160952039,0.33519553072625696,0.7658424287678128,1.0,2/16,7.26%,CD38;NEIL1
prerank,NADPH binding (GO:0070402),0.5006919851845113,1.1171427462884758,0.3372262773722628,0.7622848821349701,1.0,6/13,19.13%,CBR3;GRHPR;DUS2;MTRR;CBR4;HMGCR
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.34981694566059535,1.116613225145717,0.1813627254509018,0.7603812705500942,1.0,100/431,18.43%,ABCA1;MAP3K20;TLK1;RASEF;ERN1;RAP2A;ERCC6;ABCG1;PDK4;TGM2;PRKAG2;RAB7A;MTHFS;LANCL2;PYGL;ABCD1;RUNX3;RHOJ;SIK3;P2RX4;DAPK1;SRPK2;ENPP1;MYO9B;LONP1;PIM1;EEF1A1;RAB21;NRAS;SIK1;OLA1;STK3;IRAK3;HSPA1B;GBP6;HNRNPU;P2RX3;MFHAS1;NLRC4;RAB31;TOP1;RAB1B;ABCA2;MAP4K3;RAB28;ACVRL1;RTEL1;RRAD;VPS4A;MYO1F;ARL8B;RAP2B;RHOD;RAB10;ATP5F1A;ATP5F1D;PI4K2A;ACVR1B;SARS2;STK38;MYH9;BTK;MTHFD1L;SYN1;RAB11B;ATL2;DYRK2;RIT1;TUBA1A;ARL4C;HSPA1A;ARL8A;ARL3;RRAS;ATL1;UHMK1;MTREX;LATS1;ATP7A;TUBA1C;EIF4A3;RND2;HSPA13;PMVK;RAB2A;CARS2;RAB29;RAB22A;HSPA4;RABL6;PFKP;ARF4;ADSS1;RRM1;SRPK1;EIF2B2;HSPA4L;STK4;RHEB;ARF5
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.4214962352384514,1.1142870016525703,0.3242909987669544,0.7635413796055888,1.0,16/34,25.91%,BIRC6;UBE2Q2;UBE2L3;UBE2K;UBE2F;CDC34;UBE2O;UBE2S;UBE2R2;TAF1;UBE2H;UBE2D3;UBE2J2;UBE2E1;UFC1;UBE2G1
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.43362201782622334,1.110859476389928,0.34061696658097684,0.7704586766667492,1.0,10/28,16.18%,AGO2;ENDOV;POP4;AGO3;DROSHA;RNASEH2A;MRPL44;RNASEH1;PRORP;EDC3
prerank,acid-thiol ligase activity (GO:0016878),0.5055524786144234,1.1086614692126986,0.37009063444108764,0.7734819078130175,1.0,3/13,10.81%,ACSS3;ACSM3;AACS
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),-0.41003993824389534,-1.10822399707494,0.3087248322147651,0.6119986403343851,1.0,2/14,5.78%,KCNJ2;KCNJ3
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.34881994249347903,1.1064381887013983,0.23541247484909456,0.7767950777437639,1.0,85/269,23.76%,CXCR4;GGN;POLR2A;TPI1;IKBKE;FBXW7;CDKN1A;PSMD1;TANK;WASHC1;SNX9;JUN;RIPK1;TNFRSF1B;UBE2L3;CUL3;STAM;NPLOC4;UBE2K;TRIOBP;APC;SUMO2;HSPA1B;DET1;AMBRA1;RPS27A;UBC;MFHAS1;BRCA1;RPL23;PIAS4;RB1;XRCC5;FAF2;GSK3B;FOXO1;BAG4;ASB4;HM13;STUB1;TRAF1;FZD5;ACVR1B;CUL4A;RNF34;RELA;TRAF3;ATP6V0C;PRKN;HSPA1A;SQSTM1;CUL1;PRDX6;ARRB1;TRAF5;RTN4;HSPD1;TRAF2;LTBR;TNFRSF14;PRR7;PSMA3;CCT2;BAG1;ATXN3;FBXO7;WFS1;DNAJA1;ACTG1;DTX1;SPOP;CUL4B;JKAMP;USP2;HSPBP1;VCP;FAF1;MFN2;SLF1;HSPA9;ARIH1;BCL10;EGR2;ISG15;PA2G4
prerank,signaling receptor complex adaptor activity (GO:0030159),0.41760434996577145,1.1055636838697105,0.34088050314465407,0.7757773382068018,1.0,10/38,15.70%,NCK2;GAB2;TRAT1;STAP1;BLNK;SH2B2;DEDD2;SPAG9;SHC1;FRS2
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.5235591386488604,1.1051237408814578,0.35585585585585583,0.773584787163425,1.0,5/12,16.78%,TOE1;CNOT6L;CNOT7;CNOT6;PAN3
prerank,pre-mRNA binding (GO:0036002),0.43802789057399305,1.104931787588485,0.3282247765006386,0.7706855605598633,1.0,10/28,17.77%,CELF1;RNPC3;RBM41;DDX5;HNRNPU;PRPF8;ERI1;ZRSR2;RBM7;RBM22
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.511886583098991,1.1044648126307526,0.3712574850299401,0.7685526367064874,1.0,2/12,10.23%,XDH;SDHB
prerank,O-acyltransferase activity (GO:0008374),0.429687800686721,1.1036388499945469,0.34892541087231355,0.767503409814203,1.0,6/30,16.21%,SOAT1;GPAT2;PLAAT1;LPCAT3;PRDX6;GPAT3
prerank,tRNA methyltransferase activity (GO:0008175),0.4877801691430319,1.1010038472909454,0.3592233009708738,0.7717636001629737,1.0,9/16,26.59%,TRMT12;LCMT2;TRDMT1;TRMT44;ALKBH8;TARBP1;TRMT13;FTSJ1;THUMPD3
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.4574657462618293,1.1007557563004582,0.35182679296346414,0.7690815739715714,1.0,10/20,24.24%,SENP3;COPS5;SENP5;USP21;OTUD5;EIF3H;SENP1;UFSP2;USP9X;USP47
prerank,protein kinase inhibitor activity (GO:0004860),-0.31558446060746614,-1.1003114501398419,0.25,0.6224942047505686,1.0,13/42,13.66%,RPTOR;SPRED1;CIT;NCK1;RACK1;CAMK2N1;QARS1;PARVA;MAPK8IP1;SMCR8;SPRED2;PRKRIP1;SH3BP5L
prerank,cysteine-type endopeptidase activity (GO:0004197),0.3794160084916791,1.0997792073700996,0.31981981981981983,0.7686053554156357,1.0,30/78,25.18%,CTSB;CAPN15;CTSL;CAPN2;USP42;CTSS;CTSZ;CTSH;USP12;USP40;USP26;USP48;CTSW;USP16;CASP12;USP36;CASP6;USP8;CASP2;CASP3;USP30;LGMN;USP9X;USP2;MALT1;USP47;CASP8;USP46;CTSK;CTSO
prerank,acetyltransferase activity (GO:0016407),0.43338411099634183,1.0996023339703556,0.3563218390804598,0.7657699522606158,1.0,16/31,26.90%,NAT8;GTF2B;SAT1;CREBBP;PAFAH1B2;NAT10;NAA10;NAT14;NAA80;NAA15;KAT6B;SMARCE1;KAT6A;KAT2B;PAFAH1B3;ELP3
prerank,RNA cap binding (GO:0000339),-0.38366261740861657,-1.0988892189025146,0.3117283950617284,0.618888968262938,1.0,10/16,18.12%,SNUPN;EIF4E2;GEMIN5;DCPS;NCBP3;LSM1;LARP1;CYFIP1;EIF3D;EIF4E3
prerank,single-stranded RNA binding (GO:0003727),0.4095923116503259,1.0988634980665393,0.3418803418803419,0.7645574357670072,1.0,11/43,18.52%,TLR8;LONP1;AGO2;HNRNPU;ENDOV;POLR2G;AGO3;LACTB2;EXOSC10;RBM7;AGO4
prerank,methylated histone binding (GO:0035064),0.3797567520635363,1.0973740880994725,0.34439359267734554,0.7656017287151164,1.0,20/62,22.43%,NCAPG2;CXXC1;CBX8;TAF7;ZMYND8;ING3;CDYL;KMT2E;ING4;TDRD3;KDM7A;MPHOSPH8;RRP8;PHF13;SGF29;PHF1;PHF2;TAF1;CBX5;MTF2
prerank,Hsp70 protein binding (GO:0030544),0.4211031251017101,1.0966220796137576,0.33506493506493507,0.7644714605083419,1.0,13/31,26.85%,ERN1;MVD;PPEF2;STUB1;DNAJB14;PRKN;DNAJC18;HDAC8;DNAJA1;METTL21A;SACS;DNAJC8;DNAJB12
prerank,antiporter activity (GO:0015297),0.457315231524393,1.0962876272201192,0.3807531380753138,0.762160369822237,1.0,7/20,18.96%,SLC35D3;SLC35E3;SLC35D1;SLC35E2B;SLC35E2A;CLCN4;SLC35C2
prerank,translation initiation factor activity (GO:0003743),0.4087917245650331,1.0954994300019498,0.3586550435865504,0.7612534230907825,1.0,16/36,22.43%,EIF1;AGO2;EIF3A;COPS5;EIF3B;EIF5;EIF4A1;EIF3G;EIF3H;EIF2B2;EIF2S2;EIF4G3;EIF4G2;EIF3C;EIF2S1;MTIF3
prerank,adenyl ribonucleotide binding (GO:0032559),0.34408365227424426,1.093271671691457,0.2605210420841683,0.7644979495973034,1.0,71/291,20.28%,ABCA1;MAP3K20;TLK1;ERN1;ERCC6;ABCG1;PDK4;PRKAG2;MTHFS;LANCL2;PYGL;ABCD1;RUNX3;SIK3;P2RX4;DAPK1;SRPK2;ENPP1;MYO9B;LONP1;PIM1;SIK1;OLA1;STK3;IRAK3;HSPA1B;HNRNPU;P2RX3;NLRC4;TOP1;CNBD2;ABCA2;MAP4K3;ACVRL1;RTEL1;VPS4A;MYO1F;ATP5F1A;ATP5F1D;PI4K2A;ACVR1B;SARS2;STK38;MYH9;BTK;MTHFD1L;SYN1;DYRK2;HSPA1A;UHMK1;MTREX;LATS1;ATP7A;EIF4A3;HSPA13;PMVK;CARS2;HSPA4;PFKP;RRM1;SRPK1;EIF2B2;HSPA4L;STK4;SLC19A1;HMGCR;TLK2;MKNK2;PFKM;GCK;BRSK2
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.5155176254866439,1.0922004896638495,0.39461883408071746,0.7642668937992496,1.0,7/11,25.19%,UBE2K;STUB1;AMFR;UBE4A;UBE4B;PRPF19;UBR5
prerank,NADP binding (GO:0050661),0.41687416447761366,1.0920697219484337,0.3563218390804598,0.7613899943742063,1.0,9/32,19.13%,CBR3;PGD;CAT;GRHPR;NNT;DUS2;MTRR;CBR4;HMGCR
prerank,RNA binding (GO:0003723),0.3376570946310887,1.091151632827031,0.101,0.7607908680399993,1.0,388/1321,23.20%,LGALS3;MYO5A;RFTN1;APOBEC1;MAP3K20;RBMS1;HNRNPLL;GRB2;TLR8;RPL3L;PRDX1;DHX34;DHX8;SAMD4A;FNDC3B;DIAPH1;AHNAK;RBM47;POLR2A;TXN;IPO5;FAM120A;EIF1AX;EIF1;CPEB4;TFRC;VIM;C1D;LRP1;ALYREF;MRPS26;FARS2;ANKRD17;MRPL20;HNRNPH2;DYNC1H1;FASN;MBNL1;SNTB2;UBAP2L;JUN;EBNA1BP2;UTP23;SRPK2;MPHOSPH10;BYSL;RBM28;DDX6;SCAF4;RPP25L;SCAF11;HNRNPAB;CELF1;KPNA2;RBM39;ATXN2;IGF2BP3;TEP1;TENT4B;YTHDF3;CLNS1A;TRIM25;CHTOP;LONP1;DDX59;UBE2L3;PCID2;EEF1A1;ACTN1;AGO2;NUFIP1;ANXA2;TENT5A;MRPL39;TCERG1;TOE1;RNASEL;FNDC3A;ANKHD1;RPL18A;EIF3A;MRPL40;HNRNPUL1;DDX5;DCAF13;MRPL11;RPS14;CSTF3;RPS11;SUMO2;HELB;HSPA1B;CFAP20;HNRNPU;EIF2AK4;CNOT4;PRPF8;RPS27A;UBC;ZFP36L2;SNRNP200;BRCA1;LARP4B;MRPL23;RPL17;RPL23;DARS1;RBPMS;TOP1;MSN;TCF20;ENDOV;TES;WDR33;JAKMIP1;AKAP1;ISY1;ETF1;CHD3;MRPS23;PUM3;RPL36A;SART1;ZC3HAV1;XPOT;SMC1A;NOP14;EXOSC3;S100A16;HUWE1;MRPS7;CHD2;NAT10;HNRNPA0;TNRC6B;SF1;TPR;POP4;EXOSC9;EIF3B;NOSIP;SERBP1;EIF5;EIF4A1;XRCC5;GLRX3;RPL22;PSPC1;RPS21;MTCL1;PATL1;RRBP1;POLR2G;GRSF1;ALG13;LTA4H;DKC1;ATP5F1A;PKN2;AGO3;MRPL1;MRPL14;MRPL32;PRPF6;DDX23;RBPMS2;PTBP3;DDX55;BAG4;NUFIP2;LARP7;SREK1;ERI1;NCBP2;DROSHA;HNRNPM;SRSF3;SYF2;THOC2;ELP1;BST2;RBM42;TDRD3;MRPS35;MRPS28;PUM2;TNPO1;EPRS1;SND1;SF3A3;MEPCE;PFN1;NOL8;PTBP2;SARS2;SARS1;DQX1;RPL10A;MYH9;SNRNP35;DDX20;MRPL28;SPOUT1;LACTB2;EIF3G;POLRMT;MAZ;DUS2;MACF1;PPRC1;NPM2;BCLAF1;KRR1;SSBP1;RBM34;SUGP1;RBM10;N4BP1;RPS26;PPIE;TBCA;PRRC2B;WBP11;MRPS21;HSPA1A;LLPH;SNRPF;SIDT2;MRPL44;NOC3L;HNRNPD;SLPI;SRBD1;MCRS1;RNASEH1;YTHDC2;ATP5F1C;RPL15;RPL10;MTREX;RPL7L1;ALDH18A1;USP36;ISG20L2;RTN4;ADARB1;EIF4A3;PCBP1;FAM133B;CTNNA1;RPSA;DDX39A;PPARGC1B;PRRC2C;NUP98;DNAJC21;MBNL2;ACAA2;CFAP65;GRN;EXOSC10;HSPD1;ALKBH8;PUF60;EDC3;SYNCRIP;PTPN1;LUC7L;THRAP3;ANXA11;AIMP1;DHX38;IFIT2;RRP8;CCAR1;LRRC59;UTP11;EXOSC1;ALKBH1;MRPL43;TFB2M;RBM7;HSPE1;TAF15;RPL7;NELFE;HNRNPDL;CAPRIN1;ACIN1;UBE2O;TRMT1L;RPL26;EIF3H;ZCCHC7;SRPK1;RBM22;SEC63;HMGN5;RADX;C1QBP;PWP2;ALKBH5;PLEC;CLK3;NOC2L;NUDT7;EIF2S2;AGO4;UTP15;APEH;SECISBP2L;NFX1;GNL3L;EIF4G3;EIF4G2;NGDN;DHX37;CDK13;FUBP1;CPEB2;RBM18;RBM27;MRPS31;NCL;TRMT10C;PURB;RAMAC;EIF3C;AGFG1;PPAN;RBM15;SPEN;LARP4;PSMA6;EXOSC7;RALY;MKRN1;JMJD6;SNRNP40;PIN4;IMMT;EIF2S1;FUBP3;CMSS1;RTCA;SAFB;CCDC86;PEF1;RPS27;MTIF2;SNRPB;WDR43;ABT1;RPGR;PPP1R10;GTPBP4;PCDHGA9;NOL12;FARSA;PRKDC;FBL;SLC4A1AP;NAA15;ACO1;PKM;BOP1;VCP;KTN1;RCC2;TSNAX;HEATR6;TPD52L2;HNRNPR;DIMT1;R3HDM1;PRPF40B;MTERF4;STAT3;NMD3;EZR;PABPC4;LSM5;HSPA9;NOLC1;DDX19A;PDAP1;FLNA;ZC3H12D
prerank,metal ion binding (GO:0046872),0.34048294411803764,1.0907357972137761,0.237,0.7587763957030571,1.0,68/477,13.15%,IQGAP1;MMP12;ANXA4;IDH1;APOE;MAP3K20;GALNT3;AOC3;PLSCR4;CERK;ANXA1;ERN1;RAP2A;MAN1C1;TGM2;TPD52;LRP1;LCP1;ABL2;SIK3;CEMIP2;ESYT1;SRPK2;MICU2;PLA2G2D;ENPP1;EFCAB11;MICU1;MYL2;ANXA5;AOAH;SLC8A1;THBS1;ANXA2;ADAM8;MELK;SIK1;STK3;IRAK3;TESMIN;ARSA;NLRC4;ENDOV;CALB1;NUDT22;LETM1;HPGDS;S100A16;NDUFAB1;PLA2G4F;PPP3CA;SYT17;PPP3R1;TPM4;MT3;FBLN1;PGM1;PI4K2A;S100A1;HMGCL;STK38;PGP;TDP2;S100A6;WRN;MCTP1;DYRK2;CRACR2A
prerank,sequence-specific mRNA binding (GO:1990825),-0.4515658127411159,-1.0900784741111387,0.36827195467422097,0.6332973530424639,1.0,3/10,5.85%,SSB;FMR1;SHFL
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.41159068825417316,1.0894305764949188,0.3420398009950249,0.759421695511169,1.0,15/37,24.11%,FARS2;DARS1;TARS3;NARS2;EPRS1;SARS2;SARS1;TARS2;IARS2;PARS2;CARS2;IARS1;FARSA;WARS2;LARS1
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.3586362574886601,-1.0894268979442168,0.33725490196078434,0.6279377412518014,1.0,8/23,14.03%,PDE3B;PDE8B;PDE11A;PDE4B;PDE1C;PDE4A;PDE5A;PDE1A
prerank,endopeptidase regulator activity (GO:0061135),0.40265416558148626,1.088470689753017,0.3625450180072029,0.7591158843828686,1.0,9/40,14.59%,ITIH2;RENBP;NLRC4;ABCA2;ITIH3;PSMF1;PSMD14;SLPI;PSME2
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.47240253598699583,1.0883450851375096,0.38362068965517243,0.7563317337787404,1.0,1/17,0.69%,AK8
prerank,protein phosphatase binding (GO:0019903),0.3605277604696339,1.088150225189958,0.3474576271186441,0.7537660750833916,1.0,22/117,14.86%,LGALS3;IQGAP1;MTMR3;LILRB1;CTNNB1;IKBKE;ENSA;MFHAS1;KIF3A;PPP1R9B;SIRPA;CD22;STRN;STYXL1;BOD1;FOXO1;STRN3;TRAF3;PHACTR4;ADCY8;JAK3;AP3B1
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.40796602525010095,1.0873692799638297,0.36702767749699156,0.7529148011028668,1.0,9/38,13.44%,SNX27;DENND1A;LANCL2;KIF16B;TECPR1;SESTD1;ZFYVE19;NCF4;SH3PXD2B
prerank,NAD binding (GO:0051287),0.4352888158507815,1.087011215642038,0.3605263157894737,0.7509105518362893,1.0,9/26,16.44%,SORD;SIRT6;NUDT6;GRHPR;ZC3HAV1;SIRT1;NNT;ALDH2;SIRT3
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),-0.2981589501086285,-1.0827619248702944,0.3105590062111801,0.636645340237641,1.0,13/42,21.97%,CCND3;CCNC;CCNG2;CDK5R1;CCNL2;CCNI;INCA1;CKS2;CCNJ;CCNF;CCNJL;CCNQ;CDK5R2
prerank,protein serine/threonine kinase activity (GO:0004674),0.34252342687836096,1.0825988347897972,0.26926926926926925,0.7602814984898251,1.0,59/334,12.25%,SGK1;MAP3K20;MAK;SYK;TLK1;PIKFYVE;PRKCH;RPS6KA2;MAP3K1;ERN1;MAPKAPK3;IRAK2;IKBKE;PLK2;TAOK3;PDPK1;PRKCD;SIK3;FAM20C;DAPK1;SRPK2;RIPK1;RAF1;MAPK6;PIM1;MAPK7;PKN3;STK35;GAK;MELK;SIK1;STK24;STK3;IRAK3;DYRK1A;EIF2AK4;TOP1;BRD2;ACVR2A;MAP3K8;HIPK1;MAP4K3;ACVRL1;HIPK2;CSNK2A2;BMPR2;TNIK;ROCK1;PIM3;GSK3B;PTK2B;PKN2;PAK2;CDK7;MOK;PRKCB;ACVR1B;MYLK;STK38
prerank,amyloid-beta binding (GO:0001540),0.36355176221563257,1.079939608324742,0.3537787513691128,0.7646171050146694,1.0,14/79,12.64%,CD36;APOE;LILRB1;LILRB3;LRP1;PGRMC1;SORL1;APBB2;PICALM;BACE1;FZD5;TREM2;APBB3;ITM2C
prerank,kinase activity (GO:0016301),0.35768626972111245,1.079485961491661,0.3425531914893617,0.7627463499100005,1.0,32/109,21.70%,CERK;PAPSS2;FCSK;ITPKB;SHPK;DGKZ;NMRK1;COASY;DGKA;SPHK2;PIK3CA;PIK3C2G;SEPHS2;IPPK;TKFC;PAPSS1;GSK3B;PKN2;DGKQ;PANK2;PRKD3;PMVK;DGKG;CSNK2A1;GK5;CERKL;PIK3CB;GK;COQ8B;CDKL5;TAF1;EPHA4
prerank,carbohydrate kinase activity (GO:0019200),0.504738382623101,1.0771088241848752,0.4088145896656535,0.7665113824193206,1.0,6/11,24.51%,HK3;GALK2;NAGK;XYLB;HK1;FGGY
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.48509081182226355,1.0765141832926082,0.3927536231884058,0.7651058103234019,1.0,3/13,6.64%,PIKFYVE;PIK3CA;PIK3C2G
prerank,sequence-specific DNA binding (GO:0043565),0.3383954359588317,1.0747790572179978,0.219,0.7667332065971256,1.0,112/590,20.16%,EPAS1;PPARG;MMP12;TFEC;ELF2;IRX3;TFEB;NFE2L2;ACD;CEBPB;ZEB2;GRHL1;FOXP3;EN2;ATF3;CXXC1;RUNX2;E2F3;FOXO3;TFAP2B;RUNX3;RXRA;JUN;RARA;FOXO4;E2F1;CHTOP;LONP1;NR3C1;NR1H4;BHLHE40;TET3;HNRNPU;KLF5;TGIF1;ATF4;ZBTB20;ZNF177;POU3F1;SOX9;SNAI2;ZNF148;FOXP1;IRF2;CBFB;SNAPC1;TERF1;NR5A1;XRCC5;PAX8;ESR1;NR2C1;WDR77;FOXK1;KDM2A;MAFG;POU3F3;FOXO1;MAFB;NFATC3;PPARD;CUX1;MYRFL;SP3;RORA;TBX6;POLRMT;RFX1;RFX5;BBX;SOX2;BCL11B;POU2F1;TEN1;ZKSCAN3;FOXJ3;UPF2;JUNB;PRDM2;HNRNPD;STN1;ETV3;MBNL2;NHLH2;KLF6;ZNF32;MTF1;SIRT3;TCF12;CREB3L4;CREB3;PLAGL2;ZBTB7A;GABPA;CREB1;ZNF23;ZBTB7B;E2F2;HOXD8;CLOCK;FLI1;SOX8;KMT2A;NFIC;CREB3L1;NR2F1;NCL;PRDM16;TCF7L2;TCF4;SP8;HSF2
prerank,R-SMAD binding (GO:0070412),-0.3746046383614822,-1.074609925870037,0.3686131386861314,0.6496640345284221,1.0,4/18,3.93%,LDLRAD4;SMAD3;TRIM33;SMURF1
prerank,transcription corepressor binding (GO:0001222),0.42310101727548965,1.0725119574777378,0.3741935483870968,0.7698602733913253,1.0,11/27,22.79%,EED;LCOR;ESR1;RORA;PER3;ZBTB7A;PHF1;ZBTB16;EHMT2;MTF2;CTBP1
prerank,poly-purine tract binding (GO:0070717),0.43207958929794393,1.0705832086213742,0.38442521631644005,0.7720885577716868,1.0,9/27,17.21%,RBMS1;ATXN1;HNRNPU;RBPMS;PATL1;PPIE;MCRS1;EIF4A3;HNRNPDL
prerank,glucuronosyltransferase activity (GO:0015020),-0.3680341729660716,-1.0693940968866251,0.3586206896551724,0.6547098369699044,1.0,6/19,16.76%,B3GAT3;CSGALNACT1;B3GAT1;B3GAT2;EXT2;CHSY1
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.4909217255529936,1.0672320405083195,0.3904899135446686,0.7781750889176922,1.0,2/13,2.54%,GPAT2;AGPAT4
prerank,adrenergic receptor binding (GO:0031690),-0.3808849924885621,-1.0657917655587172,0.3609271523178808,0.656774774012798,1.0,7/16,24.78%,MAGI2;ADRB1;GRK2;RAPGEF2;AKAP5;ADRA2A;GNAS
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.4733720713077207,1.0646795831178064,0.38205499276411,0.7822664700711915,1.0,2/14,6.83%,CAPN15;CAPN2
prerank,pentosyltransferase activity (GO:0016763),0.4031190725912209,1.0641068409311796,0.37738246505717915,0.7807413693813839,1.0,12/36,17.90%,TIPARP;PARP4;PPAT;PARP2;SIRT6;UMPS;PARP3;ZC3HAV1;SIRT1;TNKS;SIRT3;TNKS2
prerank,phosphoric ester hydrolase activity (GO:0042578),-0.2840998594539599,-1.0619188252476932,0.34911242603550297,0.6590196932293161,1.0,20/49,24.99%,PPP1CB;PTPRO;ATP1A2;PPP5C;ACP2;MPPED2;ACP6;DUSP15;ARMT1;GDPD3;PLCXD3;SMPDL3B;PTPRJ;SBF1;SACM1L;SMPD1;ENPP6;SAMHD1;ACP3;DUSP18
prerank,methylation-dependent protein binding (GO:0140034),0.3725375715759077,1.0599903888260076,0.39010356731875717,0.7891649224968248,1.0,18/57,22.43%,NCAPG2;CXXC1;CBX8;ZMYND8;ING3;CDYL;KMT2E;ING4;TDRD3;KDM7A;MPHOSPH8;RRP8;PHF13;SGF29;PHF1;PHF2;CBX5;MTF2
prerank,cell adhesion mediator activity (GO:0098631),-0.3355021909693042,-1.0570831552505562,0.3659574468085106,0.6633267325518662,1.0,8/24,11.60%,LRRC4C;NTNG1;CNTN6;CNTN2;CNTN4;BSG;IGSF9;NEXN
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.40849716802261393,1.0554259161112087,0.4098984771573604,0.7990193832518385,1.0,14/31,25.91%,BIRC6;UBE2Q2;UBE2L3;UBE2K;CDC34;UBE2O;UBE2S;UBE2R2;TAF1;UBE2H;UBE2D3;UBE2J2;UBE2E1;UBE2G1
prerank,N-acetyltransferase activity (GO:0008080),0.4449973818920107,1.054834778990664,0.4172366621067031,0.7975483743070807,1.0,5/19,14.34%,NAT8;SAT1;NAT10;NAA10;NAT14
prerank,CoA-ligase activity (GO:0016405),0.4631257106354504,1.0540046256196447,0.4244604316546763,0.7968459510059243,1.0,3/14,10.81%,ACSS3;ACSM3;AACS
prerank,hexosyltransferase activity (GO:0016758),0.3535453493701183,1.0515692258967468,0.4092373791621912,0.8004558728526299,1.0,15/101,10.52%,B4GALT5;B3GNT8;GCNT2;GYG1;EXT1;B4GALT7;HAS3;B4GALT6;HEXA;B3GALNT2;GBE1;LFNG;A4GALT;ALG12;B4GALT3
prerank,carboxypeptidase activity (GO:0004180),0.39462244797505536,1.050602429461692,0.3979974968710889,0.8001771368111164,1.0,5/35,8.57%,MINDY1;CTSA;CPXM1;CTSZ;VASH2
prerank,vitamin D receptor binding (GO:0042809),0.46381620889323144,1.050111681909288,0.4310595065312046,0.7985138914706991,1.0,5/14,16.46%,RXRA;MED12;TAF7;MED16;THRAP3
prerank,calcium ion binding (GO:0005509),0.32905623377876453,1.0491888731492496,0.3743743743743744,0.7979984735053992,1.0,44/323,13.54%,IQGAP1;MMP12;ANXA4;GALNT3;AOC3;PLSCR4;ANXA1;MAN1C1;TGM2;TPD52;LRP1;LCP1;CEMIP2;ESYT1;MICU2;PLA2G2D;ENPP1;EFCAB11;MICU1;MYL2;ANXA5;AOAH;SLC8A1;THBS1;ANXA2;ADAM8;MELK;ARSA;CALB1;LETM1;HPGDS;S100A16;NDUFAB1;PLA2G4F;PPP3CA;SYT17;PPP3R1;TPM4;FBLN1;S100A1;S100A6;MCTP1;CRACR2A;PVALB
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.387395188574892,1.0490405017704503,0.42092154420921546,0.795364139563052,1.0,17/40,23.49%,DNMT3A;GNMT;COMTD1;N6AMT1;MEPCE;PCMTD2;DNMT1;RRP8;ICMT;DPH5;AS3MT;CARNMT1;TARBP1;FBL;COMT;SETD3;METTL8
prerank,ubiquitin binding (GO:0043130),0.36044906452606945,1.0478371720730406,0.41143497757847536,0.7958853883108948,1.0,24/73,23.45%,CXCR4;FBXW7;NPLOC4;ASCC2;MVB12B;RAD23A;FAF2;UBAP1;USP16;N4BP1;TNFAIP3;PRKN;USPL1;SQSTM1;BIRC2;DDI2;FBXO7;PLAA;RNF19B;VPS36;GGA3;FAF1;RNF168;SPRTN
prerank,nucleotidyltransferase activity (GO:0016779),0.44267763507151003,1.045964553283977,0.41644562334217505,0.7979720133575037,1.0,4/19,9.08%,PAPSS2;TENT4B;PAPSS1;TENT2
prerank,lipoprotein particle receptor binding (GO:0070325),0.41096979114120163,1.0453232642501291,0.42480211081794195,0.7966266928624842,1.0,5/27,15.83%,APOE;LRP1;PICALM;APBB3;SNX17
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.46626775839247836,1.044646281227506,0.4203102961918195,0.7953959367521577,1.0,3/15,8.10%,GPAT2;AGPAT4;ABHD4
prerank,transaminase activity (GO:0008483),-0.42574666725623755,-1.0442133581981718,0.41358024691358025,0.6868780316895783,1.0,3/11,13.81%,BCAT1;AGXT;ABAT
prerank,transforming growth factor beta binding (GO:0050431),0.4279863672574979,1.0426798109880255,0.42452830188679247,0.7977665296005549,1.0,3/23,8.88%,CD36;THBS1;ACVRL1
prerank,tau protein binding (GO:0048156),-0.2854406218295874,-1.041269570375042,0.37575757575757573,0.6871156856974975,1.0,12/40,12.28%,BIN1;MARK3;PPP5C;MAP2;HSP90AA1;PPP2CB;MARK1;CLU;MARK2;MARK4;HDAC6;SMAD2
prerank,estrogen receptor binding (GO:0030331),0.3987064612484013,1.0377555605111264,0.42606516290726815,0.8082940102580185,1.0,10/32,18.57%,CTNNB1;DCAF13;LCOR;STRN;NCOA1;ESR1;DCAF1;LATS1;PPARGC1B;NCOA6
prerank,AMP binding (GO:0016208),0.4957903444085521,1.0372663624603642,0.4462934947049924,0.8065775093112443,1.0,2/11,3.41%,PRKAG2;PYGL
prerank,snRNA binding (GO:0017069),0.383075515625355,1.0360197185755728,0.43337334933973587,0.8070158960347789,1.0,11/42,17.77%,RNPC3;TOE1;RBM41;HNRNPU;PRPF8;LARP7;NCBP2;MEPCE;SNRNP35;RBM7;RBM22
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",-0.4260098386304899,-1.0357406627065697,0.38920454545454547,0.6935815619215958,1.0,2/10,3.23%,EXD2;DCLRE1C
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.3939303188818973,1.0343056016861003,0.4292682926829268,0.808654611761265,1.0,10/35,18.97%,TRMT12;DTWD1;LCMT2;TRDMT1;FTO;DUS2;TARS2;QRSL1;ALKBH1;MTFMT
prerank,pyrophosphatase activity (GO:0016462),0.37643882885453683,1.0289323735255227,0.4310747663551402,0.8202061594332682,1.0,10/50,10.50%,NUDT14;ENPP1;ENTPD1;ITPA;NUDT6;PLPP5;BNIPL;NUDT22;LHPP;ADPRM
prerank,ubiquitin-specific protease binding (GO:1990381),0.42671829470518174,1.0284998772410083,0.4332425068119891,0.8183624370035453,1.0,8/19,25.02%,PTEN;LCOR;RAD23A;PRKN;DERL2;AMFR;VCP;CLTC
prerank,histone acetyltransferase activity (GO:0004402),0.40242888521116477,1.027683143216292,0.4359637774902975,0.8176664976850466,1.0,12/30,25.74%,BAZ1A;CREBBP;EPC1;NCOA3;ARRB1;CLOCK;TAF1;KAT2A;KAT6B;BRCA2;KAT6A;KAT2B
prerank,protein tyrosine kinase binding (GO:1990782),-0.2617166140818322,-1.0259937990035461,0.44545454545454544,0.7100213350335965,1.0,11/71,6.08%,NRG3;GRM5;ACVR1;GRB14;DOCK4;SH2B3;BANK1;NCK1;HSP90AA1;KHDRBS1;RACK1
prerank,DNA binding (GO:0003677),0.3213403047716576,1.0250442590458881,0.395,0.8216715688765024,1.0,164/694,22.11%,EPAS1;PPARG;MMP12;RBMS1;TLR8;NFE2L2;ZNF3;POLR2A;CEBPB;ZEB2;ERCC6;GRHL1;FOXP3;DNMT3A;ZMYM6;C1D;ARID4A;NR1H3;E2F3;FOXO3;APLP2;TFAP2B;MCM9;RXRA;MSH4;JUN;RFC3;PARP4;FOXO4;BRIP1;E2F1;LONP1;FAM111A;PCID2;NUFIP1;AIFM2;NR1H4;CREBBP;POLG2;HNRNPU;PMS1;ATF4;BRCA1;TOP1;POU3F1;ENDOV;SOX9;SNAI2;ZNF148;RAD23A;IRF2;CHD3;CBFB;SMC1A;CARF;TOPORS;ARID5B;HUWE1;CHD2;SNAPC1;TERF1;NR5A1;DDIT3;XRCC4;DNTTIP1;XRCC5;PAX8;NR2C1;DDB1;POLR2G;ZFPL1;POU3F3;FOXO1;POLL;MAFB;DNASE1L1;GTF3C4;PPARD;CUX1;MBD4;NBN;APP;MYRFL;RORA;TBX6;DCLRE1B;PQBP1;CAMTA2;DEDD2;TDP2;POLRMT;WRN;RFX5;RELA;BCLAF1;SSBP1;JRKL;SOX2;POLA1;POU2F1;ZKSCAN3;WBP11;FOXJ3;JUNB;GTF2A1;PRDM2;SLPI;ZNF513;INO80;STN1;ORC1;QRICH1;PCBP1;TWNK;CENPX;DNMT1;HSPD1;DNASE2;TIGD2;MTF1;SIRT3;THRAP3;ATAD5;PLAGL2;RPL7;CRY1;CDT1;ZBTB7A;NKX2-1;SMARCB1;NFYC;RADX;E2F2;CLOCK;FLI1;SOX8;FUBP1;NR2F1;PURB;PRDM16;TCF7L2;TCF4;SAP30L;PHF1;MRE11;TOP3A;POLR3C;SREBF1;CUL4B;ZBTB16;FUBP3;NPAS2;SAFB;RPS27;RAD51B;CEBPA;XPC;TAF1;NR1H2;RTF2;RARB;PRKDC;SNAPC4;CCNT1
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.4038361818041308,1.0239548706281913,0.4265279583875163,0.8216535993786888,1.0,4/27,6.03%,SLC9A3;SLC8B1;SLC8A1;SLC12A3
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.4915626747686692,1.0227393122413488,0.4572784810126582,0.8219890799347047,1.0,7/11,26.56%,SLC35B3;SLC25A42;SLC17A9;SLC19A1;SLC25A17;SLC25A24;SLC25A23
prerank,carboxylic acid binding (GO:0031406),0.3781764958697941,1.022500020094772,0.44485294117647056,0.8197300128259709,1.0,4/38,5.19%,PSAP;SESN2;GNMT;GRIN3B
prerank,adenylyltransferase activity (GO:0070566),0.424980515168948,1.0215127208133068,0.4491180461329715,0.8196021808193571,1.0,4/21,9.08%,TENT4B;COASY;NMNAT1;TENT2
prerank,phospholipid transfer activity (GO:0120014),0.42161817136280466,1.0213305703601872,0.45135135135135135,0.8171721616931485,1.0,7/21,17.98%,CERT1;PLTP;ABCA3;PITPNA;PITPNC1;PRELID3A;PITPNM1
prerank,protein tyrosine phosphatase activity (GO:0004725),-0.2582733926612299,-1.0206713532548592,0.4158415841584158,0.715727843444995,1.0,16/71,11.33%,PTPRD;PTPRM;PTPRT;PTPRG;HACD2;UBASH3B;PTPRO;PTP4A3;PTPRN2;PTPN21;PALD1;PTPDC1;PTPN3;PTPN4;PTPN5;DUSP15
prerank,G protein-coupled receptor activity (GO:0004930),0.323240280254419,1.020397703270148,0.4564777327935223,0.8167400425954631,1.0,25/239,11.30%,ADGRE5;APLNR;CXCR4;TAS1R3;HRH1;GPR15;ADGRG3;ADRA1D;ADRA1A;P2RY14;GPR157;C3AR1;LPAR2;GPR83;GPR171;CNR2;ADGRE1;PTAFR;GPR176;VIPR1;PAX8;PTH2R;GPR173;GRPR;XPR1
prerank,myosin II binding (GO:0045159),0.49103408403375,1.0197543439229082,0.4813664596273292,0.8156201129319829,1.0,2/10,7.75%,TRIOBP;STXBP5
prerank,chemokine receptor binding (GO:0042379),-0.2998446741851214,-1.019410379985516,0.39644970414201186,0.712102264261991,1.0,3/35,7.30%,CX3CR1;CCL4;CXCL16
prerank,peptidase activator activity (GO:0016504),0.4081693224922064,1.0192163707135866,0.45478374836173,0.8141383667101244,1.0,9/22,22.96%,TANK;PCOLCE2;NLRC4;PSMD14;PSME2;CLPX;VCP;APH1B;PSME3
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.47641851606280117,1.0187012961668673,0.47205882352941175,0.8127041202172438,1.0,2/12,5.95%,NQO2;AIFM2
prerank,muscle alpha-actinin binding (GO:0051371),0.4483533536958559,1.017429622332329,0.45863570391872277,0.813044517860691,1.0,2/15,6.79%,PALLD;PDLIM5
prerank,intracellular chloride channel activity (GO:0061778),0.4490114413704888,1.0165063062291855,0.44846796657381616,0.8098052146902635,1.0,2/16,2.68%,ANO6;TTYH2
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.4490114413704888,1.0165063062291855,0.44846796657381616,0.8098052146902635,1.0,2/16,2.68%,ANO6;TTYH2
prerank,tumor necrosis factor receptor binding (GO:0005164),0.4721413979085556,1.0101001511838508,0.4622222222222222,0.8235107249137403,1.0,5/12,16.07%,BABAM2;TRAF1;TRAF3;TRAF5;TRAF2
prerank,poly-pyrimidine tract binding (GO:0008187),0.4192046002224447,1.009237426505446,0.47692307692307695,0.8229292307334599,1.0,5/23,14.58%,RBMS1;ATXN1;HNRNPU;PATL1;MCRS1
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.42932677080385784,-1.0091640755362432,0.4346590909090909,0.7295797669899886,1.0,5/10,31.09%,KAT8;NAA60;MSL3;NAA40;HAT1
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.4942188412095688,1.008685990687807,0.4761194029850746,0.821577107730681,1.0,1/10,3.14%,CDKN1A
prerank,deubiquitinase activity (GO:0101005),0.3400712276238254,1.0066038853216215,0.4908108108108108,0.8240742058045295,1.0,26/88,22.04%,MINDY1;MINDY4;TANK;USP42;USP12;VCPIP1;COPS5;USP40;USP26;USP48;PSMD14;USP21;USP16;TNFAIP3;USP36;BRCC3;USP8;OTUD5;EIF3H;USP32;USP30;ATXN3;STAMBP;USP3;USP9X;USP2
prerank,protein kinase C activity (GO:0004697),0.45595644821450265,1.0049074068396306,0.45185185185185184,0.8256798180610474,1.0,5/14,15.75%,PRKCH;PRKCD;PRKCB;PRKCG;PRKD3
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.4232868798144921,1.0022558240644297,0.47441217150760717,0.8296370810843577,1.0,9/20,29.24%,SLC39A14;SLC39A12;SLC39A3;SLC39A11;SLC30A1;SLC39A10;SLC39A1;SLC39A13;SLC30A5
prerank,phosphatidylglycerol binding (GO:1901611),0.4601296897864404,1.0013538555996657,0.49255952380952384,0.829243954512951,1.0,5/13,23.70%,PLTP;PITPNA;PITPNC1;GSDMD;PLEKHN1
prerank,adenyl nucleotide binding (GO:0030554),0.46308666336649007,0.9997727705303737,0.5066864784546805,0.8276059774309074,1.0,8/11,30.40%,SIL1;BAG4;PFN1;BAG1;HSPBP1;BAG3;GRPEL2;HSPH1
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.46308666336649007,0.9997727705303737,0.5066864784546805,0.8276059774309074,1.0,8/11,30.40%,SIL1;BAG4;PFN1;BAG1;HSPBP1;BAG3;GRPEL2;HSPH1
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.46644215413624396,0.9951548729382595,0.487256371814093,0.8366542397882379,1.0,7/12,26.56%,SLC35B3;SLC25A42;SLC17A9;SLC19A1;SLC25A17;SLC25A24;SLC25A23
prerank,SH2 domain binding (GO:0042169),-0.29408629087514293,-0.9932557717471011,0.44075829383886256,0.7609592386417512,1.0,5/31,6.08%,PAG1;ARHGAP5;IRS1;KHDRBS1;RACK1
prerank,motor activity (GO:0003774),0.34885288096911143,0.9929827524420997,0.489337822671156,0.8392784012475011,1.0,14/60,18.32%,KIF13B;KIF20B;MYO1E;KIF9;KIF16B;KIF27;KIF3A;DYNLRB1;KIF6;MYH9;SMC3;KIF5B;KIF5C;DNAH3
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.4783003945747819,0.9920267636136516,0.4699537750385208,0.8389979572227141,1.0,5/10,23.56%,NSD3;SMYD2;ASH1L;SETD3;SETD5
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.41896768724195765,-0.9920254062528066,0.4720670391061452,0.7499968231533046,1.0,2/10,6.49%,DUSP6;DUSP7
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.41896768724195765,-0.9920254062528066,0.4720670391061452,0.7499968231533046,1.0,2/10,6.49%,DUSP6;DUSP7
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.398147501676254,0.9883765768076985,0.4926372155287818,0.8451533723675159,1.0,2/24,3.20%,AK8;ITPKB
prerank,GTP binding (GO:0005525),0.3172218372495499,0.9877156736034465,0.5348360655737705,0.8439876401214293,1.0,43/172,20.55%,RASEF;RAP2A;TGM2;RAB7A;LANCL2;RHOJ;EEF1A1;RAB21;NRAS;GBP6;MFHAS1;RAB31;RAB1B;RAB28;RRAD;ARL8B;RAP2B;RHOD;RAB10;RAB11B;ATL2;RIT1;TUBA1A;ARL4C;ARL8A;ARL3;RRAS;ATL1;TUBA1C;RND2;RAB2A;RAB29;RAB22A;RABL6;ARF4;ADSS1;EIF2B2;RHEB;ARF5;GCH1;ARL5B;RAB13;TUBE1
prerank,ribosomal large subunit binding (GO:0043023),0.46649387833767847,0.9865244644579217,0.4940119760479042,0.8442637360234883,1.0,8/11,31.47%,EIF6;MALSU1;CPEB2;NMD3;CPSF6;NEMF;MRRF;DHX33
prerank,P-type ion transporter activity (GO:0015662),0.4582895432543326,0.9849010104204557,0.514018691588785,0.8454603858334774,1.0,2/12,3.33%,ATP6V1E1;ATP2B1
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.32539739544811846,-0.9830289013978529,0.45348837209302323,0.7645258063988752,1.0,13/21,49.04%,FGF2;FGF10;FRS3;FGF7;NPTN;FGF5;KL;FGF20;FGF18;FGF16;FGF23;KLB;FGF22
prerank,carboxy-lyase activity (GO:0016831),0.39617567390501335,0.9824730142110514,0.5053475935828877,0.848803877162375,1.0,7/23,21.75%,MVD;UMPS;ACOD1;AZIN1;ECHDC1;AZIN2;UXS1
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.39435739296178207,0.9819458669829779,0.515748031496063,0.8474808312349609,1.0,14/27,24.92%,RNF19A;ARIH2;DCUN1D5;DCUN1D3;DCUN1D4;PRKN;DCUN1D1;RNF19B;RNF125;SIAH2;ARIH1;TRAF6;RNF180;DCUN1D2
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.3910670985542737,0.9814630724514817,0.4986737400530504,0.8459811569326708,1.0,3/26,8.01%,SLC6A6;SLC16A1;SLC27A1
prerank,guanyl ribonucleotide binding (GO:0032561),0.3128660947472315,0.981362423325781,0.5429726996966633,0.8434837106209235,1.0,45/196,19.44%,RASEF;RAP2A;RAB8B;TGM2;RAB7A;LANCL2;RHOJ;EEF1A1;RAB21;NRAS;GBP6;MFHAS1;RAB31;RAB1B;RAB28;RRAD;ARL8B;RAB12;RAP2B;RHOD;RAB10;RAB18;RAB11B;ATL2;RIT1;TUBA1A;ARL4C;ARL8A;ARL3;RRAS;ATL1;TUBA1C;RND2;RAB2A;RAB29;RAB22A;RABL6;ARF4;ADSS1;EIF2B2;RHEB;ARF5;SLC19A1;GCH1;ARL5B
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.3981743901061709,0.9779382196088601,0.5116279069767442,0.8488176825582119,1.0,8/22,26.75%,APOE;PICALM;APBB3;SNX17;DNAJA1;LDLRAP1;CLTC;AP2A1
prerank,peptide N-acetyltransferase activity (GO:0034212),0.47147466838082414,0.977320325271068,0.5147058823529411,0.8476421183359018,1.0,5/10,22.19%,NAA10;NAA30;NAA25;NAA80;NAA15
prerank,calcium channel regulator activity (GO:0005246),0.3666134116721873,0.9767958810791042,0.511377245508982,0.8461177116764724,1.0,8/37,19.32%,SGK1;RRAD;NRXN2;CACNB3;STIMATE;SRI;CALM2;SLC30A1
prerank,hexosaminidase activity (GO:0015929),0.4493234595046725,0.9762330791073657,0.5082956259426847,0.84477599089249,1.0,4/12,12.27%,CEMIP2;HEXA;OGA;HEXD
prerank,glutamate receptor binding (GO:0035254),-0.34931464161794856,-0.9741072129388738,0.46488294314381273,0.7799613368202742,1.0,10/17,24.78%,IGSF11;HOMER1;SHISA6;SYNDIG1;CAMK2A;AKAP5;SHISA7;SHANK2;NSF;GNAS
prerank,aspartic-type endopeptidase activity (GO:0004190),0.4513854673851378,0.9702219977653478,0.5278969957081545,0.8566950469050915,1.0,7/12,30.05%,BACE1;HM13;DDI2;SPPL3;SPPL2A;PSEN1;NAPSA
prerank,epidermal growth factor receptor binding (GO:0005154),-0.30339828140259206,-0.9686917991804386,0.49130434782608695,0.7873447182390991,1.0,6/25,11.70%,ERBB4;TGFA;FER;SNX2;TNK2;LINGO1
prerank,phosphoric diester hydrolase activity (GO:0008081),-0.28383039166282586,-0.9679761527374787,0.47474747474747475,0.7821516783645808,1.0,18/35,24.34%,PLCL1;ENPP2;PLD4;PDE11A;MPPED2;SMPD3;GDPD3;PDIA3;PLCXD3;SMPDL3B;SMPD1;SMPD4;SMPD2;PLCB3;ENPP3;FAM83B;ENPP6;MPPE1
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.44132342987823936,0.9669493976856481,0.4910979228486647,0.8618997432136546,1.0,1/12,0.65%,B3GNT8
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.3735249193137764,0.9669062537828625,0.5435056746532156,0.8593276788184014,1.0,15/33,24.92%,RNF19A;TCERG1;ARIH2;DCUN1D5;DCUN1D3;DCUN1D4;PRKN;DCUN1D1;RNF19B;RNF125;SIAH2;ARIH1;TRAF6;RNF180;DCUN1D2
prerank,DNA-binding transcription factor binding (GO:0140297),0.3132568863242174,0.9668238645556951,0.5785207700101317,0.856835841107519,1.0,51/189,22.79%,PPARG;NFE2L2;CTNNB1;ID2;JUN;NCOR1;FOXO4;ZMYND8;TCERG1;CRTC1;SIK1;CREBBP;BHLHE40;ATF4;PIAS4;RB1;WWP2;HIPK2;DDIT3;GSK3B;SIRT1;RERE;PPARD;NBN;TBX6;DDX20;HCLS1;RELA;DGKQ;NHLH2;TCF12;ZBTB7A;GABPA;CREB1;NOC2L;BBS7;CRTC3;PURB;PRDM16;PIAS2;TCF7L2;BBS1;SPEN;SIN3A;PIAS1;DMAP1;TAF1;CBX5;TLE3;STAT3;CTBP1
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.3038140663155119,0.9644580252336217,0.641,0.8596287214719337,1.0,107/597,20.16%,PPARG;TFEC;ELF2;IRX3;TFEB;NFE2L2;CEBPB;GRHL1;FOXP3;EN2;ATF3;RUNX2;ARID4A;NR1H3;E2F3;FOXO3;TFAP2B;RUNX3;MCM9;RXRA;JUN;NCOR1;RARA;MZF1;FOXO4;E2F1;TAF7;RNF10;NR3C1;BHLHE40;HNRNPU;KLF5;TGIF1;ATF4;ZBTB20;BRCA1;ZNF177;POU3F1;SOX9;SNAI2;GABPB1;GABPB2;FOXP1;IRF2;CHD3;BRD7;ARID5B;TBL1XR1;NR5A1;DDIT3;XRCC5;PAX8;ESR1;NR2C1;PSPC1;FOXK1;MAFG;NFATC3;PPARD;CUX1;MBD4;SP3;TBX6;RFX1;RFX5;RELA;BBX;SOX2;BCL11B;POLA1;FOXJ3;SUV39H2;JUNB;ZNF513;PER3;ORC1;ETV3;MBNL2;HSPD1;NHLH2;KLF6;ZNF32;ORC4;MTF1;TCF12;CREB3L4;CREB3;ZBTB7A;NKX2-1;GABPA;NFYC;CREB1;ZNF23;ZBTB7B;E2F2;HOXD8;CLOCK;FLI1;SOX8;NFIC;CREB3L1;NR2F1;PRDM16;TCF7L2;TCF4;SP8;HSF2
prerank,MAP kinase activity (GO:0004707),0.4407212702246305,0.96335411611325,0.5298507462686567,0.8594186645652109,1.0,2/14,5.25%,MAPK6;MAPK7
prerank,syntaxin binding (GO:0019905),0.3350749968289575,0.962236441390682,0.5317919075144508,0.8595634323640632,1.0,18/61,20.56%,ABCA1;SNAP29;DAPK1;STX8;VPS54;STXBP5;SYT17;VPS52;STXBP3;VAMP3;SYPL1;STX6;VPS11;SNAP47;BAIAP3;STXBP2;VAMP2;SNAP23
prerank,5'-3' exonuclease activity (GO:0008409),-0.36063209588588463,-0.9620465143022762,0.48494983277591974,0.7895880024821568,1.0,8/14,29.79%,DCLRE1C;TRIR;XRN1;CPSF3;DCLRE1A;EXO1;FEN1;DCP2
prerank,acylglycerol lipase activity (GO:0047372),0.45273614585121846,0.9596357393556422,0.532448377581121,0.863071839255193,1.0,1/11,1.78%,MGLL
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.43699080529416773,0.9568118689350316,0.5350609756097561,0.8668497933561101,1.0,8/12,28.37%,GTF2B;RELA;POU2F1;GTF2A1;TAF1;RUVBL2;HDAC1;FOS
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.3918174003413025,-0.9546509332026457,0.5400593471810089,0.8017209139985895,1.0,1/11,0.86%,SRRM2
prerank,endopeptidase inhibitor activity (GO:0004866),0.3248815241833359,0.9530014575193806,0.5633802816901409,0.8728286172188414,1.0,14/82,14.45%,TIMP1;ITIH2;BIRC6;RENBP;ANXA2;TIMP2;ITIH3;ROCK1;PSMF1;APP;BST2;SERPINB8;SLPI;SERPINC1
prerank,nuclear receptor coactivator activity (GO:0030374),0.3394383965033723,0.9526453092530232,0.5679723502304147,0.8708771324453439,1.0,15/52,19.02%,ZMIZ1;MED12;ACTN1;NCOA3;NCOA1;WDR77;PRKCB;PPRC1;BUD31;CNOT6;PPARGC1B;THRAP3;CCAR1;NCOA6;NCOA2
prerank,solute:sodium symporter activity (GO:0015370),-0.3004710186274157,-0.9525671606868281,0.5450819672131147,0.8001305169999073,1.0,3/27,9.70%,SLC4A7;SLC4A10;SLC4A8
prerank,diacylglycerol kinase activity (GO:0004143),0.4511729311393259,0.9518450805619182,0.536697247706422,0.8699967775280089,1.0,4/11,17.23%,DGKZ;DGKA;DGKQ;DGKG
prerank,protein kinase regulator activity (GO:0019887),-0.2293358728127989,-0.9503338797148189,0.5333333333333333,0.7987158766234036,1.0,33/95,20.65%,CCND3;RPTOR;CCNC;CCNG2;STK11;CDK5R1;NCK1;FGF13;MADD;RPLP1;QARS1;MARK2;PARVA;CCNL2;MAPK8IP1;SMCR8;WNK1;CCNI;PRKRIP1;SH3BP5L;ANKRD54;PRKAR2B;CSNK2B;TPX2;CCNJ;CCNF;NPM1;CCNJL;RGCC;STRADA;AGAP2;DUSP19;CCNQ
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.42345042549510115,0.9500027756225443,0.5331412103746398,0.8716192323624203,1.0,2/15,9.26%,PLA2G2D;PLA2G4F
prerank,telomeric DNA binding (GO:0042162),0.36629437816945104,0.9495886309536279,0.5498783454987834,0.8699110602175036,1.0,8/32,14.85%,ACD;TERF1;XRCC5;WRN;TEN1;UPF2;HNRNPD;STN1
prerank,endonuclease activity (GO:0004519),0.3424399198330099,0.9492469588557229,0.5646100116414435,0.8680511303079211,1.0,9/49,12.49%,ERN1;ZRANB3;AGO2;RNASEL;NOB1;AGO3;MBD4;SND1;LACTB2
prerank,dynactin binding (GO:0034452),0.4447497575734721,0.947955244509834,0.5514705882352942,0.8683685887456384,1.0,5/12,18.65%,HOOK3;SNX5;GSK3B;PAFAH1B1;HTT
prerank,ephrin receptor binding (GO:0046875),0.39680368940893723,0.9469948143539378,0.5465425531914894,0.8679427834321352,1.0,5/21,16.37%,GRB2;ANKS1B;SHC1;CBL;PTPN1
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.39301542835569003,-0.946249588066636,0.5141242937853108,0.8015763051505362,1.0,4/10,13.79%,GABRA2;GABRA3;GABRG3;GABRA4
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.3604478778259745,0.9454294568888131,0.5602484472049689,0.8688049564365423,1.0,9/34,22.11%,IQGAP1;STK3;INCENP;DBF4;STK4;CALM2;CAB39;RICTOR;CCNT1
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.4196905928658739,0.9442437282939623,0.5616835994194485,0.868799815485476,1.0,5/15,17.41%,ALDH3A2;ALDH1A2;ALDH2;ALDH7A1;ALDH9A1
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.3768742172966502,0.9436802662440457,0.5512321660181583,0.8673921214643425,1.0,6/25,16.90%,GAB2;KIF16B;SESTD1;PLEKHA1;MAPKAP1;NCF1
prerank,voltage-gated ion channel activity (GO:0005244),-0.35371029026317435,-0.9418761225870823,0.5259515570934256,0.805678511288767,1.0,3/14,1.15%,KCND2;HCN1;CACNA1E
prerank,nuclease activity (GO:0004518),0.34028392133151825,0.9408351939078007,0.5869311551925321,0.8712042491148054,1.0,12/52,17.16%,ENPP1;RNASE3;RNASEL;DFFB;DNASE1L1;SND1;WRN;N4BP1;RNASEH2A;RNASEH1;ISG20L2;REXO5
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),-0.2801887970860739,-0.939819143795527,0.5340314136125655,0.8036998559829498,1.0,9/29,17.04%,RPTOR;SPRED1;CIT;PKIG;PKIA;SPRED2;YWHAG;INCA1;PRKAR2B
prerank,microtubule motor activity (GO:0003777),0.33755038479242366,0.9389945770644633,0.5743707093821511,0.8727681052113508,1.0,12/51,18.32%,KIF13B;KIF20B;KIF9;KIF16B;KIF27;KIF3A;DYNLRB1;KIF6;SMC3;KIF5B;KIF5C;DNAH3
prerank,sodium channel regulator activity (GO:0017080),0.3505721319430452,0.9374793633142837,0.5799256505576208,0.8734822897870342,1.0,7/37,13.24%,SGK1;RANGRF;FGF11;GPD1L;NEDD4L;GPLD1;PRSS8
prerank,death receptor activity (GO:0005035),0.43730626826575497,0.9347565664369317,0.5568862275449101,0.8767949163324406,1.0,2/11,4.35%,FAS;TNFRSF1B
prerank,receptor tyrosine kinase binding (GO:0030971),0.32845233055974543,0.9319451207535743,0.5757575757575758,0.8804027170508234,1.0,14/56,17.98%,CBLB;GAB2;DUSP3;TRAT1;STAP1;BLNK;SH2B2;GAS6;SQSTM1;SHC1;CBL;FRS2;PTPN1;PITPNM1
prerank,cytokine activity (GO:0005125),0.30104766404956085,0.9309293532715778,0.6230529595015576,0.8801182425505588,1.0,5/131,2.99%,GDF15;TIMP1;VEGFA;IL36G;IL6
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.3704941015583495,-0.9300512189054404,0.5571847507331378,0.8200497254627013,1.0,4/12,11.57%,PDE3B;PDE8B;PDE4B;PDE4A
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.4490204649023746,0.9298991430692966,0.5500770416024653,0.8798183707856629,1.0,1/11,1.90%,AQP1
prerank,peptide hormone receptor binding (GO:0051428),-0.37281717941993786,-0.9295526707859895,0.5446685878962536,0.8145068259746309,1.0,5/11,40.10%,ADCYAP1;CCK;PTHLH;GNRH1;VIP
prerank,nucleoside-triphosphatase activity (GO:0017111),0.2949660914333682,0.9293356951472771,0.6797583081570997,0.8783745196349465,1.0,47/248,17.12%,RAP2A;RAB8B;KIF20B;MYO1E;GNAQ;RAB20;RAB7A;ATP2B1;ABCD1;RHOJ;RAB33B;GNA13;EEF1A1;RAB21;NRAS;GNA12;MYO19;HSPA1B;GBP6;RAB31;RAB1B;ABCA3;CHD3;RAB28;ARL8B;GNG11;RAP2B;RHOD;RAB18;TBC1D24;GNGT2;RAB24;MYH9;RAB43;RAB11B;ATL2;RIT1;HSPA1A;ARL8A;RRAS;ATL1;RND2;RAB2A;RAB29;ABCG4;RAB22A;MTG1
prerank,protein tyrosine kinase activity (GO:0004713),0.30696988540258585,0.9290826430129604,0.6240760295670539,0.8763028538874621,1.0,18/108,13.54%,SYK;WEE2;FRK;TEC;ABL2;FGFR4;MERTK;MELK;DYRK1A;PKDCC;HIPK1;HIPK2;PTK2B;FES;ROR1;BTK;DYRK2;FGR
prerank,kinesin binding (GO:0019894),0.3715370843462805,0.9272411237336943,0.5837628865979382,0.8775955999123141,1.0,11/27,25.74%,PLEKHM2;AP1G1;SPAG9;RAB29;ARHGEF10;IFT88;TOR1A;CROCC;SPTBN5;ACTB;MAPK8IP3
prerank,myosin V binding (GO:0031489),-0.338378706126695,-0.926746423349022,0.5596026490066225,0.814673106070794,1.0,5/15,19.56%,RAB6B;RAB8A;RAB11A;RAB3B;RAB39B
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.41872204675015345,0.9265868409637072,0.5883977900552486,0.8764012744029586,1.0,3/14,11.70%,TIMP1;TIMP2;BST2
prerank,kinase binding (GO:0019900),0.2918748236036065,0.9261682581896626,0.7284569138276553,0.8746980660987994,1.0,73/434,15.78%,IQGAP1;LYST;SASH1;TPCN2;KIF13B;GRB2;MAP3K1;CTNNB1;POLR2A;PRAM1;TFRC;PRKAG2;WWC2;PRKCD;CDKN1A;FOXO3;TOM1L2;FAS;FAM83F;EEF1A1;MAML1;DUSP3;SIKE1;GADD45A;NR3C1;IFNAR2;WDCP;GSKIP;SIK1;IRAK3;APC;ATF4;CACUL1;MSN;STAP1;RB1;CNKSR2;BLNK;RAD23A;DVL1;ACVRL1;HNRNPA0;MAVS;ESR1;RHOD;GSK3B;PAK2;CCNA2;STUB1;MIDN;FZD5;TAX1BP1;RELB;HCLS1;SYN1;RELA;ATG13;ERCC6L2;DGKQ;POLA1;VDAC1;FGR;PRKN;CEP192;SLC12A7;SQSTM1;SHC1;MAP3K2;LATS1;MAPKAP1;STK11IP;RND2;UTRN
prerank,poly(U) RNA binding (GO:0008266),0.3943968943640638,0.9261395965463556,0.5699208443271768,0.8722416098917498,1.0,2/20,1.94%,RBMS1;ATXN1
prerank,mitogen-activated protein kinase binding (GO:0051019),0.3617096684385167,0.9260480473418842,0.5798212005108557,0.8699107543188368,1.0,8/29,19.92%,MAPKAPK3;TNIP1;MAPK7;TPR;SIRT1;ACE;GCH1;DUSP10
prerank,gated channel activity (GO:0022836),0.41869592308352716,0.9259200076345057,0.5815295815295816,0.8676710706282491,1.0,3/14,11.82%,TMEM266;PIEZO1;PIEZO2
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.38687849652893047,0.9258157210045889,0.5751724137931035,0.8654053890219138,1.0,2/20,2.02%,AK8;MPP1
prerank,RNA polymerase core enzyme binding (GO:0043175),0.3515088003676574,0.9255335734172712,0.5739130434782609,0.8634869712067906,1.0,11/33,22.76%,WAC;GTF2B;AGO2;HNRNPU;NCOA3;SMYD2;CDC73;ELP4;RRN3;WDR43;SUPT4H1
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.36737913949641376,0.9249418046492278,0.5732484076433121,0.8622297291712016,1.0,6/25,19.69%,POR;CYP46A1;MICAL2;MTRR;CYP27A1;MICAL1
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.35455239077556855,-0.9226317054191312,0.5578635014836796,0.8174968365295011,1.0,7/12,18.12%,EIF4E2;GEMIN5;DCPS;NCBP3;LARP1;CYFIP1;EIF4E3
prerank,DNA replication origin binding (GO:0003688),0.37400822086350993,0.920107300310022,0.6048714479025711,0.8699285426585036,1.0,5/23,16.14%,MCM9;POLA1;ORC1;HSPD1;ORC4
prerank,transcription coactivator binding (GO:0001223),-0.3004386603059905,-0.9198931000701677,0.5580524344569289,0.8173493312998683,1.0,8/20,18.77%,SMAD3;CIT;MED25;PGR;AR;CDK9;AHR;SMAD4
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.43814691154933977,0.919447632729333,0.5931952662721893,0.8687698006819115,1.0,4/12,14.36%,KDM4C;KDM3A;JMJD1C;KDM7A
prerank,protein phosphatase 1 binding (GO:0008157),0.3847794499961599,0.9191652051517735,0.5956284153005464,0.8668771822277282,1.0,3/21,13.62%,LILRB1;PPP1R9B;PHACTR4
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.34814734491974464,-0.9190262027247588,0.5627009646302251,0.81292685997506,1.0,4/14,10.09%,SLC1A3;SLC17A6;SLC1A2;SLC1A1
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.3500893497090185,0.9188733948846839,0.5667915106117354,0.8650088186905156,1.0,9/33,16.99%,WAC;GTF2B;AGO2;HNRNPU;NCOA3;LLPH;SMYD2;CDC73;ELP4
prerank,calcium:sodium antiporter activity (GO:0005432),-0.38054855167456164,-0.918640087087933,0.5880597014925373,0.8073474820981902,1.0,2/10,2.00%,SLC24A3;SLC24A2
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.35367277973888434,0.9159853153364299,0.6044499381953028,0.8683346038685228,1.0,9/34,16.78%,TOE1;EXOSC3;CNOT6L;EXOSC9;CNOT7;ERI1;CNOT6;EXOSC10;PAN3
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.2931004163248335,0.915171544589989,0.7155778894472362,0.8675833895356506,1.0,68/254,25.16%,TFEC;LITAF;MITF;GRHL1;ATF3;VEZF1;E2F3;FOXO3;TFAP2B;JUN;MZF1;FOXO4;NR3C1;NR1H4;KLF5;ATF4;REL;RREB1;SOX9;IRF2;DDIT3;ESR1;FOXO1;SALL2;NFATC3;RFX5;RELA;FOXJ3;SMARCD1;ATF1;PRDM2;KLF6;MTF1;TCF12;CREB3;PLAGL2;GABPA;NFYC;CREB1;ZNF319;E2F2;HOXD8;CLOCK;STAT6;NFIC;CREB3L1;PRDM16;TCF4;HSF2;ZFP62;ZBTB16;MLXIP;HNF4G;CEBPA;NR1H2;HOXB3;STAT3;TFCP2;GMEB1;CASZ1;EGR2;TFDP1;NRF1;MYBL1;SOX4;ELF1;NFAT5;SMARCD2
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.3873668345005934,0.9137819180004905,0.5929919137466307,0.8680791325111844,1.0,2/20,2.54%,GPAT2;AGPAT4
prerank,protein kinase binding (GO:0019901),0.2857614845562334,0.912422487334251,0.787,0.8686071456234825,1.0,85/479,16.07%,IQGAP1;LYST;SASH1;TPCN2;KIF13B;GRB2;NEDD9;MAP3K1;MAPKAPK3;PRAM1;TFRC;PRKAG2;ADAM9;PRKCD;CDKN1A;FOXO3;TNIP1;TOM1L2;FAM83F;RARA;MAPK7;EEF1A1;MAML1;DUSP3;NELL2;SIKE1;NR3C1;IFNAR2;GSKIP;SIK1;PPEF2;IRAK3;APC;PDLIM5;ATF4;CACUL1;MSN;STAP1;SOX9;CNKSR2;SIRPA;BLNK;DVL1;ACVRL1;HNRNPA0;BMPR2;TPR;ITGB1;MAVS;ESR1;RHOD;GSK3B;PAK2;SIRT1;CCNA2;PRKCB;FZD5;STK38;RELB;APPL1;TREM2;SPAG9;HCLS1;SYN1;RELA;ATG13;ERCC6L2;POLA1;VDAC1;FGR;PRKN;CEP192;SLC12A7;SQSTM1;PARD6A;SHC1;MAP3K2;LATS1;CD247;MAPKAP1;STK11IP;RND2;UTRN;NELL1;TRAF2
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.35925864235634986,0.912068800503509,0.5865139949109415,0.8668780828435613,1.0,8/28,16.22%,RIPK1;BABAM2;TRAF1;TRAF3;TRAF5;MYD88;TRAF2;BID
prerank,RNA polymerase II complex binding (GO:0000993),0.35033334089608736,0.9116951846805328,0.5924528301886792,0.8652014415245959,1.0,11/32,22.76%,WAC;GTF2B;AGO2;HNRNPU;NCOA3;SMYD2;CDC73;ELP4;PCIF1;WDR43;SUPT4H1
prerank,growth factor activity (GO:0008083),0.3091108001102065,0.911039404622746,0.6052631578947368,0.8641432329873128,1.0,5/74,4.94%,VEGFA;IL6;HGF;PDGFA;OSGIN1
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.44499482369154,0.9094576256187422,0.6012084592145015,0.8648707701233995,1.0,4/10,19.31%,TNFAIP3;OTUD5;ATXN3;STAMBP
prerank,sodium:proton antiporter activity (GO:0015385),-0.3588112377004414,-0.9070055771818855,0.5454545454545454,0.8267376370675631,1.0,1/11,0.23%,SLC9A9
prerank,potassium:proton antiporter activity (GO:0015386),-0.3632465575344519,-0.9069930600824678,0.5825825825825826,0.8203865583629181,1.0,1/10,0.23%,SLC9A9
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.3315546885989389,0.9054606566507644,0.6109785202863962,0.8704890078385245,1.0,6/46,7.45%,B3GNT8;GCNT2;MGAT5;EXT1;HEXA;LFNG
prerank,cytochrome-c oxidase activity (GO:0004129),0.4019866442672739,0.9047506790222827,0.5911680911680912,0.8694356262687946,1.0,6/15,22.61%,COX6A1;CYB5A;COX8A;COX15;COX4I1;COX5A
prerank,UDP-glycosyltransferase activity (GO:0008194),0.31270913629063973,0.9030714706797814,0.6416573348264277,0.8703647896246838,1.0,8/70,7.78%,B3GNT8;GCNT2;EXT1;HAS3;HEXA;B3GALNT2;LFNG;GXYLT2
prerank,mRNA binding (GO:0003729),0.2842304289731284,0.8990943045916052,0.7236180904522613,0.875790516828998,1.0,59/249,19.72%,RBMS1;HNRNPLL;SAMD4A;RBM47;CPEB4;UTP23;DDX6;HNRNPAB;CELF1;IGF2BP3;YTHDF3;AGO2;EIF3A;DDX5;RPS14;CSTF3;HNRNPU;LARP4B;RBPMS;ETF1;PUM3;MRPS7;HNRNPA0;SF1;TPR;SERBP1;EIF4A1;GRSF1;RBPMS2;PTBP3;NCBP2;HNRNPM;THOC2;PUM2;PTBP2;SNRNP35;N4BP1;RPS26;PPIE;SLPI;SRBD1;ADARB1;EIF4A3;PCBP1;NUP98;EDC3;SYNCRIP;LUC7L;RPL7;RPL26;C1QBP;EIF2S2;SECISBP2L;EIF4G3;EIF4G2;FUBP1;CPEB2;NCL;PURB
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.34856204376554195,0.8987326996891425,0.6385093167701863,0.8741215287762856,1.0,8/33,15.92%,TOE1;EXOSC3;CNOT6L;EXOSC9;CNOT7;ERI1;CNOT6;EXOSC10
prerank,chemokine binding (GO:0019956),0.3509834477784112,0.8985758997609642,0.6155810983397191,0.8720631157632945,1.0,3/30,3.95%,CXCR4;ITGA4;XCR1
prerank,G protein-coupled receptor binding (GO:0001664),0.2899549092539482,0.8981743995609005,0.6770508826583593,0.8704916006441944,1.0,25/132,20.00%,SDCBP;GNAQ;GNA13;HOMER3;ZNRF3;GNA12;HSPA1B;PDCD6IP;DVL1;FZD7;STUB1;PRKN;HSPA1A;LRP6;CXCL12;ARRB1;CCDC88C;GPRASP2;ACE;C1QBP;RNF43;CALCA;CCL25;DNAJA1;BBS1
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.3728828380078697,0.8977918551261116,0.6172506738544474,0.8689285345311111,1.0,2/21,7.23%,P2RX4;P2RX3
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.2913034813840161,-0.897383121955852,0.6141078838174274,0.8353433635634243,1.0,4/23,4.92%,CCR5;PLCB1;CHRM3;PLCH1
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.37436737264522546,-0.8954099826691666,0.5861111111111111,0.8334046266034716,1.0,3/10,14.24%,ANKRD13B;IDE;ANKRD13A
prerank,O-methyltransferase activity (GO:0008171),-0.3577953617541087,-0.8940506460998968,0.6112759643916914,0.8301005960386276,1.0,4/10,18.76%,COQ3;CMTR1;BCDIN3D;ASMT
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.3793342952892711,0.8933027382036497,0.625,0.8752474832381781,1.0,6/18,22.41%,ALDH3A2;ALDH1A2;ALDH2;ALDH18A1;ALDH9A1;HSD17B12
prerank,insulin-like growth factor binding (GO:0005520),0.3883264539081826,0.8932619855630995,0.6214689265536724,0.8730057955900871,1.0,5/15,21.95%,IGF2R;IGFALS;LRP2;ITGAV;IGFBP3
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.28048070475235937,0.8926982027233634,0.882,0.871815799310965,1.0,157/831,21.63%,EPAS1;PPARG;TFEC;LITAF;IRX3;TFEB;TRPS1;NFE2L2;ZNF3;MITF;CEBPB;ZEB2;GRHL1;FOXP3;EN2;DNMT3A;ST18;ATF3;VEZF1;RUNX2;NR1H3;E2F3;FOXO3;ZNF160;ZNF692;TFAP2B;RUNX3;RXRA;JUN;RARA;ZFP28;MZF1;GTF2B;FOXO4;BACH1;E2F1;ZBTB42;STAT5B;NR3C1;NR1H4;BHLHE40;HNRNPU;KLF5;TGIF1;ATF4;REL;ZBTB20;ZNF177;ETV6;RREB1;TOP1;POU3F1;SOX9;SNAI2;RBAK;RB1;HOXA3;ZNF148;FOXP1;IRF2;ZFAT;CARF;CHD2;DACH1;NR5A1;DDIT3;PAX8;ESR1;NR2C1;FOXK1;MAFG;POU3F3;FOXO1;MAFB;SALL2;NFATC3;PPARD;CUX1;ZNF691;ZKSCAN7;SP3;RORA;TBX6;SARS1;RELB;RFX1;MAZ;RFX5;RELA;BBX;SOX2;BCL11B;HBP1;POU2F1;ZKSCAN3;FOXJ3;PGBD1;JUNB;ATF1;GTF2A1;ZKSCAN5;PRDM2;NHLH2;KLF6;ZNF32;MYT1;MTF1;THRAP3;TCF12;CCAR1;ZBTB11;CREB3L4;CREB3;ZNF18;ZBTB7A;NKX2-1;ZBTB41;GABPA;NFYC;CREB1;ZNF23;ZBTB7B;ZNF319;E2F2;HOXD8;CLOCK;SOX8;KLF8;NFX1;ZNF431;ZBTB40;STAT6;NFIC;NR2F1;PURB;PRDM16;ZNF367;TCF7L2;TCF4;SP8;HSF2;BCL11A;NFE2L3;SREBF1;HES5;ZFP62;ZBTB16;MLXIP;MGA;NPAS2;SAFB;MYPOP;HNF4G;CEBPA;TAF1;NR1H2;ZBTB24
prerank,double-stranded DNA binding (GO:0003690),0.2818114569000375,0.8925653465614648,0.837,0.8697215592475772,1.0,86/531,20.19%,PPARG;TFEC;RBMS1;ELF2;IRX3;TFEB;CEBPB;GRHL1;FOXP3;EN2;ATF3;RUNX2;E2F3;FOXO3;TFAP2B;RUNX3;RXRA;JUN;RARA;FOXO4;E2F1;PCID2;NR3C1;BHLHE40;POLG2;HNRNPU;KLF5;TGIF1;ATF4;ZBTB20;ZNF177;TOP1;POU3F1;SOX9;SNAI2;FOXP1;IRF2;TERF1;NR5A1;XRCC5;PAX8;ESR1;NR2C1;FOXK1;MAFG;NFATC3;PPARD;CUX1;SP3;TBX6;PQBP1;CAMTA2;RFX1;RFX5;BBX;BCL11B;FOXJ3;JUNB;ETV3;MBNL2;CENPX;NHLH2;KLF6;ZNF32;MTF1;TCF12;CREB3L4;CREB3;CRY1;ZBTB7A;GABPA;CREB1;ZNF23;ZBTB7B;E2F2;HOXD8;CLOCK;FLI1;SOX8;NFIC;CREB3L1;NR2F1;TCF4;SP8;HSF2;MRE11
prerank,NAD+ binding (GO:0070403),-0.35225882338793824,-0.8921496402107539,0.5637982195845698,0.827918716047503,1.0,5/12,12.96%,HPGD;CRYL1;GLUD1;SIRT5;SIRT2
prerank,tRNA binding (GO:0000049),0.327884033167367,0.8918839371531808,0.6305655836341757,0.8686520675835023,1.0,11/43,16.93%,FARS2;EEF1A1;EIF2AK4;XPOT;NAT10;ELP1;SARS2;SARS1;ALKBH8;AIMP1;ALKBH1
prerank,GTPase activity (GO:0003924),0.28726305660919005,0.8906843641322357,0.7244897959183674,0.8687249195235738,1.0,36/192,17.12%,RAP2A;RAB8B;GNAQ;RAB20;RAB7A;RHOJ;RAB33B;GNA13;EEF1A1;RAB21;NRAS;GNA12;GBP6;RAB31;RAB1B;RAB28;ARL8B;GNG11;RAP2B;RHOD;RAB18;TBC1D24;GNGT2;RAB24;RAB43;RAB11B;ATL2;RIT1;ARL8A;RRAS;ATL1;RND2;RAB2A;RAB29;RAB22A;MTG1
prerank,MHC class I protein binding (GO:0042288),0.40790784175823847,0.8903014695573445,0.6034985422740525,0.8671979432432578,1.0,2/13,10.59%,LILRB1;ATP5F1A
prerank,enoyl-CoA hydratase activity (GO:0004300),0.4304178372430829,0.8901963671080374,0.6123417721518988,0.8650970620562257,1.0,3/10,15.60%,HADHA;ECHDC1;EHHADH
prerank,organic cation transmembrane transporter activity (GO:0015101),0.39050795777181513,0.8881614261081895,0.6240822320117474,0.8666017041871523,1.0,5/16,21.68%,SLC25A42;SLC44A2;SLC7A8;SLC25A17;SLC22A5
prerank,rRNA binding (GO:0019843),0.32470891098641114,0.8862491089349842,0.6595238095238095,0.867842028366163,1.0,7/42,11.44%,TST;UTP23;MRPL11;RPS14;RPL23;MRPS7;ERI1
prerank,cAMP response element binding (GO:0035497),0.42353354280535294,0.8849208919869084,0.5969230769230769,0.8679287061366526,1.0,3/10,19.55%,JUN;CREB1;CREB3L1
prerank,mRNA methyltransferase activity (GO:0008174),-0.34809345542871795,-0.8838775840489933,0.6195965417867435,0.8398565947869493,1.0,3/12,8.56%,METTL3;CMTR1;NSUN2
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.364623807282746,0.878013563739823,0.6368563685636857,0.8783327776599076,1.0,5/22,12.03%,CPSF1;ZFP36L2;HNRNPA0;EXOSC9;EXOSC8
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.41744941681716785,0.8779995173106686,0.6166180758017493,0.8760866630111622,1.0,5/11,22.19%,NAA10;NAA30;NAA25;NAA80;NAA15
prerank,lysophospholipase activity (GO:0004622),0.3713710297141639,0.8778121783837901,0.6514360313315927,0.8741511977183416,1.0,5/20,17.97%,MGLL;PNPLA7;ABHD4;GDE1;LYPLA2
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.27583312802042376,0.876061329903954,0.913,0.8751404553671278,1.0,141/732,21.63%,PPARG;TFEC;LITAF;IRX3;TFEB;NFE2L2;MITF;CEBPB;ZEB2;TIPARP;GRHL1;FOXP3;EN2;DNMT3A;ST18;ATF3;RUNX2;NR1H3;E2F3;FOXO3;ZNF160;ZNF692;TFAP2B;RUNX3;RXRA;JUN;RARA;ZFP28;MZF1;FOXO4;BACH1;E2F1;ZBTB42;STAT5B;NR3C1;NR1H4;BHLHE40;HNRNPU;KLF5;TGIF1;ATF4;REL;ZBTB20;RREB1;TOP1;POU3F1;SOX9;SNAI2;HOXA3;ZNF148;FOXP1;IRF2;ZFAT;CARF;CHD2;DACH1;NR5A1;DDIT3;PAX8;ESR1;NR2C1;FOXK1;MAFG;POU3F3;FOXO1;MAFB;SALL2;NFATC3;PPARD;ZNF691;ZKSCAN7;SP3;RORA;TBX6;SARS1;RELB;RFX1;MAZ;RFX5;RELA;SOX2;BCL11B;HBP1;POU2F1;ZKSCAN3;FOXJ3;PGBD1;JUNB;ATF1;ZKSCAN5;NHLH2;KLF6;ZNF32;MYT1;MTF1;THRAP3;TCF12;CCAR1;ZBTB11;CREB3L4;CREB3;ZNF18;ZBTB7A;NKX2-1;ZBTB41;GABPA;NFYC;CREB1;ZNF23;ZBTB7B;ZNF319;E2F2;CLOCK;SOX8;KLF8;ZNF431;ZBTB40;STAT6;NFIC;NR2F1;PRDM16;ZNF367;TCF7L2;TCF4;SP8;HSF2;BCL11A;NFE2L3;SREBF1;HES5;ZFP62;ZBTB16;MLXIP;MGA;NPAS2;SAFB;MYPOP;HNF4G;CEBPA;NR1H2;ZBTB24
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.39847251731391214,0.8742527607913558,0.6266666666666667,0.8760846177617807,1.0,5/13,17.41%,ALDH3A2;ALDH1A2;ALDH2;ALDH7A1;ALDH9A1
prerank,C-C chemokine receptor activity (GO:0016493),0.3632192113147936,0.871915384226497,0.645466847090663,0.8779564287103979,1.0,2/21,3.95%,CXCR4;XCR1
prerank,RNA polymerase binding (GO:0070063),0.37340273384353695,0.8708445678659261,0.6519174041297935,0.8775605081730624,1.0,7/18,22.11%,TCERG1;ANP32B;BRCA1;PKN2;YTHDC2;TCERG1L;CCNT1
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.27371962809429917,0.8697647107071043,0.917,0.8772162241963594,1.0,141/731,21.63%,PPARG;TFEC;LITAF;IRX3;TFEB;NFE2L2;MITF;CEBPB;ZEB2;GRHL1;FOXP3;EN2;DNMT3A;ST18;ATF3;RUNX2;NR1H3;E2F3;FOXO3;ZNF160;ZNF692;TFAP2B;RUNX3;RXRA;JUN;RARA;ZFP28;MZF1;FOXO4;BACH1;E2F1;ZBTB42;STAT5B;NR3C1;NR1H4;BHLHE40;HNRNPU;KLF5;TGIF1;ATF4;REL;ZBTB20;RREB1;TOP1;POU3F1;SOX9;SNAI2;HOXA3;ZNF148;FOXP1;IRF2;ZFAT;CARF;CHD2;DACH1;NR5A1;DDIT3;PAX8;ESR1;NR2C1;FOXK1;MAFG;POU3F3;FOXO1;MAFB;SALL2;NFATC3;PPARD;ZNF691;ZKSCAN7;SP3;RORA;TBX6;SARS1;RELB;RFX1;MAZ;RFX5;RELA;SOX2;BCL11B;HBP1;POU2F1;ZKSCAN3;FOXJ3;PGBD1;JUNB;ATF1;ZKSCAN5;NHLH2;KLF6;ZNF32;MYT1;MTF1;THRAP3;TCF12;CCAR1;ZBTB11;CREB3L4;CREB3;ZNF18;ZBTB7A;NKX2-1;ZBTB41;GABPA;NFYC;CREB1;ZNF23;ZBTB7B;ZNF319;E2F2;CLOCK;SOX8;KLF8;ZNF431;ZBTB40;STAT6;NFIC;CREB3L1;NR2F1;PRDM16;ZNF367;TCF7L2;TCF4;SP8;HSF2;BCL11A;NFE2L3;SREBF1;HES5;ZFP62;ZBTB16;MLXIP;MGA;NPAS2;SAFB;MYPOP;HNF4G;CEBPA;NR1H2;ZBTB24
prerank,general transcription initiation factor binding (GO:0140296),-0.27341986467457435,-0.8690061017276106,0.6781609195402298,0.8653122773092757,1.0,12/25,22.77%,THRA;PSMC2;YEATS2;TBP;TAF12;AR;HHEX;DRAP1;AHR;DR1;BRF2;GTF2A2
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.41899392564137333,0.8683479908153957,0.6469719350073855,0.8775392677605702,1.0,4/10,17.02%,KDM4C;KDM2A;KDM7A;RIOX2
prerank,C-C chemokine binding (GO:0019957),0.357017741663058,0.864027635109966,0.636734693877551,0.8828878729692758,1.0,2/22,3.95%,CXCR4;XCR1
prerank,telomerase RNA binding (GO:0070034),0.3575945186604748,0.862810126197748,0.6547770700636942,0.8827517789114165,1.0,5/22,15.92%,TEP1;TENT4B;HNRNPU;DKC1;EXOSC10
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.413041420985221,0.862610794375559,0.6380368098159509,0.8808852817647932,1.0,6/10,28.32%,SUV39H2;PRDM16;ASH1L;EHMT2;SETD5;EHMT1
prerank,chemokine receptor activity (GO:0004950),0.3495920513486297,0.862294345302762,0.660427807486631,0.8791212828432844,1.0,2/24,3.95%,CXCR4;XCR1
prerank,lipase activator activity (GO:0060229),0.41645488794996344,0.8617542363850248,0.6271186440677966,0.8777595064245747,1.0,2/10,12.65%,PDPK1;BTK
prerank,protein tyrosine kinase activator activity (GO:0030296),0.3618791941163941,0.8536597908047249,0.6760168302945302,0.8893227998568906,1.0,6/19,13.29%,ERCC6;ABI1;PAK2;AFAP1L2;GAS6;DGKQ
prerank,cation:chloride symporter activity (GO:0015377),-0.3600845917720213,-0.8520607893058181,0.6554878048780488,0.8943454016460143,1.0,4/10,13.19%,SLC12A2;SLC12A6;SLC6A1;SLC12A4
prerank,transcription coregulator binding (GO:0001221),0.3082460999007168,0.8514330686765726,0.6948955916473318,0.8907571872730351,1.0,15/50,22.79%,CTNNB1;EED;RPL23;LCOR;ESR1;PPARD;RORA;RELA;PER3;ZBTB7A;PHF1;ZBTB16;EHMT2;MTF2;CTBP1
prerank,methyl-CpG binding (GO:0008327),-0.2754922659558062,-0.8486351662193479,0.7093023255813954,0.8948705379641338,1.0,7/22,16.23%,CXXC5;TET1;CXXC4;PRMT1;ERH;ZBTB33;ZCWPW1
prerank,poly(A) binding (GO:0008143),0.3565177066232136,0.8470963330121969,0.6735483870967742,0.8956881762798169,1.0,8/21,22.93%,RBMS1;HNRNPU;RBPMS;PPIE;EIF4A3;HNRNPDL;LARP4;PABPC4
prerank,ribosomal small subunit binding (GO:0043024),0.36324534711956896,0.8470823813882548,0.6619318181818182,0.8934908205798661,1.0,2/17,5.04%,EIF1;PIM1
prerank,metal ion:proton antiporter activity (GO:0051139),0.3844452415703029,0.8463815487689537,0.6738197424892703,0.8924552517019667,1.0,3/13,13.74%,SLC9A3;LETM1;SLC11A1
prerank,phosphatase activity (GO:0016791),0.28843560301505233,0.8452300173734493,0.7233115468409586,0.8920216853277922,1.0,11/73,14.07%,PLPP3;LPIN3;DUSP3;PLPP6;ACP5;PLPP5;LHPP;HDHD2;PGP;OCRL;PPP1CA
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.40385690594555884,0.8413834055466632,0.6566929133858268,0.8962333144174296,1.0,1/10,2.43%,PRKAG2
prerank,insulin-like growth factor I binding (GO:0031994),-0.3168285553317932,-0.8412081384157856,0.6601307189542484,0.9030383765967754,1.0,6/13,29.90%,ITGA6;IGF1R;ITGB4;IGFBP6;IGFBP5;IGFBP2
prerank,neuropeptide binding (GO:0042923),-0.29568575642963735,-0.8391447404586903,0.7047244094488189,0.9006328254731194,1.0,3/18,13.46%,OPRM1;GPR37;GPR149
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.3403359755067123,0.8354572970190693,0.6846254927726675,0.9034631738195121,1.0,7/23,17.72%,KIF16B;SESTD1;CLVS2;SH3PXD2B;SNX14;MAPKAP1;SNX3
prerank,ribosome binding (GO:0043022),0.30204503471785954,0.8341054193414402,0.7435597189695551,0.9034213706176516,1.0,17/46,23.46%,CPEB4;YTHDF3;EIF6;ETF1;SERBP1;ERI1;NAA10;RPSA;NOMO1;C1QBP;CPEB2;EIF3C;EIF2S1;NAA15;MTIF3;TMCO1;CPEB1
prerank,MHC class II protein complex binding (GO:0023026),-0.3308363289975477,-0.8332689967700451,0.6360655737704918,0.9055385169795005,1.0,2/11,5.11%,ATP1B1;HSP90AA1
prerank,tropomyosin binding (GO:0005523),-0.29972139134887277,-0.8304995821337684,0.7133333333333334,0.9046253278659647,1.0,3/16,12.62%,TMOD2;PYCARD;NEBL
prerank,microtubule binding (GO:0008017),0.2649216838034283,0.8295103729644685,0.8533872598584429,0.9084413781167638,1.0,36/222,14.93%,KIF13B;GAS2L3;FMN1;KIF20B;HOOK3;SPEF1;REEP4;CCDC69;KIF9;KIF16B;KIF27;HAUS6;SAXO2;APC;PEX14;GTSE1;KIF3A;EML3;UXT;VASH2;VAPA;TERF1;SKA2;MTCL1;ARHGEF2;CCDC66;TOGARAM1;TUBGCP4;KIF6;GAS2L1;MACF1;CLASP1;ARL3;WHAMM;ALMS1;NDE1
prerank,CARD domain binding (GO:0050700),-0.31187708498799865,-0.8293166453620631,0.6601307189542484,0.9004787392214436,1.0,5/14,20.64%,CASP4;IRGM;CARD16;CARD9;NOD1
prerank,protein-arginine N-methyltransferase activity (GO:0016274),-0.34545398155701545,-0.8266452102077041,0.6938775510204082,0.899399986239857,1.0,5/11,18.10%,PRMT1;PRMT9;PRMT7;PRMT2;PRMT8
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.3839984813583145,0.8265087330726594,0.6911764705882353,0.9108741426434485,1.0,2/12,8.59%,SLC9A3;LETM1
prerank,single-stranded DNA binding (GO:0003697),0.2796443535475218,0.8263908823879763,0.781897491821156,0.9088059503175342,1.0,27/93,23.45%,RBMS1;MCM9;LONP1;FAM111A;HNRNPU;TOP1;RAD23A;POLR2G;TDP2;SSBP1;POLA1;WBP11;STN1;PCBP1;TWNK;HSPD1;RADX;FUBP1;PURB;TOP3A;POLR3C;FUBP3;RAD51B;XPC;RNF138;ERCC4;SPRTN
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.31380600261693925,-0.8263743997995672,0.6750788643533123,0.8937043047214439,1.0,8/14,25.33%,EBAG9;RACK1;MAL;PYCARD;BAD;NOD1;RPS27L;ATP2A3
prerank,exonuclease activity (GO:0004527),0.29930898689136465,0.8260403127779855,0.7295081967213115,0.907216238773487,1.0,16/46,21.55%,ENPP1;EXOSC3;EXOSC9;CNOT7;ERI1;EXOSC8;DCLRE1B;WRN;CNOT6;ISG20L2;EXOSC10;EXOSC1;REXO5;MRE11;EXOSC7;APEX2
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.3241299406883901,0.8259011696492677,0.7176470588235294,0.9052614050772253,1.0,8/30,18.01%,BIRC6;TNFAIP8;XIAP;BIRC3;MT3;GAS6;UBE2O;BIRC2
prerank,bHLH transcription factor binding (GO:0043425),0.3532098874684496,0.8237496836518482,0.6972602739726027,0.9065365145121986,1.0,4/19,16.48%,CREBBP;BHLHE40;SIRT1;TCF12
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.39307895596145515,0.820640105672792,0.6904400606980273,0.9090759511757905,1.0,7/10,29.58%,CASP12;CASP6;CASP2;CASP3;CASP8;CASP9;CFLAR
prerank,lysine N-methyltransferase activity (GO:0016278),0.3442009577566422,0.8200232683903841,0.7082191780821918,0.9078101913288297,1.0,8/20,28.32%,ETFBKMT;SETD7;SMYD2;EHMT2;SETD3;METTL21A;SETD6;EHMT1
prerank,SH3 domain binding (GO:0017124),0.28800560662804187,0.8185864220840952,0.7668571428571429,0.907887361284011,1.0,7/62,7.48%,CBLB;GRB2;ADAM9;ABI1;PTPN12;CYBA;SH3BP2
prerank,endopeptidase activator activity (GO:0061133),0.3884949927440557,0.8182983207209039,0.6926536731634183,0.9061759021144346,1.0,5/10,22.96%,NLRC4;PSMD14;PSME2;APH1B;PSME3
prerank,N-methyltransferase activity (GO:0008170),0.33747539533034576,0.8179724564740929,0.717663421418637,0.9045656876129745,1.0,9/20,26.30%,GNMT;N6AMT1;TFB2M;TRMT1L;SETD3;DIMT1;ZCCHC4;TRMO;FDXACB1
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),-0.2258736924235798,-0.8167378431515653,0.8268156424581006,0.9050889144495722,1.0,5/38,12.35%,SPOCK1;SERPINE2;SERPINA2;SERPINI1;AGT
prerank,four-way junction DNA binding (GO:0000400),0.3505439459562786,0.8148442176962524,0.7050561797752809,0.9072604497662764,1.0,8/17,31.24%,XRCC2;WRN;RAD51B;FANCM;MEN1;YY1;RAD51C;HMGB1
prerank,anion channel activity (GO:0005253),0.28722069573678277,0.8148378529071691,0.7398190045248869,0.9051020947742803,1.0,12/61,17.12%,LRRC8D;ANO6;VDAC2;GABRE;LRRC8C;VDAC1;CLCN7;GABRA1;CLIC1;GPR89A;GPR89B;CLCN4
prerank,tubulin binding (GO:0015631),0.2570207639123717,0.8115334992493879,0.8898898898898899,0.9081776365260741,1.0,54/295,16.38%,KIF13B;GAS2L3;FMN1;KIF20B;HOOK3;SPEF1;REEP4;CCDC69;KIF9;WASHC1;KIF16B;KIF27;HAUS6;SAXO2;DAG1;APC;PEX14;RITA1;BRCA1;GTSE1;KIF3A;EML3;UXT;DLEC1;VASH2;VAPA;TERF1;TPR;SKA2;ARL8B;MTCL1;ARHGEF2;CCDC66;BCAS3;TOGARAM1;TUBGCP4;KIF6;APPL1;GAS2L1;TBCA;CLASP1;PRKN;ARL4C;ARL8A;ARL3;WHAMM;INO80;ALMS1;NDE1;SMC3;OFD1;RABGAP1;CCDC88C;TBCEL
prerank,phospholipase activator activity (GO:0016004),0.397028435659575,0.8113133248413718,0.7009345794392523,0.9063176360810142,1.0,2/10,12.65%,PDPK1;BTK
prerank,thiol-dependent deubiquitinase (GO:0004843),0.27562129512178124,0.8103452139287657,0.8037077426390403,0.9056891717516412,1.0,26/83,24.66%,TANK;USP42;USP12;VCPIP1;COPS5;USP40;USP26;USP48;PSMD14;USP21;USP16;TNFAIP3;USP36;BRCC3;USP8;OTUD5;USP32;USP30;ATXN3;STAMBP;USP3;USP9X;USP2;USP53;USP47;USP46
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.33486667149136023,-0.8084888743339815,0.6923076923076923,0.9134967317644602,1.0,2/10,6.60%,JUP;CD200
prerank,secondary active transmembrane transporter activity (GO:0015291),0.28662456747448406,0.8083823698786141,0.750599520383693,0.9064279628338672,1.0,13/51,20.67%,SLC35D3;SLC16A10;SLC5A5;SLC35E3;SLC35D1;SLC35E2B;SLC35E2A;CLCN4;SLCO3A1;SLC20A2;SLC35C2;SLC7A8;SLC28A2
prerank,death receptor binding (GO:0005123),-0.3002737649562462,-0.8077896369282139,0.7163120567375887,0.9086443090670248,1.0,4/15,10.86%,EDA;MADD;DAB2IP;FEM1B
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.30195508844363284,-0.807664967487212,0.7128712871287128,0.9026785975856833,1.0,7/14,27.26%,RPP14;TSEN34;RPP30;ELAC2;RPP38;POP5;POP7
prerank,ion gated channel activity (GO:0022839),0.32906857923147304,0.8076125348088397,0.7380025940337225,0.9054156141754482,1.0,2/24,2.68%,ANO6;TTYH2
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.34984152476851726,0.806538680601369,0.6898016997167139,0.9049100967941506,1.0,6/15,26.65%,CXXC1;KMT2A;SETD3;KMT2D;SETD1B;KMT2C
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.3562577714717024,0.8062596977199724,0.7136752136752137,0.9032275874708948,1.0,5/15,19.97%,LANCL2;SESTD1;SH3PXD2B;SNX3;SAP30L
prerank,beta-tubulin binding (GO:0048487),0.3123956343209505,0.8053419592146928,0.7458492975734355,0.9025546615487453,1.0,8/31,14.94%,PEX14;UXT;DLEC1;ARL8B;BCAS3;APPL1;ARL8A;SMC3
prerank,protein phosphatase 2A binding (GO:0051721),0.3317595333519598,0.8053001884273722,0.7376171352074966,0.9004957437870565,1.0,7/23,14.11%,ENSA;MFHAS1;STRN;BOD1;FOXO1;STRN3;ADCY8
prerank,pyridoxal phosphate binding (GO:0030170),0.34242911537612297,0.8049062314783754,0.7266576454668471,0.8990003318497242,1.0,8/20,28.65%,PYGL;PLPBP;OAT;PYGB;SHMT2;PDXK;PNPO;SRR
prerank,alpha-tubulin binding (GO:0043014),0.312201398255416,0.8041030078355436,0.7614795918367347,0.8980577275376946,1.0,8/31,16.38%,WASHC1;DLEC1;ARL8B;ARL4C;ARL8A;INO80;OFD1;TBCEL
prerank,voltage-gated chloride channel activity (GO:0005247),0.39178857637781,0.803844052117441,0.7119645494830132,0.8963453753777343,1.0,1/10,2.38%,ANO6
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.3187124375596898,0.803552905973574,0.7506393861892583,0.8947150405641601,1.0,3/29,7.56%,SLC1A5;SLC26A1;SLC38A7
prerank,phosphatase binding (GO:0019902),0.2679906449627213,0.8019596653483433,0.8064864864864865,0.8949648427768532,1.0,20/105,19.57%,LGALS3;IQGAP1;MTMR3;CTNNB1;IKBKE;KIF3A;SIRPA;CD22;STYXL1;PPP3R1;TRAF3;CEP192;JAK3;AP3B1;TRAF2;CRY1;SNX3;TRPC4AP;STAT6;TBK1
prerank,cytokine receptor activity (GO:0004896),0.27079292224570767,0.8006996819598037,0.8037077426390403,0.894762064456907,1.0,14/83,14.22%,IL17RE;CD44;XCR1;IL10RB;IFNGR2;IFNAR2;CSF2RB;IL20RB;IL6R;IL3RA;CSF2RA;IL7R;ACKR4;IL4R
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.28017732458375666,0.7988907997920045,0.7761529808773904,0.8953004660340699,1.0,18/57,23.59%,UQCRFS1;NDUFS8;NDUFA10;NDUFC1;COX6A1;CYB5A;COX8A;NDUFB6;NDUFS6;NDUFS1;COX15;NDUFS3;NDUFB4;NDUFB8;COX4I1;COX5A;NDUFB9;NDUFA13
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.3033873276049458,-0.7956656363634365,0.7348242811501597,0.9177821374270441,1.0,4/13,17.04%,PJA2;RYR2;PKIA;PRKAR2B
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.3812661926947922,0.7946714806143367,0.7179878048780488,0.8994201438892931,1.0,2/10,6.64%,PIK3CA;PIK3C2G
prerank,damaged DNA binding (GO:0003684),-0.2153358502300256,-0.7909254663357115,0.8918918918918919,0.92011270685823,1.0,15/44,24.65%,DCLRE1C;SMC6;CRY2;DDB2;ERCC5;POLQ;NEIL3;FANCG;XPA;RAD1;RPA3;RPA1;DCLRE1A;ERCC2;PCNA
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.32026749489602374,-0.7903283156452298,0.7102803738317757,0.915005124021983,1.0,7/11,46.46%,KCNJ3;KCNQ1;KCNE3;KCNE4;KCNJ5;KCNJ8;KCNE2
prerank,microtubule plus-end binding (GO:0051010),-0.2597304884511087,-0.7901232345120508,0.7644787644787645,0.9093618098571029,1.0,9/20,30.96%,DST;NUMA1;KIF18A;MAPRE1;TTBK2;DCTN1;CLIP4;CLASP2;KIF2C
prerank,symporter activity (GO:0015293),0.3758668456346733,0.7886615176236803,0.7140549273021002,0.9059867841046096,1.0,2/10,20.67%,SLC5A5;SLC28A2
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.35702568590683437,0.7881915317258277,0.7319587628865979,0.9045937099982604,1.0,2/13,10.79%,ENDOV;DNASE1L1
prerank,tau-protein kinase activity (GO:0050321),0.32877360988507554,0.7865914320451689,0.7617728531855956,0.9048772477243223,1.0,4/20,10.31%,SIK3;DYRK1A;ROCK1;GSK3B
prerank,histone demethylase activity (GO:0032452),0.3147020834702543,0.7853974844405684,0.7509829619921363,0.904513629612893,1.0,9/27,22.16%,KDM4C;KDM3A;JMJD1C;KDM2A;KDM7A;RIOX2;PHF2;JMJD6;KDM5C
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.2796510729133289,0.7825356253228613,0.7889908256880734,0.9064829459805017,1.0,7/54,12.34%,KLK3;TGM2;SIRT6;DARS1;AGA;SIRT1;SIRT7
prerank,miRNA binding (GO:0035198),0.3011221270899009,0.779308242560776,0.7660668380462725,0.9089612180178628,1.0,6/30,13.49%,AGO2;AGO3;PUM2;SPOUT1;SOX2;RBM10
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.29856089682199516,0.7784174393706033,0.7706535141800247,0.9080259791067248,1.0,6/31,14.19%,AQP1;TMEM38B;SLC12A3;SLC12A8;KCNK4;SLC12A7
prerank,anion transmembrane transporter activity (GO:0008509),0.36503295518919326,0.7780926737989743,0.759825327510917,0.9064549045757181,1.0,1/12,0.43%,SLC26A11
prerank,kinase inhibitor activity (GO:0019210),0.2997938069197488,0.7774611914486694,0.779467680608365,0.9052265427770344,1.0,7/33,19.68%,TAOK3;CDKN1A;GSKIP;DUS2;LRP6;SH3BP5;GMFB
prerank,Notch binding (GO:0005112),0.3218880740267411,0.7774151642715528,0.7352150537634409,0.9032577776044083,1.0,7/22,24.10%,CUL3;ADAM17;SNED1;DTX1;KCTD10;AAK1;CCN3
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.31063847868369265,-0.7771922257934271,0.7647058823529411,0.9247778834780405,1.0,5/11,32.45%,PPP1R8;PPP1R14B;PPP1R1A;PPP1R14C;PPP1R2
prerank,microtubule minus-end binding (GO:0051011),-0.2981889440202538,-0.7752880859280382,0.7781350482315113,0.9214949079120778,1.0,5/13,22.57%,TUBGCP5;NUMA1;CEP290;TUBGCP6;CAMSAP1
prerank,mRNA 5'-UTR binding (GO:0048027),0.3140941238664511,0.7752578283257795,0.7691292875989446,0.9040057375061119,1.0,6/24,19.65%,UTP23;IGF2BP3;RPS14;SYNCRIP;RPL26;NCL
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.3532802907565732,0.7690730691570145,0.7478386167146974,0.9102017311031344,1.0,2/12,6.64%,PIK3CA;PIK3C2G
prerank,chloride channel inhibitor activity (GO:0019869),0.36767356812471536,0.7679336065560625,0.7577160493827161,0.9095721661144697,1.0,2/10,5.64%,STX8;VTI1B
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.35344886974240786,0.7678289616099806,0.776595744680851,0.9076802149950999,1.0,2/12,8.55%,APAF1;CTSH
prerank,TBP-class protein binding (GO:0017025),-0.26059739834530177,-0.766606829581183,0.8043478260869565,0.9283487451126865,1.0,10/21,22.77%,THRA;PSMC2;YEATS2;TAF12;HHEX;DRAP1;AHR;DR1;BRF2;GTF2A2
prerank,omega peptidase activity (GO:0008242),0.2580272328819494,0.7640688279029655,0.8576051779935275,0.9104805742910057,1.0,24/89,22.04%,TANK;USP42;USP12;VCPIP1;COPS5;USP40;USP26;USP48;PSMD14;USP21;USP16;TNFAIP3;USP36;BRCC3;USP8;OTUD5;USP32;APEH;USP30;ATXN3;STAMBP;USP3;USP9X;USP2
prerank,GABA receptor binding (GO:0050811),0.36812042554551205,0.7637121197988388,0.75,0.9089576254979268,1.0,3/11,13.44%,JAKMIP1;ARFGEF2;PLCL2
prerank,myosin binding (GO:0017022),0.2715218517180575,0.7624522271147836,0.815242494226328,0.9086189866082369,1.0,7/55,13.02%,CXCR4;MYL2;TRIOBP;STXBP5;MYBPC3;RAB10;RAB11B
prerank,single-stranded DNA helicase activity (GO:0017116),0.318430116495922,0.7610141125554738,0.7695473251028807,0.908497610826806,1.0,2/19,6.67%,RFC3;HELB
prerank,ATPase binding (GO:0051117),0.26340175591903353,0.7602231226976972,0.8612652608213096,0.9074132608215595,1.0,10/71,12.44%,ABCA1;SNX10;ATP6V1E1;TCIRG1;NUFIP1;PPP3CA;ATP6V0A1;ESR1;S100A1;TMTC4
prerank,MHC protein binding (GO:0042287),0.31923235661056554,0.7568238794556753,0.7771812080536913,0.9097517229864283,1.0,2/20,10.59%,LILRB1;ATP5F1A
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.3309880020025724,0.7557128812915224,0.7581792318634424,0.909138408180344,1.0,2/16,7.56%,SLC1A5;SLC38A7
prerank,chemokine activity (GO:0008009),0.2898418448684842,0.7529356806734608,0.8210262828535669,0.9107174646150294,1.0,5/31,19.25%,CKLF;CX3CL1;CXCL12;CCL7;CCL25
prerank,nucleotide diphosphatase activity (GO:0004551),0.3426153272362745,0.7529329844450539,0.7753623188405797,0.9087375568607773,1.0,2/14,6.72%,ENPP1;NUDT6
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.30373412171776604,0.7465675471516,0.7936085219707057,0.9146625305236025,1.0,2/22,5.43%,MTMR3;DUSP3
prerank,snoRNA binding (GO:0030515),0.2806869585598389,0.7360853814311321,0.8404669260700389,0.9255922491413908,1.0,5/30,10.53%,BYSL;NUFIP1;NOP14;XRCC5;DKC1
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.32002020163324196,0.7284454437615101,0.8102710413694721,0.9324291929693075,1.0,4/17,17.58%,BLVRB;PTGR2;BLVRA;DECR2
prerank,DNA secondary structure binding (GO:0000217),-0.21902811737499744,-0.7284205810676252,0.8490566037735849,0.9747267166353282,1.0,2/31,2.28%,MEF2C;MAPT
prerank,metallocarboxypeptidase activity (GO:0004181),-0.22709947625266802,-0.7259202310081876,0.9032258064516129,0.9716483540702948,1.0,8/26,21.09%,AGBL4;AGBL5;FOLH1;AEBP1;AGBL1;AGTPBP1;VASH1;CPD
prerank,potassium ion leak channel activity (GO:0022841),0.3215280808703835,0.7254895229327393,0.8014492753623188,0.9337712122847709,1.0,3/15,19.19%,KCNK13;KCNK4;KCNK5
prerank,death domain binding (GO:0070513),0.34286643392360283,0.7198744054405778,0.8035982008995503,0.9382261859098638,1.0,4/11,18.61%,RIPK1;BAX;MCL1;CRADD
prerank,CCR chemokine receptor binding (GO:0048020),-0.2192930788567871,-0.7147122290362997,0.9230769230769231,0.9794447292611536,1.0,7/28,25.27%,CCL4;CCR2;NES;CCL3;CCL14;CCL5;DEFB130A
prerank,potassium channel regulator activity (GO:0015459),0.25657903869292964,0.7119278288664583,0.8833922261484098,0.945177487958508,1.0,4/49,8.05%,SGK1;ENSA;KCNAB2;NEDD4L
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.29029441215927504,0.7088994101946137,0.8350923482849604,0.94651889352521,1.0,6/24,20.32%,MAPKAPK3;DAPK1;PTK2B;CAMK1;MKNK2;PHKG2
prerank,insulin-like growth factor receptor binding (GO:0005159),0.3281068331337713,0.706493037837076,0.8240601503759398,0.9470923395534359,1.0,3/12,15.19%,IGF1;SHC1;ARRB1
prerank,ribonuclease P RNA binding (GO:0033204),-0.2893015117258816,-0.7035044168331095,0.8100558659217877,0.9860256679459514,1.0,5/10,27.26%,RPP14;RPP30;RPP38;POP5;POP7
prerank,chloride transmembrane transporter activity (GO:0015108),-0.24868393764538052,-0.7017597373344515,0.8831168831168831,0.9818711618035422,1.0,5/16,19.64%,SLC4A8;SLC1A1;CLCN6;SLC26A8;SLC26A6
prerank,ion channel inhibitor activity (GO:0008200),0.2629843126377929,0.7002169088939766,0.8730350665054414,0.9517501899522328,1.0,4/35,8.05%,STX8;VTI1B;ENSA;NEDD4L
prerank,Hsp90 protein binding (GO:0051879),0.2646736867774576,0.6991263744444982,0.8740359897172236,0.9508644884742302,1.0,8/33,21.14%,ERN1;NR3C1;PPEF2;STUB1;CSNK2A1;HDAC8;AHSA1;NPAS2
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.3115100121041415,0.696707724653078,0.8282387190684134,0.9514188373936187,1.0,1/14,2.10%,BLVRB
prerank,MAP kinase phosphatase activity (GO:0033549),-0.27658294167589326,-0.6966102626541603,0.8625730994152047,0.9811753220842272,1.0,2/12,6.49%,DUSP6;DUSP7
prerank,3'-5' exonuclease activity (GO:0008408),0.2555823623507671,0.6950497557483456,0.8890200708382526,0.9511677282377919,1.0,17/45,28.08%,TOE1;EXOSC3;CNOT6L;EXOSC9;CNOT7;ERI1;WRN;CNOT6;EXOSC10;MRE11;EXOSC7;POLD1;XRN2;EXOSC4;POLG;NOCT;DIS3L
prerank,endodeoxyribonuclease activity (GO:0004520),0.2924284759255821,0.6930639903406585,0.8551532033426184,0.9513122197980363,1.0,3/20,11.12%,ZRANB3;ENDOV;MBD4
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.2798403541532989,0.6928342258006966,0.8544061302681992,0.9495285981926206,1.0,2/26,7.10%,B3GNT8;B3GALNT2
prerank,disordered domain specific binding (GO:0097718),0.28509267953547834,0.6921267844712564,0.8852672750977836,0.948186298564035,1.0,9/23,28.95%,RB1;DFFB;NCOA3;HSPA1A;CALM2;FKBP8;CLTC;FYN;TP53
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.28863905139247664,0.691319274939256,0.8647214854111406,0.9470068770568557,1.0,6/21,19.00%,GSKIP;AKAP1;PRRC1;ARFGEF2;AKAP7;ARFGEF1
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.28606758066213833,0.6846899173953137,0.8569553805774278,0.951560134859266,1.0,9/21,28.97%,POLH;POLL;POLA1;POLI;POLD1;POLE3;PRIMPOL;POLG;POLE
prerank,Wnt-activated receptor activity (GO:0042813),0.30484191145697287,0.6841843689966931,0.8490566037735849,0.9500349511912857,1.0,4/15,12.71%,FZD7;FZD5;ROR1;FZD2
prerank,cyclin-dependent protein kinase activity (GO:0097472),-0.2246035661309211,-0.6813566877682002,0.9365671641791045,0.9843258604890968,1.0,11/21,32.08%,CDK14;CDKL3;CDK4;CDKL1;CDK10;CDK9;CDK11B;CDK19;CDK1;CDKL2;CDK20
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),-0.2246035661309211,-0.6813566877682002,0.9365671641791045,0.9843258604890968,1.0,11/21,32.08%,CDK14;CDKL3;CDK4;CDKL1;CDK10;CDK9;CDK11B;CDK19;CDK1;CDKL2;CDK20
prerank,histone deacetylase binding (GO:0042826),0.23012570253652473,0.6790304356628256,0.9532608695652174,0.9529679618866789,1.0,12/88,13.96%,FOXP3;NCOR1;KPNA2;HSPA1B;NIPBL;KCTD21;LCOR;PKN2;CAMTA2;RELA;PRKN;HSPA1A
prerank,kinase activator activity (GO:0019209),0.2657353894235691,0.6790200399869124,0.8856416772554002,0.950988591430826,1.0,2/30,2.43%,GPRC5D;PRKAG2
prerank,cardiolipin binding (GO:1901612),-0.2774372035595558,-0.6776279264552179,0.8567415730337079,0.9821047296744978,1.0,4/10,35.20%,GSDME;UQCC3;STOML2;NME4
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.31675450009775225,0.6765120991466964,0.8565022421524664,0.9513775649380172,1.0,7/11,29.58%,CASP12;CASP6;CASP2;CASP3;CASP8;CASP9;CFLAR
prerank,"DNA binding, bending (GO:0008301)",-0.24895708892152313,-0.6746839162605497,0.909375,0.9788393975135423,1.0,6/14,26.99%,TFAM;HHEX;TOP2A;FOXC1;LEF1;HMGB3
prerank,syntaxin-1 binding (GO:0017075),0.27570373699174444,0.6728925709726346,0.8755186721991701,0.9528195138476107,1.0,7/22,20.18%,DAPK1;STXBP5;STXBP3;VAMP3;SYPL1;STXBP2;VAMP2
prerank,nuclear export signal receptor activity (GO:0005049),-0.26384317717917916,-0.6667776797588023,0.8760563380281691,0.9802919297507785,1.0,4/11,25.83%,NUP214;RANBP17;XPO6;XPO4
prerank,hydro-lyase activity (GO:0016836),0.24630535362368602,0.6656577834792445,0.9043583535108959,0.9575012328152596,1.0,8/41,19.22%,HADHA;HACD4;ENO3;CDYL;ECHDC1;EHHADH;CA2;ALAD
prerank,regulatory RNA binding (GO:0061980),0.25018695857822165,0.6650671195680026,0.9111675126903553,0.9560027759197808,1.0,6/38,13.49%,AGO2;AGO3;PUM2;SPOUT1;SOX2;RBM10
prerank,DNA polymerase activity (GO:0034061),0.27401605604911994,0.6605824668949115,0.8822768434670116,0.9580354259969496,1.0,9/22,28.97%,POLH;POLL;POLA1;POLI;POLD1;POLE3;PRIMPOL;POLG;POLE
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.25915275287085787,-0.6603616662195206,0.9122807017543859,0.9795650198870072,1.0,4/11,22.22%,CTC1;RAD50;HNRNPA2B1;RPA1
prerank,active ion transmembrane transporter activity (GO:0022853),0.24468390435535353,0.6602644533767389,0.9157509157509157,0.9563480663345958,1.0,5/37,10.73%,ATP13A3;UQCRFS1;COX6A1;CYB5A;COX8A
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.2260842656533128,0.6555163210283274,0.9517396184062851,0.9585033563049102,1.0,2/73,1.12%,APLNR;EDNRA
prerank,translation elongation factor activity (GO:0003746),0.2911269808372037,0.6529707110079924,0.876453488372093,0.9585924859551129,1.0,2/14,11.65%,EEF1A1;GTPBP2
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.2882500885970781,0.6509972510146091,0.8755490483162518,0.9583036242660514,1.0,2/15,7.56%,SLC1A5;SLC38A7
prerank,protein kinase C binding (GO:0005080),0.23624706060733275,0.6463699987213591,0.9333333333333333,0.9599795507220747,1.0,11/43,22.24%,ADAM9;NELL2;PDLIM5;PRKCB;SQSTM1;PARD6A;NELL1;CAVIN3;CAVIN2;ITGAV;TIRAP
prerank,methyltransferase activity (GO:0008168),0.23247202650676643,0.6452577831254386,0.9250302297460702,0.9588695684984508,1.0,17/46,26.88%,NSUN3;COMTD1;N6AMT1;MEPCE;MRM2;DNMT1;RRP8;NDUFAF7;AS3MT;CARNMT1;MGMT;COMT;GCSH;AMT;NSUN4;FTSJ1;METTL4
prerank,fibroblast growth factor binding (GO:0017134),0.26704289865890485,0.6394166125950926,0.8998628257887518,0.9614975416312156,1.0,2/21,5.50%,FGFR4;THBS1
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.2899664632157706,0.6391283508562391,0.9002890173410405,0.9597739259300877,1.0,1/15,5.34%,SLC26A1
prerank,histone deacetylase activity (GO:0004407),0.2675776925953044,0.6376918656265631,0.9055555555555556,0.9588226010692907,1.0,5/19,19.37%,SIRT6;SIRT1;SIRT7;SIRT3;HDAC8
prerank,RNA stem-loop binding (GO:0035613),-0.24678883212779495,-0.632020739710441,0.9215116279069767,0.9958207828156556,1.0,3/12,17.43%,FMR1;MYH10;CPEB3
prerank,phosphatase activator activity (GO:0019211),-0.23592250804204926,-0.63109572691916,0.925531914893617,0.9905117162368405,1.0,6/14,24.58%,B3GAT3;PPP2R5D;GTF2F1;PPP2R5A;PPP2R5B;CALM3
prerank,BMP binding (GO:0036122),0.2885250655969618,0.6306580454457363,0.8940092165898618,0.9622357631743993,1.0,2/11,21.72%,BMPR2;GREM2
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",-0.2175360764794005,-0.6234936844882009,0.971830985915493,0.9896158604040305,1.0,11/18,47.47%,HSD17B7;HSD17B10;HSD17B1;HSD11B1;HSD3B7;DHRS9;SRD5A2;HSD3B2;HSD17B14;AKR1C1;HSD17B3
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.2846179229017656,0.6110409689389449,0.9209726443768997,0.9738606934375734,1.0,4/12,22.86%,CDK7;CDK8;CDK13;CDK6
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.29335949936330824,0.6090414537853588,0.9028831562974203,0.973170261922617,1.0,3/10,23.33%,CRMP1;OPLAH;DPYSL3
prerank,U6 snRNA binding (GO:0017070),0.27108884200698385,0.6065841618397145,0.9324522760646109,0.9725860390726134,1.0,8/14,31.05%,PRPF8;LARP7;RBM22;EIF5A;LSM8;LSM4;METTL16;TUT1
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.2318581742462913,0.6009640201347946,0.9610062893081761,0.972021331785506,1.0,11/34,23.59%,NDUFS8;NDUFA10;NDUFC1;NDUFB6;NDUFS6;NDUFS1;NDUFS3;NDUFB4;NDUFB8;NDUFB9;NDUFA13
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.2318581742462913,0.6009640201347946,0.9610062893081761,0.972021331785506,1.0,11/34,23.59%,NDUFS8;NDUFA10;NDUFC1;NDUFB6;NDUFS6;NDUFS1;NDUFS3;NDUFB4;NDUFB8;NDUFB9;NDUFA13
prerank,ankyrin binding (GO:0030506),0.25489362180369707,0.5980619092256212,0.9258241758241759,0.971898766404995,1.0,3/19,21.13%,SLC8A1;PLEC;PTPRC
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.2384172277470525,-0.585621017418604,0.9398280802292264,1.0,1.0,4/11,17.80%,APLF;NEIL2;NEIL3;HMCES
prerank,steroid hydroxylase activity (GO:0008395),-0.20355455567093622,-0.5815198932649288,0.9686411149825784,1.0,1.0,6/16,38.33%,CYP7B1;CH25H;CYP2U1;CYP1A1;CYP2R1;CYP1B1
prerank,leak channel activity (GO:0022840),0.24499120272763386,0.5726225703904186,0.9404432132963989,0.9832335450337164,1.0,2/18,12.62%,KCNK13;KCNK4
prerank,titin binding (GO:0031432),0.2604231252252812,0.5698159644889552,0.9340175953079178,0.9826621438351706,1.0,3/13,19.19%,MYBPC3;MYBPC1;CALM2
prerank,hormone activity (GO:0005179),0.2023736197775592,0.5693373569609772,0.9873853211009175,0.9809167906512369,1.0,3/54,9.23%,IGF1;METRNL;TRH
prerank,pseudouridine synthase activity (GO:0009982),-0.2160642436654089,-0.5638506117112123,0.9819277108433735,1.0,1.0,3/13,18.29%,PUS7;TRUB2;RPUSD4
prerank,nucleosomal DNA binding (GO:0031492),0.23325579122702017,0.56283915875675,0.9695290858725761,0.9818244274037927,1.0,9/21,28.77%,SMARCC1;SMARCB1;MBD2;SMARCE1;SMARCD2;ACTB;HDAC1;SMARCA4;HNRNPC
prerank,CXCR chemokine receptor binding (GO:0045236),0.2598862590646389,0.5612109988626071,0.9556962025316456,0.9806138895949426,1.0,1/11,14.71%,CXCL12
prerank,ATPase activator activity (GO:0001671),0.23118036405218806,0.5522862760616097,0.9560439560439561,0.9823791823609967,1.0,2/20,8.19%,DNAJB6;MYBPC3
prerank,protein phosphatase activator activity (GO:0072542),-0.20822241595946755,-0.5514946795001108,0.9804560260586319,1.0,1.0,5/13,24.58%,B3GAT3;PPP2R5D;PPP2R5A;PPP2R5B;CALM3
prerank,calcium channel inhibitor activity (GO:0019855),0.2586925636160811,0.5475545794078399,0.96875,0.9822723139347412,1.0,3/11,22.37%,CALM2;SLC30A1;FKBP1A
prerank,mechanosensitive ion channel activity (GO:0008381),0.25256039787877815,0.5467652349809684,0.9492537313432836,0.9806384604131012,1.0,2/12,11.82%,PIEZO1;PIEZO2
prerank,nucleoside-diphosphatase activity (GO:0017110),0.24733586709381017,0.5460782586370595,0.9501424501424501,0.9789614835843312,1.0,2/12,14.55%,ENTPD1;SLC25A42
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",-0.20187306270997646,-0.5457268179440491,0.9864864864864865,0.9966125130417918,1.0,2/14,5.26%,NFU1;ACO2
prerank,adenylate cyclase binding (GO:0008179),-0.22380214310420188,-0.5354939525331909,0.9670658682634731,0.9938525481641951,1.0,4/10,24.58%,AKAP12;AKAP5;ADCY2;CALM3
prerank,ribonuclease P activity (GO:0004526),-0.21355311625813314,-0.5347277532886611,0.9649122807017544,0.9884787236563448,1.0,5/11,27.26%,RPP14;RPP30;RPP38;POP5;POP7
prerank,SUMO binding (GO:0032183),0.22558264146809193,0.49456385699054317,0.9840116279069767,0.9913889042417197,1.0,3/13,18.47%,SERBP1;USPL1;SIMC1
prerank,hormone receptor binding (GO:0051427),-0.18577348066298344,-0.4909998782935102,0.993127147766323,0.9923672078081318,1.0,14/14,81.45%,ADCYAP1;CCK;JAK1;PTHLH;VIP;NPPA;GHRH;GPHA2;NPPB;TYK2;NPPC;SOCS2;JAK2;NCOA6
prerank,phosphate ion binding (GO:0042301),0.2259301210528039,0.46637982438690484,0.9893129770992366,0.9943173025553722,1.0,3/10,25.20%,RELA;ADSS1;ADSS2
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.21585425525358046,0.450527726822752,0.9923780487804879,0.9944344254841936,1.0,2/11,21.68%,SLC25A20;SLC22A5
